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ABSTRACT

One aspectt oI
of une
th presentt i1nvenuon
ti
lates to
relates
to isolated
1solate

nucleic acid molecules encoding avirulence proteins or

polypeptides of Pseudomonas Syringae pv. Syringae DC

3000, or nucleic acid molecules which are complementary

thereto. Expression vectors, host cells, and transgenic plants
which include the DNA molecules of the present invention
are also disclosed. Another aspect relates to the isolated

proteins or polypeptides and compositions containing the

same. The various nucleic acid molecules and proteins of the
present invention can be used to impart disease resistance to
a plant, make a plant hypersusceptible to colonization by
nonpathogenic bacteria, modify a metabolic pathway in a
cell, cause eukaryotic cell death and treat a cancerous

condition, as well as inhibit programmed cell death.
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1.
PSEUDOMONAS AVR AND HOP PROTEINS,
THEIR ENCODING NUCLEIC ACIDS, AND
USE THEREOF

This application claims benefit of U.S. Provisional Patent
Application Ser. Nos. 60/356,408, filed Feb. 12, 2002, and
60/380,185, filed May 10, 2002, each of which is hereby
incorporated by reference in its entirety.
This work was supported by National Science Foundation
Grant Nos. MCB-9982646 and IBN-0096348, National Sci

ence Foundation Plant Genome Research Program Coop
erative Agreement DBI-0077622, and National Research
Initiative Competitive Grants Program, U.S. Department of
Agriculture, Grant No. 01-35319-10019. The U.S. Govern
ment may have certain rights in this invention.
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FIELD OF THE INVENTION

The present invention relates to isolated DNA molecules
corresponding to the open reading frames of Pseudomonas
syringae pv. tomato DC3000, the isolated avirulence effector
proteins and hrp-dependent outer proteins encoded thereby,
as well as their various uses.
25

BACKGROUND OF THE INVENTION

The plant pathogenic bacterium Pseudomonas Syringae is
noted for its diverse and host-specific interactions with
plants. A specific strain may be assigned to one of at least 40
pathovars based on its host range among different plant
species and then further assigned to a race based on differ
ential interactions among cultivars of the host. In host plants
the bacteria typically grow to high population levels in leaf
intercellular spaces and then produce necrotic lesions. In
nonhost plants or in host plants with race-specific resistance,
the bacteria elicit the hypersensitive response (HR), a rapid,
defense-associated programmed death of plant cells in con
tact with the pathogen (Alfano & Collmer, J. Bacteriol.
179:5655–5662 (1997)). The ability to produce either of
these reactions in plants appears to be directed by hrp (HR
and pathogenicity) and hrc (HR and conserved) genes that
encode a type III protein secretion pathway and by avr (avi
rulence) and hop (Hrp-dependent outer protein) genes that
encode effector proteins injected into plant cells by the
pathway (Alfano & Collmer, J. Bacteriol. 179:5655–5662
(1997)). These effectors may also betray the parasite to the
HR-triggering R-gene Surveillance system of potential hosts
(hence the avr designation), and plant breeding for resistance
based on Such gene-for-gene (avr-R) interactions may pro
duce complex combinations of races and differential culti
vars (Keen, Annu. Rev. Genet. 24:447 463 (1990)). hrp/hrc
genes are probably universal among necrosis-causing gram
negative plant pathogens, and they have been sequenced in
P. syringae pv. Syringae (Psy) 61, Erwinia amylovora
Ea321, Xanthomonas Campestris pv. vesicatoria (Xcv)
85-10, and Ralstonia Solanacearum GMI1000 (Alfano &
Collmer, J. Bacteriol. 179:5655–5662 (1997)). Based on
their distinct gene arrangements and regulatory components,
the hrp/hrc gene clusters of these four bacteria can be
divided into two groups: I (Pseudomonas and Erwinia) and
II (Xanthomonas and Ralstonia). The discrepancy between
the distribution of these groups and the phylogeny of the
bacteria provides some evidence that hrpf.hrc gene clusters
have been horizontally acquired and, therefore, may repre
sent pathogenicity islands (Pais) (Alfano & Collmer, J.
Bacteriol. 179:5655–5662 (1997)).
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Virulence effector proteins delivered to or into host cells
by type III secretion systems are key factors in the patho
genicity of many bacteria, including animal pathogens in the
genera Salmonella, Yersinia, Shigella, and Escherichia, and
plant pathogens in the genera Pseudomonas, Erwinia, Xan
thomonas, Ralstonia, and Pantoea (Galán & Collmer, Sci
ence 284:1322–1328 (1999)). In plant pathogens, the type
III secretion machinery is referred to as the hypersensitive
response and pathogenicity (Hrp) system because secretion
mutants typically lose their ability to elicit the defense
associated hyperSensitive response in nonhost plants and to
grow parasitically or be pathogenic in host plants (Alfano &
Collmer, J. Bacteriol. 179:5655–5662 (1997)). These phe
notypes demonstrate the importance of the Hrp system in
bacterium-plant interactions, and global identification of
effectors will be important for understanding the pathogen
esis of bacteria that use type III secretion systems. Unfor
tunately, several factors have hindered searches for type III
effector genes. These factors include: (i) effectors are often
redundant with mutants having only Subtle phenotypes; (ii)
with few exceptions (see e.g., Miao & Miller, Proc. Natl.
Acad. Sci. USA 97:7539–7544 (2000)) motifs that can
identify proteins as substrates for type III secretion have not
been recognized (Lloyd et al., Mol. Microbiol. 39:520–523)
(2001); (iii) many effectors show no similarity to known
proteins; and (iv) some pathogens have multiple type III
secretion systems which deliver different sets of effectors
(Cornelis & Van Gijsegem, Annu. Rev. Microbiol.
54:735–774 (2000)). Thus, a complete inventory of type III
effector genes is lacking for any pathogen, although it seems
that pathogens such as Salmonella may have many such
genes (Worley et al., Mol. Microbiol. 36:749 761 (2000)).
Plant pathogen type III effector proteins are mostly des
ignated AVr or Hop, depending on whether their primary
phenotype involves plant reaction or secretion behavior.
Many effectors were initially discovered through their abil
ity to betray the pathogen to the host R (resistance) gene
Surveillance system, thereby rendering the pathogen aviru
lent on a test plant (Keen, Annu. Rev. Genet. 24:447 463
(1990)). Over 25 effector genes have been identified by Avr
or Hop phenotypes in various P. syringae pathovars and
races (Vivian & Arnold, J. Plant Pathol. 82:163–178 (2000);
Alfano et al., Proc. Natl. Acad. Sci. USA 97:4856–4861

45

50

55

60

65

(2000)). The encoded effectors seem to determine both basic
pathogenicity and host range, but the number of Such
proteins produced by any single strain has not been system
atically investigated. P. S. tomato DC3000 is known to carry
at least three avr genes, avrPto (Ronald et al., J. Bacteriol.
174:1604–1611 (1992)), avrPtoB (Kim et al., Cell 109:
589–598 (2002)), and avrE (Lorang & Keen, Mol. Plant
Microbe Interact. 8:49–57 (1995)), with the latter being in
the Hrp pathogenicity island along with five other candidate
effector genes (Alfano et al., Proc. Natl. Acad. Sci. USA
97:4856–486 (2000); Lorang & Keen, Mol. Plant-Microbe
Interact. 8:49–57 (1995)).
The present invention is a further advance in the effort to
identify, clone, and sequence AVr and Hop proteins or
polypeptides from plant pathogens.
SUMMARY OF THE INVENTION

One aspect of the present invention relates to an isolated
nucleic acid molecule that includes a nucleotide sequence
which (i) encodes a protein or polypeptide having the amino
acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID
NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12,
SEQID NO: 14, SEQID NO: 16, SEQID NO: 18, SEQ ID

US 7,220,583 B2
4
invention into cancer cells of a patient under conditions
effective to cause death of cancer cells, thereby treating the

3
NO: 20, SEQID NO: 22, SEQID NO: 24, SEQID NO:26,
SEQID NO: 28, SEQ ID NO:30, SEQID NO:32, SEQ ID
NO:34, SEQID NO:36, SEQID NO:38, SEQID NO:40,
SEQID NO:42, SEQID NO: 44, SEQID NO:46, SEQ ID
NO:48, SEQID NO:50, SEQID NO:52, SEQID NO:54,
SEQID NO:56, SEQ ID NO:58, SEQID NO: 60, SEQ ID
NO: 62, SEQID NO: 64, SEQID NO: 66, SEQID NO: 68,
SEQID NO: 70, SEQ ID NO: 72, SEQID NO: 74, SEQ ID
NO: 76, SEQID NO: 78, SEQID NO:80, SEQID NO: 82,
SEQID NO: 84, SEQ ID NO: 86, SEQID NO: 88, SEQ ID
NO:90, SEQID NO: 92, SEQID NO: 94, SEQID NO: 96,
SEQ ID NO: 98, SEQ ID NO: 100, SEQ ID NO: 102, SEQ
ID NO: 104, SEQ ID NO: 106, SEQ ID NO: 108, SEQ ID
NO: 110, SEQID NO: 112, SEQ ID NO: 114, SEQID NO:
116, SEQ ID NO: 118, SEQID NO: 120, SEQID NO: 122,
SEQ ID NO: 124, SEQ ID NO: 126, or SEQ ID NO: 209;
or (ii) hybridizes, under stringency conditions comprising a
hybridization medium which includes 0.9xSSC at a tem
perature of 42°C., to a DNA molecule complementary to
SEQID NO: 1, SEQID NO:3, SEQID NO:5, SEQID NO:
7, SEQ ID NO:9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ
ID NO: 15, SEQ ID NO: 17, SEQID NO: 19, SEQID NO:
21, OR SEQ ID NO. 23, SEQ ID NO: 25, SEQ ID NO: 27,
SEQID NO: 29, SEQ ID NO:31, SEQID NO:33, SEQ ID
NO:35, SEQID NO:37, SEQID NO:39, SEQID NO:41,
SEQID NO:43, SEQ ID NO:45, SEQID NO:47, SEQ ID
NO:49, SEQID NO:51, SEQID NO:53, SEQID NO:55,
SEQID NO:57, SEQ ID NO. 59, SEQID NO: 61, SEQ ID
NO: 63, SEQID NO: 65, SEQID NO: 67, SEQID NO: 69,
SEQID NO: 71, SEQ ID NO: 73, SEQID NO: 75, SEQ ID
NO: 77, SEQID NO: 79, SEQID NO: 81, SEQID NO: 83,
SEQID NO: 85, SEQID NO: 87, SEQID NO: 89, SEQID
NO: 91, SEQID NO: 93, SEQID NO:95, SEQID NO: 97,
SEQ ID NO: 99, SEQ ID NO: 101, SEQ ID NO: 103, SEQ
ID NO: 105, SEQ ID NO: 107, SEQ ID NO: 109, SEQ ID
NO: 111, SEQID NO: 113, SEQID NO: 115, SEQ ID NO:
117, SEQID NO: 119, SEQID NO: 121, SEQID NO: 123,
or SEQID NO. 208; or (iii) is complementary to the nucleic
acid molecules of (i) and (ii). Expression vectors, host cells,
and transgenic plants which include the DNA molecules of
the present invention are also disclosed. Methods of making
Such host cells and transgenic plant are disclosed.
A further aspect of the present invention relates to isolated
effector proteins or polypeptides encoded by the nucleic acid
molecules of the present invention. Compositions which
contain the proteins or polypeptides are also disclosed.
Yet another aspect of the present invention relates to
methods of imparting disease resistance to a plant. Accord
ing to one approach, this method is carried out by trans
forming a plant cell with a heterologous DNA molecule of
the present invention and regenerating a transgenic plant
from the transformed plant cell, wherein the transgenic plant
expresses the heterologous DNA molecule under conditions
effective to impart disease resistance. According to another
approach, this method is carried out by treating a plant with
a protein or polypeptide of the present invention under
conditions effective to impart disease resistance to the
treated plant.
A further aspect of the present invention relates to a
method of causing eukaryotic cell death which includes:
introducing into a eukaryotic cell a cytotoxic Pseudomonas
protein of the present invention, said introducing being
performed under conditions effective to cause cell death.
A still further aspect of the present invention relates to a
method of treating a cancerous condition which includes
introducing a cytotoxic Pseudomonas protein of the present

cancerous condition.
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Yet another aspect of the present invention relates to a
method of inhibiting programmed cell death which includes
introducing into a eukaryotic cell Susceptible to programmed
cell death, a protein of the present invention that is a
hypersensitive response Suppressor, said introducing being
performed under conditions effective to inhibit programmed
cell death of the eukaryotic cell.
Yet another aspect of the present invention relates to a
method of modifying a metabolic pathway in a cell which
includes: introducing into a cell a protein or polypeptide of
the present invention which interacts with a native cellular
protein involved in a metabolic pathway, wherein the protein
or polypeptide modifies the metabolic pathway through its
interaction with the native cellular protein.
It is believed that bacteria have evolved effector proteins
to make exquisite alterations in host metabolism. While
plant disease resistance, Suppression of programmed cell
death, and cancer cell toxicity are important uses, as men
tioned above, it is believed that these effector proteins can be
used to modify or effect metabolic targets in eukaryotes,
including both yeasts and higher order species, such as
plants and animals. It is noteworthy that several of the
effector proteins disclosed herein have homologs in other
phytopathogenic bacteria. Thus, these proteins appear to
represent a set of effectors that are conserved among
Pseudomonas, Erwinia, Xanthomonas, and Ralstonia spp.
By disrupting or augmenting the function of these effectors
through, for example, transgenic expression thereof in a host
plant, it is believed that use of these effectors may lead to
widely applicable means for controlling diseases of plants.
BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A–C illustrate assays for Hrp system-dependent
secretion in culture or translocation in planta of candidate
effector proteins. P. S. tomato DC3000 and a Hrp secretion
mutant derivative were used for tests of newly identified
candidate effectors (1A–B). DC3000 or a DC3000 hrcC
mutant (Yuan & He, J. Bacteriol. 178:6399–6402 (1996),
which is hereby incorporated by reference in its entirety)
carrying test ORFs (i.e., candidate effectors) fused to either
the FLAG (F) or hemagglutinin (HA) epitopes were grown
in Hrp-inducing media, and cultures were separated into cell
(lanes 1-3) and Supernatant (lanes 4 and 5) fractions and
analyzed by SDS/PAGE and immunobloting. Lanes 1 and 4.
wild-type DC3000; lanes 2 and5, wild-type DC3000 (pTest
ORF); lanes 3 and 6, DC3000 hrcC mutant (pTestORF). As
an additional control against leakage, pCPP2318 was
included in all strains, which encodes the mature form of

55
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B-lactamase (B-lac). The presence of an epitope-tagged
protein in the supernatant fraction of the wild type (lane 5),
but absence in the hrcC secretion mutant (lane 6), indicated
that the test ORF encoded a secreted product. In FIG. 1C, an
AvrRpt2 translocation assay was performed with DC3000
HopPtoG. Test strains were infiltrated into A. thaliana Col-0
(RPS2) and Col-0 rps2-201 (rps2) plants. Plant responses
were scored 18 h after inoculation for hypersensitive
response (HR) or no visible response (N).
FIGS. 2A–C illustrate pHIR11-dependent HR is sup
pressed by HopPtoE, and a P. S. tomato DC3000 hopPtoE
mutant exhibits an enhanced HR. FIG. 2A is a schematic

65

representation of the pHIR11-based suppression assay in P.
fluorescens (Pf)55. When DC3000 effectors are individually
expressed in trans in Pf(pHIR 11), they can potentially

US 7,220,583 B2
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(noted above each picture). Complete suppression of the HR
is denoted with N. FIG. 4C is an image of the same strains
(as illustrated in FIG. 4B) infiltrated into Arabidopsis WS-0.
producing identical results.
FIGS. 5A-B illustrate that the HR elicited by HopPsyA
can be suppressed via Agrobacterium transient expression of

5
suppress the HopPsyA-dependent HR. FIG. 2B shows N.
tabacum cv. xanthi leaves that were infiltrated with

Pf(pHIR11) (left panel) or Pf(pHIR11, phopPtoE)(right
panel). N denotes no HR. FIG. 2C shows quantitative
differences in the ability of DC3000 wild-type (WT), hopP
toE mutant UNL139, and complemented mutant UNL 139
(phopPtoE) to elicit the HR in N. tabacum cv. xanthi leaves.

effectors. In FIG. 5A, N. tabacum cv. xanthi leaves were

Different dilutions of bacterial cells/ml (1, 10 cells/ml; 2.
107 cells/ml: 3, 10° cells/ml; and 4, 10 cells/ml) were

infiltrated into leaves, then leaves were photographed after

10

24 hr.

FIGS. 3A-C illustrate that HR suppression is not due to
blocking TTSS, and the TTSS is functional. FIG. 3A is an
image of an immunoblot showing that AvrPto is type III
secreted from DC3000 (WT), but not from a secretionde
fective DC3000 hrcC mutant (hrcC). B-Lactamase (B-Lac)
was used as a lysis control. C. cell pellet fractions; S.
Supernatant fractions. FIG. 3B is an image showing that the
HR elicited in N. tabacum cv. xanthi by DC3000 is inhibited
when hopPtoE is expressed in trans. FIG. 3C shows the
results of Pfluorescens(pHIR11) mixing experiments in N.
tabacum cv. Xanthi, demonstrating that HR Suppression can
occur when HopPtoE and HopPsyA are TTSS-delivered by
different bacteria. pl. N18 is a pHIR11 derivative that lacks
hopPsyA, but encodes a functional TTSS. pCPP2089
(Huang et al., Mol. Plant-Microbe Interact. 4:469-476
(1991), which is hereby incorporated by reference in its
entirety) is a pHIR11 derivative encoding a defective TTSS.
FIGS. 4A-C identify P. S. tomato DC3000 effectors that
suppress the HR on tobacco and Arabidopsis. FIG. 4A lists
DC3000 effectors that were tested in the pHIR11 assay. A y
indicates that the effector inhibited the HR, an ‘n’ indicates
that it did not, and a y indicates that it partially suppressed

15

diluted from 10 cells/ml. The last dilution (10 cells/ml) that
resulted in an HR is shown. In all cases, the mutants exhibit

25

30

the HR. Refer to the Materials and Methods for information

regarding effector constructs. The nucleic acid and amino
acid sequences of AvrPphE, AvrPpiB1, HopPtoB,
HopPtoC, HopPtoD1, HopPtoD2, HopPtoF (previously des
ignated AvrPphF ORF2), HopPtol, and HopPtoK are
disclosed in U.S. patent application Ser. No. 09/825,414 to
Collmer et al., filed Apr. 2, 2002, which is hereby incorpo
rated by reference in its entirety. The nucleic acid and amino
acid sequence of AVrPto is reported at Genbank Accession

35

40

L20425; Salmeron & Staskawicz, Mol. Gen. Genet. 239:

6–16 (1993), each of which is hereby incorporated by
reference in its entirety. The nucleic acid and amino acid
sequence of AvrPtoB is reported at Genbank Accession
AY074795 and Kim et al., Cell 109:589–598 (2002), each of
which is hereby incorporated by reference in its entirety.
AvrPtoB was independently shown to suppress the pro
grammed cell death elicited by AvrPto or by heterologously
expressed BAX in Nicotiana benthamiana (Abramovitch et
al., EMBO.J. 22:60–69 (2003), which is hereby incorporated
by reference in its entirety). FIG. 4B is an image of N.

co-infiltrated with A. tumefaciens C58C1 carrying
phopPsyA and another strain carrying each candidate Sup
pressor. All of the suppressive effectors identified in the
pHIR11 screen also suppressed the HR elicited by HopPsyA
in this test. In FIG. 5B, an immunoblot of plant tissues with
different agroinfiltrations shows that each HA epitope
tagged effector was made in planta. The asterisks indicates
a protein of the predicted size of the effector in that lane.
FIG. 6 is an image showing that Pseudomonas syringae
pv. tomato DC3000 suppressor mutants display an enhanced
ability to elicit the HR. N. tabacum cv. xanthi leaves were
infiltrated with P. syringae strains that were 10-fold serially

45

more HR at this dilution than the wild type, and this
phenotype was complemented when the Suppressors were
provided in trans. The following strains were infiltrated:
DC3000 wild type, WT: avrPphEPto mutant, UNL113:
avrPpiB1Pto mutant, UNL114; avrPtoB mutant, UNL127:
hopPtoF mutant, UNL109; hopPtoG mutant, UNL124. HR
was scored for each sample: spotty HR (HR-); strong HR
(HR+); or no HR.
FIGS. 7A-B illustrate that Pseudomonas Syringae pv.
tomato DC3000 HR suppressors inhibit the PCD initiated by
Bax in plants and yeast. In FIG. 7A, Agrobacterium C58C1
strains carrying binary vectors that encode Bax or a specific
effector were co-infiltrated into N. benthamiana leaves.

Leaves were photographed after 7 days. N* indicates that the
HR was nearly absent. Effector constructs were the same as
in FIG. 4. In FIG. 7B, yeast strain EGY48 carrying plasmids
that encoded for Bax (p.G4-5-Bax) and a specific effector
were spotted on plates at 5-fold dilutions. Expression of Bax
was induced by galactose, whereas effector expression was
constitutive. Only AVrPpiB1 was unable to suppress Bax
induced killing. Bcl-XL (pGilda-Bcl-XL), an animal protein
known to inhibit Bax-induced PCD, was used as a positive
control.
DETAILED DESCRIPTION OF THE
INVENTION

tabacum cv. xanthi leaves that were infiltrated with P.

One aspect of the present invention relates to Pseudomo
nas Syringae pv. Syringae DC 3000 nucleic acid molecules
which encode Avr or Hop effector proteins.
A first nucleic acid molecule encodes HopPtol (ORF1)
and has a nucleotide sequence according to SEQ ID NO: 1

fluorescens(pHIR11) with different effector constructs

as follows:

50

atgcttatcggg cacagottgcatcacatgc gacccactgctgtggattotagoctaccaact tcc.gca
actagoc agacitatcago: aataccaaaagtcggctggat.ccgcatcgtgtc.cgtgaacttacattcatc
ggagtgggtag tagtgttgcctacct act caatgagcttaatgg to gotttgcc.gatagoggggtaa.ca
acgcc gtttittaggaaaagttcagtattgtaggcaaggacgactcittgggcc.gagaatgttcgtgggaaa
ggittatattalaccaccagacitgaaattataagccaatgg gaccaac aggttccaaaatatgatcc taac
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HopPtol has been shown to be a protein that is secreted by

10

DC3OOO.

A second nucleic acid molecule encodes HopPtoH
(ORF2) and has a nucleotide sequence according to SEQID
NO:3 as follows:

atgatcactc.cgtotcg at atcCaggcatctatato gocc cccitcagtaac galaccgacago agcticac
acatttaaagaacaagcagaggaag cacttgaccatat cagogcc.gcacccitctgg.cgataagctattg
cgaaaaat atcc actottgc.cagtcaaaaagatagaaaagttcacgctaaaagagattgaaataaataac
cagtgttataccgaagctgttctgagcagraggcaactggaaaagtacgaaccagaaaactittaac gag
aaccgg cacattgcatcacagot atcacgaaagggg acctttaccalaaggtgaaggaa.gcaacg.cgatt
attggctggtoaccagacaaagcaa.gcatacgcttaaatcagaatggct caccgttacaccittggaatg
gataacgacgacaaaatcacg accotagotcatcagctic gttcatgctogacatgtgttaggtogcago
to cittagoggatgg.cggagat.cgctataatccacgtacgg gatctggcaaagaggaacttagg gcc gtt
ggattagataagtaccgctatto acttacaaaaaaaccgtcagagaacticcatcc.gagctgaac acggc
citgc citctg.cgcatcaagtacaggg cacatcaatag
25

The HopPtoH protein encoded by this nucleic acid molecule
has an amino acid sequence according to SEQID NO. 4 as
follows:

MITPSRYPGIYIAPLSNEPTAAHTFKEQAEEALDHISAAPSGDKLLRKISTLASQKDRKVTLKEIEINN
QCYTEAWLSRRQLEKYEPENFNENRHIASQLSRKGTFTKGEGSNAIIGWSPDKASIRLNQNGSPLHLGM
DNDDKITTLAHELWHARHWLGGSSLADGGDRYNPRTGSGKEELRAWGLDKYRYSLTKKPSENSIRAEHG

LPLRMKYRAHQ

HopPtoH has been shown to be a protein that is secreted by CAC16702, each of which is hereby incorporated by refer
DC3000. HopPtoH has significant homology (1e-114), as "ence in its entirety.
detected by BLAST search, to ORF3 from Pseudomonas
A third nucleic acid molecule encodes HopPtoE (ORF3)
syringae pv. pisi avrPpiC2 locus (Arnold et al., Microbiol- and has a nucleotide sequence according to SEQ ID NO: 5
ogy 147:1171–1182 (2001); GenBank Accession No.

as follows:

atgaatagagtttcc.ggtag citcgtoag.cgacittggcaggcagt caac gatcttgttggagcaagtaagc
gag agaaccacgttgtctacgacaggittatcagacggcaatgggcc.gcttgaacaaaccggaaaaatca
gatgcggatgcgctgatgacitatgaggaggg.cgcaa.cagtacacggatagogcgaag.cgaacttatatt
toggaaacgct gatgaatctgg cagatttgcagoaaaggaaaatctatogcacca acagogggaacttg
cgtgg.cgcgattgagatgacgccitacgcaactcacagattgcgtacagaagit gcc.gc galagaggggttc
to caattgttgacatacaggcgctdgaaatcggcttgcaccitt.cgacataagttaggaatctoagatttic
accatctacagoa accgtaagttaa.gc.catalactatotgg to atccaccc.ca.gcaatgcatttcc gaaa
ggagc gattgtag act cittggacgggacagggcgtggtggagctgg acttcaag acco gattgaaattic
aag caccgggaag agaactacgcagtgaacgc.caatatgcacgagtggat.cgagagatacggccaag.cg
catgtgattgactga

US 7,220,583 B2
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The HopPtoE protein encoded by this nucleic acid molecule
has an amino acid sequence according to SEQID NO: 6 as
follows:

MNRWSGSSSATWQAVNDLVEQVSERTTLSTTGYOTAMGRLNKPEKSDADALMTMRRAQQYTDSAKRTYI
SETLMNLADLQQRKIYRTNSGNLRGAIEMTPTOLTDCVOKCREEGFSNCDIQALEIGLHLRHKLGISDF
TIYSNRKLSHNYWWIHPSNAFPKGAIVDSWTGQGWWELDFKTRLKFKHREENYAVNANMHEWIERYGQA
HWID

HopPtoE has been shown to be a protein that is secreted by
DC3000 as well as translocated in planta.

15

A fourth nucleic acid molecule encodes HopPtoG (ORF4)
and has a nucleotide sequence according to SEQ ID NO: 7
as follows:

atgcaaataaagaacagtcatctotattoagcttcaagaatggtgcagaatacttittaatgc citcgc.ct
aagatggaagtaactaatgcaatagoaaaaaataatgaacct gctg.cgctgag cqctacgcaaactgca
aag acacacgaaggcgattcaaaaggccaatccago: aataactictaaattgcc citt.ccgc.gc.catgagg
tacgctgcataccttgcaggcag cqcctacctctacgataaaactg.ccaataattitttittctittctacc
acttct citgcatgatggcaaaggtogttttaccago gatgccaggcttaac gatgcacaagataaag.cg
cgaaag.cgctaccaaaacaac catagoagc actottgaaaataaaaacticgcttittaa.gc.ccgcttagg
citttgcggagagaatcagttcttaacgatgattgattatcgtgcagdaactaagatttacct citcc gac
citagttgacacggagcaa.gc.gcacacatcaattctgaagaatattatgtgcctgaaaggtgagcttacc
aatgaagaggcaataaaaaaactica accoggaaaaaacaccaaaagacitat gaccttacaaatago gaa
gcctatataagcaagaacaaatattotttgaccggc gttaaaaatgaggagacgggat.ct acto gttat
acatctogttctato acaaagcc atttgttggaaaaaggcc toaaacactittataaaag.cgacitcatggc
gaaaaagctotcacgcc caag cagtgitatggaaact cittgata acttactt.cgaaaaagtat cacgcto
aacagtgatticc caattic.gcago aggc.caggc acttittggttittcagacaggtotato.cgggtogalagac
gcttggggggatgcggaacgggtoatattgaaaag.ccattataatcggggc actogtactic caagatgaa
gctgataaaatagalactaagtagg.ccgttctgaga.gcaagatttagcaaagaacatgtttaa gaggaat
accago attgcagg gcc agtgct citaccacgcatatatttatatacaagaaaaaatcttcaagctaccc
cc.cgacaaaatagaagatttgaaacataaatcaatggcag acttgaaaaacct gcc tittgacticatgtt
aagcttagcaattic.cggtgtgggatttgaagacgc.citcagggittaggagacitcgtttacagotcitcaac
gc gacgtoctotgttaatcacgcaagaataatgagtggtogagcct cocittgtcaaaagatgatgttgttg
attctgataggttgcct caacgc.cgtatacgacaattic gag.cggaataagg cattctotcc.gc.gaaatt
gcac gagggtgctttgttgggtgctggttttacgg to caggacggtgacg acttctacaaacagatctgc
aaaaacgc.ctictaag cagttttacaacggctaa

The HopPtoG protein encoded by this nucleic acid molecule
has an amino acid sequence according to SEQ ID NO: 8 as
follows:

MQIKNSHLYSASRMVONTFNASPKMEWTNAIAKNNEPAALSATOTAKTHEGDSKGOSSNNSKLPFRAMR
YAAYLAGSAYLYDKTANNFFLSTTSLHDGKGGFTSDARLNDAQDKARKRYONNHSSTLENKNSLLSPLR
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-continued
LCGENQFLTMIDYRAATKIYLSDLVDTEQAHTSILKNIMCLKGELTNEEAIKKLNPEKTPKDYDLTNSE
AYISKNKYSLTGVKNEETGSTGYTSRSITKPFWEKGLKHFIKATHGEKALTPKQCMETLDNLLRKSITL
NSDSQFAAGOALLVFRQWYAGEDAWGDAERVILKSHYNRGTVLQDEADKIELSRPFSEQDLAKNMFKRN
TSIAGPWLYHAYIYIQEKIFKLPPDKIEDLKHKSMADLKNLPLTHWKLSNSGWGFEDASGLGDSFTALN
ATSCVNHARIMSGEPPLSKDDWWILIGCLNAVYDNSSGIRHSLREIARGCFVGAGFTVQDGDDFYKQIC
KNASKOFYNG

HopPtoG has been shown to be a protein that is secreted by
DC3000 as well as translocated in planta by recombinant
Pseudomonas syringae pv. pisi. Thus, HopPtoG appears to
be a Hrp-injected effector protein. HopPtoG has significant
homology, as detected by BLAST search (1e-137), to a
hypothetical protein of Ralstonia Solanacearum (see Gen
Bank Accession No. NP 521884, which is hereby incorpo
rated by reference in its entirety).
A fifth nucleic acid molecule encodes HopPtoS1 (ORF5)
and has a nucleotide sequence according to SEQ ID NO: 9

15

as follows:

Chem. 269:27451–27457 (1994); GenBank Accession No.
P55807, each of which is hereby incorporated by reference
in its entirety), as well as significant homology to a type
III-secreted ADP-ribosyltransferase from P. aeruginosa
(Yahr et al., Mol. Microbiol. 22:991–1003 (1996), which is
hereby incorporated by reference in its entirety). Further
confirming its similarity to ADP-ribosyltransferases, HopP
toS1 has been determined to possess an ART domain
(pfam1129).

atgggtaatatttgtgg tactitctggctocaatcatgtgtatagt cogcct attagcc citcaiacatgca
totggttcgtccacaccagtgcc cagtgcttctgggacgatgctttctotcagtcatgaacaaatatta
agcc agaactatoctagoaatataaaggggaaat atc.gcacga accoccgaaaaggaccatctoctagg
citttctgatacgct gatgaag caggcgctgtc.ttcagtgatcacaca agagaaaaag.cgacittaaaagt
caac caaagttcaatagoccaagatattoagccitccaaacagoatgatcaaaaatgcacttgatgaaaaa
gacago cacccttittggtgattgcttittcagacgatgaatttcttgc gatcCatctotatacgagttgt
citttacagaccgatcaiaccatcatctg.cgg tatgcc.ccgaaaaatgatgtc.gc.gc.ctdttgttggaggca
atgaatagoggtttggccaaacttgct caataccct gattatcaggtgtctggtoagctgcatagaggc
atcaa.gcaaaagatggatgatggtgaagttatgagtc.gcttcaag.ccgggtaatacittatcgtgatgac
gc gttcatgageac atcgacitagaatggatgttacagaagaatttactitcc gatgtcacgttacatctg
cagticcitcatcago.cgtcaatataggtoccittittcaaaaaaccoatacgaggacgaag.cgct catc.ccg.
cc cctoacgc.ctttcaaagta accq gttctgcacaag caggacgataggtgg cacgtcc acttgaac gag
atc.gcagaga.gctotgacgagtga

The HopPtoS1 protein encoded by this nucleic acid mol
ecule has an amino acid sequence according to SEQID NO:

nucleotide sequence according to SEQ ID NO: 11 as fol

10 as follows:

lows:

A sixth nucleic acid molecule encodes ORF6 and has a

MGNICGTSGSNHWYSPPISPQHASGSSTPWPSASGTMLSLSHEQILSONYASNIKGKYRTNPRKGPSPR
LSDTLMKQALSSWITQEKKRLKSQPKSIAQDIQPPNSMIKNALDEKDSHPFGDCFSDDEFLAIHLYTSC
LYRPINHHLRYAPKNDWAPVVEAMNSGLAKLAQYPDYQVSGQLHRGIKQKMDDGEVMSRFKPGNTYRDD
AFMSTSTRMDWTEEFTSDWTLHLQSSSAVNIGPFSKNPYEDEALIPPLTPFKVTGLHKQDDRWHVHLNE
IAESSDE

HopPtoS1 has been shown to be a protein that is secreted by
DC3000 as well as translocated in planta. HopPtoS1 has
significant homology, as detected by BLAST search (1e-5),
to a chicken ADP-ribosyltransferases (Tsuchiya, J. Biol.

atgagcttatc.gc.cgacgctgcaaaagctaactaatatattgggc.ccgac
65

aaaaaatgccaagcctdtcacagaggctatocagtggcaggaagg catgg
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16

-continued

-continued

atataacgctgcatotoag.cggcgacagocttacct tactagotaaaatc

cc.ggggaaacgc.cittitcCaggctg.ccgtgcgc gagctttgc gaagaalacc

atagaactg.cgtacagaccctaaagacgacattittattgcgcaa.gctgct

ggtotggaaaatcto gatctgttgtacctggcggtgtacgagaaaggtoga

tacccatacgtttc.cgggcctg.cgtctg.cgcc.gtgg.cgc.gcttaccatca

gg to acgcactacgtgttcaccactcaggttcct gcctacago gagc citt

accotgatggaagtg.ccctggittittctottatgaacacgattittcaccitt

cgc.cccagaacgagatttctgcctgcaaatggcttgc.gc.ccaaaaatctt

citggacaaag.ccc.gttittgagag cctoctogcca actittgctdaaacggc

10 ggcg accitta aggccagoagcgc gacca aggctatogtoaagtcgitatgg

gcaggagctt.cgagacacagogacacatttitcgttitta actoga

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 12 as
follows:

cc.gc.caggctgaagacggtttacticagogctaac tag

15

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 14 as
follows:

MSLSPTLQKLTNILGPTKNAKPWTEAIQWQEGMDITLHVSGDSLTLLAKI

MKQRATWICKRDGQWLYWRKPKSRWALPGGKIEAGETPFOAAVRELCEET

IELRTDPKDDILLRKLLTHTFPGLRLRRGALTINPDESALWFSYEHDFHL

GLENLDLLYLAVYEKGEWTHYWFTTOWPAYSEPSPONEISACKWLAPKNL
LDKARFEsLLANFAETAQELRDTATHFRFN

GDLKASSATKAIWKSYGRQAEDGLLSAN

Although the protein of SEQ ID NO: 12 possesses N-ter
minal Hop features and features shared by type III chaper
ones, this protein was shown not to be secreted by DC3000.
Because ORF6 is located directly upstream of ORF17
(described infra), it is believed that the protein of SEQ ID
NO: 12 is a type III chaperone for the protein encoded by
ORF17.
A seventh nucleic acid molecule encodes ORF7 and has

25

30

a nucleotide sequence according to SEQ ID NO: 13 as
follows:
atgaaacaac gag.cgacagtcatctgcaaacgtgacggcc aggtgctitta
cgitacgcaaaccaaaatcc.cgctgggctttgc.caggtggcaagattgaag

35

This protein shares significant homology, as detected by
BLAST analysis (3e-7), to MutT mutator of Mesorhizobium
loti (Genbank Accession No. NP 104556, which is hereby
incorporated by reference in its entirety). The protein of
SEQ ID NO: 12 was shown not to be secreted by DC3000.
Although this protein is not secreted, it may still be an
effector protein, because AvrB similarly is not secreted in
culture although it is translocated in planta (see Van Dijk et
al., J. Bacteriol. 181:4790 4797 (1999); Gopalan et al.,
Plant Cell 8:1095-1105 (1996), each of which is hereby
incorporated by reference in its entirety).
An eighth nucleic acid molecule encodes ORF8 and has
a nucleotide sequence according to SEQ ID NO: 15 as
follows:

gtgctic gottttgcatacgt.ca.gc.ct gattagaga.gcagaaattggacatcaaaaaacgttggcc titcc
agtgagcaggagttggtagaagtc.cgacggtttaacaaaaccotc.gc.ccggctg.ccg.cgtttcCaggitt

cgcaatcgcct cacgc.ccc.gcttgattcdgg.cgctgctg.cggg.cggcticagattggtogc.gc.gttgaaa
ccggtoaaacatgacctg.cggattgaaacaaccatcgtoagcaccggtaacgtocct gtttcagtgcga
atcataaggcc caaaggcaaac coaaaggcgtggtgtttgatatto acgg.cggcggttgggtgatcggc
aacgc.ccagatgaacgatgaccitcaatat cqgt atcgittaacgc.gtgcaacgtgg.cggtogtgtc.cgtt
gattacagattggctittatc gaccc.ccg.tc.gaagggctgatggatgactgcttittctgcc.gcatgctgg
citgctgggtag cqact gtaaggagtttgc.cggcctg.ccggittattgtcgtcggtgagtcc.gcggg.cggg
catcttgcc.gcagocactittgctoaaattgaaag.ccaggc.ccgacittgctcaag.cgc.gtag togg cacg
gttctgt attacggcgtgtacgacct gaccgggacaaaaag.cgttcgtaccgcaggc.ccggaaacgctg
gtgctic gacggcc.cgggcatcgtoggcgcaatgcgcttgctogcc.ccggacagaaccgacgagaag.cgc
cgc gagcc.gc.cgittatc.gc.ccttgtatgg.cg acct cacggatctgcc.gc.ccgc.cctgatgtttgtcggc
gaacticga.ccc.gctgctggacgacacgctggaaatggcc gag.cgatggaaaaacticggcagacgttgaa
atgcatcttctg.ccc.gag to tccacatgg gttcatcc actitc.ccgact gccittgg.cgc.gcaagg tactt
gcgc.gcago Cacgagtggataaacgc gaggatggaaggacggCCttaa
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The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 16 as
follows:
WLAFAYWSLIREQKLDIKKRWPSSEQELVEVRRFNKTLARLPRFQWRNRL
TPRLIQALLRAAQIGRALKPWKHDLRIETTIVSTGNWPWSWRIIRPKGKP
KGVWFDIHGGGWWIGNAQMNDDLNIGIVNACNVAWWSWDYRLALSTPVEG
10
LMDDCESAAcWLLGSDCKEFAGLPWIWWGESAGGHLAAATLLKLKARPDL
LKRWWGTWLYYGWYDLTGTKSWRTAGPETLWLDGPGMWGAMRLLAPDRTD
EKRREPPLSPLYGDLTDLPPALMFWGELDPLLDDTLEMAERWKNSADWEM
HILLPESPHGFIHFPTALARKWLARSHEWINARMEGRP

18
This protein shares significant homology, as detected by
BLAST analysis (1e-12), to a putative esterase/lipase of
Mesorhizobium loti (Genbank Accession No. NP 105776,
which is hereby incorporated by reference in its entirety).
The protein of SEQID NO: 16 was shown not to be secreted
by DC3000. Although this protein is not secreted, it may still
be an effector protein, because AvrB similarly is not secreted
in culture although it is translocated in planta (see Van Dijk
et al., J. Bacteriol. 181:4790 4797 (1999); Gopalan et al.,
Plant Cell 8:1095-1105 (1996), each of which is hereby
incorporated by reference in its entirety).
A ninth nucleic acid molecule encodes ORF9 and has a

15

nucleotide sequence according to SEQ ID NO: 17 as fol
lows:

atgcaaaccitatatacccitatccaaaaaaccotcc caccgttggtacagttctgctgactitcc tatggc
to attc.gcc catgaaaacgagatacctaaatcttgtgctg.ccgacgctittaagagtaggcaaagagctic
gct gatggtttcgatggc gaggttcatcatctagg.cgctctgatgctgatgattitcc.gactitt.ccagoa
gag.ccgctgctgaaag catctgctgctaagaaaggttctittgctagga attactitc.gcttggctaccta
ttatccitatggat.ctactggtgaaaaag.cgaag.cgaatcatcgaag caggttgtgg tatttittct cqtc
agagtgagtggtgatattgaaaac cotaaag caaaaattgaagtttatagotcittggtotgaataccag
aagttcc ttgaac coattittgaag acaggtoacttittatccagtgaaaacg.tc.gtcgttitt.ccgaataa

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 18 as
follows:
35

MQTYIPYPKNPPTVGTVLLTSYGSFAHENETPKSCAADALRVGKELADGF
DGEWHHL.GAL.MLMISDFPAEPLLKASAAKKGSLLGITSLGYLLSYGSTGE

40

KAKRIIEAGCGIFLWRVSGDIENPKAKIEWYSSWSEYQKELEPILKTGDF
YPWKTSSFSE

45 This protein shares significant homology, as detected by
BLAST analysis (3e-50), to ORF4 of Pseudomonas seri
Oboryae (Genbank Accession No. BAA87063, which is
hereby incorporated by reference in its entirety).
50

A tenth nucleic acid molecule encodes ORF10 and has a

nucleotide sequence according to SEQ ID NO: 19 as fol
lows:

atgat caacct cacco acattgcgtottcattggcgcgggcagogctdag cq attcgacaaag.ccgaag
atggagc.gc.gc gataaacgt.cgc.gagccacatcgctggcaaagtc.gc.gttgcagg to accagotcatta
citggagcagaaaggtotgcttaac gag.cgtcagoagaaagggct citcgatgattotgaaggccittgagc
ggcaaggagcc.ggtgaacaatgtc.gaga.cgcacga agggggaggc.cgattcaatctggc gC gag.ccgCC
titcgacgtggc.ca.gc.gttgttctgggagcgcgacaagtic gatgcatalacgtgatgagctttctggg.cgtc
agogacagoaagggcaagatgttgttctotctgggcaagaagctgg.cggatgcaatggccaa.gc.ctdag
cctggcaaggacaa.ca.gtgaggccacaaatgcgc.gc.catgcc tatttcto cagoa acttgaaactgaac
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22
-continued

cgc.cacagtCct cqc.gcggaCaggtotgcCaagggacgacctggcc.gagaggagaggalacgggg Caagg
ttcaatgccaa.gcaaacaaag.ccgacagaggctgaagccitacggtgatcatcagacaccolaatcct gat
ttgcacaggcaaaaagaga cagotcaacgc gttgctgaaagcatcaa.cago atgc.gagag cago: aaaat
ggaatgcaacgc.gc.cga-agggcttctoragagccaaagaag.cgttgcaa.gctcgggaagcc.gc.gc.gcaag
cagottctggacgtgctic gaggc catcCaggctdgcc.gtgaagacitccaccgacaagaagat cagogcc
actgaaaagaacgc.cacgggcatcaactaccagtga

15

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 22 as
follows:

MNITPLTSAAGKGSSAQGTDKISIPNSTRMINAASIKWLNKVRSAISDHIRTSIEKGKLFELASLGSNM
FGWPALSARPSTLQPWLAFEADPNHDLNLVRVYMODSAGKLTPWDPTPNAVTTTSNPSEPDAQSDTASS
SLPRRPPAGSWLSLLGIALDHAQRHSPRADRSAKGRPGREERNGARFNAKQTKPTEAEAYGDHQTPNPD
LHRQKETAQRVAESINSMREQQNGMQRAEGLLRAKEALQAREAARKQLLDWLEAIQAGREDSTDKKISA
TEKNATGINYQ

This protein possesses N-terminal Hop features (see U.S. AAB00126.1, which is hereby incorporated by reference in
patent application Ser. No. 10/341,180 to Collmer et al., filed its entirety).
Jan. 13, 2003, which is hereby incorporated by reference in 35
its entirety), Suggesting that it is likely to be secreted, and

A twelfth nucleic acid molecule encodes ORF13 and has

has significant homology, as detected by BLAST analysis
(5e-7), to a HrpA-like protein (Genbank Accession No.

a nucleotide sequence according to SEQ ID NO: 23 as
follows:

atgcgcacatc.cgittaatggtotgcttgagcacagoctogaag accotgggctittgatactitcggcattg
caggccttgcgcgacgacggittatttact.gtggcaaggcaaggataagcaa.gc.ca.gtc.ttctggttcc c
totactgacgg.cgacgc.gctttitcgctatotgtaccttgagcc.gtgtc gatc.ccgag cacgacggacgt.

citgctgg.cgcttgcattgcacctgaacctgtcticcitgtccacac gatgag cqcatgtatagodicttgat
gtoga.gcaaaacacgttgttgtc.ttc.gctacacccatgaccttgg.cgggaacgggg cagataccctgttg
cittgcgctogaaaacgcc caag.cgcttgctgaacagatcaag caggtaatcgaaaactittagg cacgat
Cagggacgc.cgatag

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 24 as
follows:

MRTSVNGLLEHSLKTLGFDTSALQALRDDGYLLWQGKDKQASLLWPSTDGDALEAICTLSRVDPEHDGR
LLALALHLNLSPWHTMSACIALDWEQNTLCLRYTHDLGGNGADTLLLALENAQALAEQIKQVIENFRHD
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Because ORF13 shares features common to type III chap
erones and is located directly upstream of hopPtoS1
(ORF5), it is believed that the protein of SEQID NO: 24 is
a type III chaperone for HopPtoS1.
A thirteenth nucleic acid molecule encodes ORF14 and 5
has a nucleotide sequence according to SEQ ID NO: 25 as
follows:
atgatcgc gttcgcaa.ccggactgctagaacacagoctdaaacggcttggatacgacgcc.gcagatttg
caatcc ctitcgg gatgaaggg tatttgctgtggcacgggaaaaacgg to acaccagotctgttggtgccc
gctgctgg.cgggatgcgcttitttgtcatcago accotgagctacatc gatcctgaacaggacggg.cgg
citgctggcgcttgcgctgcatttgaacttgtc.gc.ca.gc.ccacactctggg.cgc.cagtatcgc.gctggat
atcgagcaaaataccttgtgcctg.cgttacacgcac gaccitcactgggcacgg cacagacaatttgtc.c
cgc.gc.gcttgaaag cactcaggc acttgcc gag cagatcaagcaggtoatcgaaactt.ccgcagtgaa
titcggacgc.ccgc.caatgc.ccgc.ccacacagoccgacggccagatgcc.ctggcgctittag
2O

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 26 as
follows:
MIAFATGLLEHSLKRLGYDAADLQSLRDEGYLLWHGKNGHTSLLWPAAGGDALFWISTLSYIDPEQDGR
LLALALHLNLSPAHTLGASIALDIEQNTLCLRYTHDLTGHGTDNLSRALESTQALAEQIKQVIETFRSE
FGRPPMPAHTARRPDAWAL

30

ORF14 shares features common to type III chaperones and
shares weak similarity with ORF8 of the DC3000 Conserved
Effector Locus (“CEL) (U.S. patent application Ser. No.
09/825,414 to Collmer et al., filed Apr. 3, 2001, which is
hereby incorporated by reference in its entirety), which is a 35
candidate chaperone for the protein encoded by CEL ORF7.
Thus, the protein of SEQID NO: 26 is likely a chaperone for
the protein of SEQ ID NO: 28.
A fourteenth nucleic acid molecule encodes ORF15 and

has a nucleotide sequence according to SEQ ID NO: 27 as
follows:
gtgaaaaagttctgg.cgctggaactcaa.gc.ctato.cgttgttc.gc.citctg.cgacgggaagctogtogaag
ggcgttctaagtaccattgcc aggcaccitgacgg gatgttittgcacccaacaag acto cqcttcattca
gcaa.cago.cgtttcgitatgagctattgcc.gggcaattattotgtc.gcc.gc.cagtgtgcatggcttgtcg
gttgat caccgc.ca.gc.cgg.cgctgacacgactgagtaacgtgctgttcaatcaggcactggcgctggac
citggag cqttittgacgaggg.cgc.gc.ca.gc.cgacgaaatgttcaggccitt cactgaaacgc galacgtgcc
catcc.ccgattggc.cgact cactgggtggc gagcaactggctdtgcaaaccatggaga agggccittaaa
cggctggcagaggatcc to cqcagtcc tittgcgc gatgcc attcatttittttaccc gatcagtagt gat
accactitcaccitcaagcatcactitcattctgtgg.cgagct catctggctga

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 28 as
follows:

WKKSGAGTQAYALFASATGSSSKGVLSTIARHLTGCFAPNKTALHSATAWSYELLPGNYSWAASWHGLS
WDHRQPALTRLSNWLFNQALALDLERFDEGAPADEMFRPSLKREGAHPRLADSLGGEQLAWQTMEKGLK
RLAEDPAQSFARCHSFFYPISSDTTSPQASLHSVASSSG

24
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This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted, and
has significant homology, as detected by BLAST analysis
(2e-92), to a putative protein of Ralstonia Solacearum (Gen
bank Accession No. NP 518366, which is hereby incorpo
rated by reference in its entirety). Furthermore, the protein
of SEQ ID NO: 36 has been shown to be translocated by
DC3000 in planta.

32
WKINLPALRTTSSRVQICLTAVLLCTPLLFSAHAQAAGTASEQANVEVMI
5

RQLNALEAVAQRSWDLPQDPAQRYHLDYPRLVSDIARIRQGLQDYLSPSR
AQPRDPVELSGHYNWSGDHTP

10

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted.

A nineteenth nucleic acid molecule encodes ORF20 and

A twentieth nucleic acid molecule encodes ORF21 and

has a nucleotide sequence according to SEQ ID NO:37 as

has a nucleotide sequence according to SEQ ID NO: 39 as

follows:

follows:

atgc gttcCagg gttatalactacatcgctggtag to attatgctotcatgtgcatcago.cgcto cagot
tgcttcto cqcaga catgacitcc cagogtgtcgaac gaga.gcacgtoggaggcggattitt cagdaatgg
citggct acttitcc.gcagdaatgcaactactaagggcatcgacacago cacactic gatcttgcttitccala
aa.catcacgcttgaccc.gactgtgcaccagttggatatgg.cgcaaccagagttcacgacggc catctgg
gattatttgttctgaacgtctgacitc.cgaagaatato cago aaggg caggagcttctgcaaaaagagcca
gttctgaacgaggtagagcgtcactacggtgtggatgc galagattatc.gcggc catctggtgtattgaa
agcggctacggtaaggatattgg tagt cqc gatgtgatto gttcc ttggcc acgcttgcttaca agggc
cggcggatggattacggggctacacagttgatggcc.gc.ccttcat atcgtgcaaaacaaaga catcgcc
cgtgcgcaattgattggctic gtgggctggcgc gatggggcagacgcaattcatcc.cgacg accitat citc

gacitat gcagttgattittalaccacgacaatcggcgc gacgtttggagttcc.cggg.ccgatgcgctggcc
to cact gcct cittatttacaacgcagogcttggaactc.gc.gc.gtotcittggggacaggaggtgcagttg
ccc.gagaattitcgattacgcticaggctgacatgtcgatcaagaa.gc.ccgttgcc.gaatggcaa.cggcto
ggggtgatgggaac galagcaa.gc gatt.ccggg.cgagct cqCacaggagcaa.gcatcggtoct9CtgCCC
gcaggittatcgcgggcc agcatttatggtoctaagtaattitcc.gtag catcctg.cgctataacaactcc
actgcc tatgcgctaac gatcgggctactago.cgacagttatoctogcggg accqgcgtgtc.tcaccc.g
tggccaactgataatcc toccittgggcago attgcgcaggtaaccgatttgcagaaactgctgactgct
aagggctact coct gggtgctgctgacggtgttatagggg.cgatgaccoggg.cggc catc.cgggcttac
cagaag gatcago atttgccaccc.gacggittacgc.ca.goactotact actoga gag cotgc.gc.cgatag

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 40 as

gtgaaaatcaatctoccc.gc.gcticagaacaacgtc.ttcacgc.gtgcagat

follows:
citgcttgaccgcagtcc togctgtgcacaccgctdct gtttitcc.gc.gcatg

50

cc.cagg cago.cggcacggcttctgaacaa.gc.caatgtggaagtgatgatt

MRSRVITTSLWWIMLSCASAAPACFSADMTPSVSNESTSEADFQQWLATF
RSNATTKGIDTATLDLAFONITLDPTVHQLDMAQPEFTTAIWDYLSERLT

cgtoagctcaacgc.gctic gaggcc.gtogcc.ca.gc.gcagtgtc.gatctitcc
55

PKNIQQGQELLOKEPWLNEVERHYGWDAKIIAAIWCIESGYGKDIGSRDV

acaag accoggcc.caacgctato acctggacitat coccggttggtoag.cg

IRSLATLAYKGRRMDYGATQLMAALHIVQNKDIARAQLIGSWAGAMGQTQ

acatc.gc.gc.gcatcc.gc.cagggcttgcaagacitacctgtc.gc.cgt.ccc.gc
FIPTTYLDYAWDFNHDNRRDVWSSRADALASTASYLQRSAWNSRWSWGOE

gcacago.ccc.gc gaccc.cgtggagctato aggcc attacaacgtoag.cgg

60

WQLPENFDYAQADMSIKKPWAEWQRLGWMGTKQAIPGELAQEQASWLLPA

tgat cacacgc.catga

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 38 as
follows:

GYRGPAFMWLSNFRSILRYNNSTAYALTIGLLADSYAGGTGWSHPWPTDN

PPLGSIAQWTDLQKLLTAKGYSLGAADGWIGAMTRAAIRAYQKDQHLPPD
65
GYASTWILLESLRR
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This protein has significant homology, as detected by
BLAST analysis (1e-106), to a putative transglycolase from
Pseudomonas aeruginosa and Ralstonia Solanacearum (re
spectively, Genbank Accession Nos. NP 252681 and
NP 522801, each of which is hereby incorporated by 5
reference in its entirety).
A twenty-first nucleic acid molecule encodes ORF22 and
has a nucleotide sequence according to SEQ ID NO: 41 as

34

follows:
atgcttgctoctogacgg.cgtagaaatcgatat cqtgctato aggtatatgcggaacto atctgg.cggta
ttgtcggg.ccgtgaaggtggagaggtoggcattatacgcgggcacgaag cagttgg catt attatc gat
gtaggtaaggatgtag tacaccitacaaaaagg gatgcgggtggtggttgatcc caacgaatact.gtggc
gtttgc galaccittgcc.gtc.ttgctaaaacgcaccitatgcaatgggggggtgaacgctdggttggatato
gcaggtgtcaacaaacatggaacttittgcc gag.cgctt.cgttact.cgtgagcgttttgttgttatcaattg
ccagacgatatgagctggg cagotggtgttgttggttgagcctdttgcctgcattctgaataatatagac
caggcgttcattcgagcgg gaga.gc.gtgttgttgatcc tagggtotggcc citatgagtctgattgcgcag
atcgttctg.cgctdaatgggagttgacacgctic gocactdatcgaaacacacatc.gcatacagttcggc
cgct cacaaagt cittgatgttatacatgcc gatgat cittgagttgcagatgcago:accaagaaaagttt
gatgttgttatcgatactgtcggtaatcagat.cgatacagottcacgctacatcggtogcggtoggaga
attgtactttittggatttgatagtgacitat cactacatgctgcct gtaaagtact tcc to gttaacgct
atcagtattatttctgctggagaatacaatcago acttitcctagagcaatticgtottgttgcaaaaactt
cctgagctaggg.cggctggtaacgcatc.gctacgtact agaaaatcacticggaggtttitc gatgcactt

citgaacgatgctitcc.gc.ccc.caatataaaaag.cgitattoacaccaaatctogcttatctittaa

The protein encoded by this nucleic acid molecule has an 35
amino acid sequence according to SEQ ID NO: 42 as

-continued
WNAISIISAGEYNQHFPRAIRLVOKLPELGRLWTHRYWLENHSEWFDALL

follows:

NDASAPNIKSWFTPNLAYL
MLAPDGWEIDIWLSGICGTDLAWLSGREGGEWGIIRGHEAWGIIIDWGKD

40

WWHLQKGMRVWWDPNEYCGVCEPCRLAKTHLCNGGVNAGLDIAGVNKHGT
FAERFWTRERFWYOLPDDMSWAAGVLVEPVACILNNIDQAFIRAGERVLI
LGSGPMSLIAQIVLRSMGWDTLATDRNTHRIQFGRSQSLDWIHADDLELQ
MQHQEKFDWWIDTVGNOIDTASRYIGRGGRIWLFGFDSDYHYMLPWKYFL

45

This protein has significant homology, as detected by
BLAST analysis (2e-18), to a putative sorbitol dehydroge
nase (Genbank Accession No. NP 389115, which is hereby
incorporated by reference in its entirety).
A twenty-second nucleic acid molecule encodes ORF23
and has a nucleotide sequence according to SEQID NO: 43
as follows:

atgaaagttactgtattoagtcagatatocaattgatggcaagttgacgatgggcaaag.gc.gcatccago
aag.ccgttgtttcagaactittgatgatgatgacatgc gttittattoataagttcc.gc.ggcgaagttcgac
gcaat catggtaggg.cgcaataca attgttactgacgatccaca attgaccaatcgctatoagtcgggit
cgtaaccoaatacgitatcattcccaccaccitccittagatctgcc tactitcc.gc.cagtattittcaaatca
ccagagaaaactattatcgcaactagogaac aggctcgtgat catgaaatggtoaaacatato.cgtgct
tgtggaaag gaggtoctotttgcc.ggtgcaaag catgtcgacitttacacg acttittoccitatgctggag
gcqc.gcggaataalaccacat catggttgaggg.cggtggccacctgaactggcagg tattoaatcto gat
citggtagatgaaattatact catgcaggtgccitat catcataggtogtgcggcaactgcaacgcttgct
gacggggtggggt atcgggatato aa catggccaattic gtttacgctgcatoctittagaag cacgc.ccc
cattacaatctoratgcacttcaag.cgcgaatcgaacaatcggagcc.cgtact ga
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The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 44 as

36
atgaatgc gttc.gcaa.ccggtoagcttgaatacagoctoaaaaagctggg

follows:

atacgatgcc.gc.cgctttgcaggcc.ctd.cgcgaagaaggg tacttgctdt
MKVTVFSQISIDGKLTMGKGASSKPLFONFDDDDMRFIHKFRGEWDAIMV

ggaaagggaaaaacgaccagaccagottgctggit gcc.citcggc.cgatctg

GRNTIVTDDPQLTNRYESGRNPIRIIPTTSLDLPTSASIFKSPEKTIIAT

gatgcacttittcgittatcaiacac gttgagctacatc gaccc.cgag catga
cgcacgtotgctggcgcttgcattgcaccitta acctgtc.ccctgtccata

SEQARDHEMVKHIRACGKEWLFAGAKHVDFTRLFPMLEARGINHIMVEGG
10

GHLNWOWFNLDLVDEIILMQVPIIIGGAATATLADGWGYRDINMANSFTL

cgatgagc.gc.ctgcatagoccitc gatgtcgagcaaaacacgttatgcctg

HALEARPHYNLMHFKRESNNRSPY

cgctacacccatgaccttggcgg gag.cggggctdataccctgttgcttgc
gotcgaaaacgcc caggcgctggcc.gaacagg to aggcaggtogatcgaaa

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted, and
has significant homology, as detected by BLAST analysis
(8e-38), to a riboflavin specific deaminase (Genbank Acces
sion No. NP 213307, which is hereby incorporated by
reference in its entirety).
A twenty-third nucleic acid molecule encodes ORF24 and
has a nucleotide sequence according to SEQ ID NO: 45 as
follows:

15

cc titcaggcgtgaccalagg gogtc.cgtocgggcaaacgtc.tttgtc.ccgg
caatccagtgctctgatgc gataa

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 48 as
follows:
MNAFATGQLEYSLKKLGYDAAALQALREEGYLLWKGKNDQTSLLWPSADL
25

DALFWINTLSYTDPEHDGRLLALALHLNLSPWHTMSACIALDWEQNTLCL
RYTHDLGGSGADTLLLALENAQALAEQWRQVIETFRRDQGRPSGQTSLSR

atggag caggaaaagagttcc tdtttgcgctacggcgtgaccottaatga
aaaagatctgtcacgttttittgg galactacacago act acatgtggagca

QSSALMR

30

cgattaaaaatgagtacgc.gctcactgaatcCatcgacCacttgatggca
cago atcaiacagdaattaatgcgct caatcagttittgaattgtttcaatc
catgcctggcgtggaggcgcttctoaatttactggagcataccggagtgc

35

This protein shares features common to type III chaperones
and is a putative chaperone for the product of ORF26
(described below).
A twenty-fifth nucleic acid molecule encodes ORF26 and
has a nucleotide sequence according to SEQ ID NO: 49 as
follows:

cctgtgcc.gtag cotctitcgtc.tccacgtaatttgg to gagcttatattg
aagaaaacgaaattgcgtcgatttittcaaagaggittatttgttggtactga
tgttaaagagagtaaac cqaatc.cggagatttittcttacggcggcca agg

40

gcagaagticcitcttcaaaagggctgctdagtggitttggccaag catttca

gacittggagtgtcaccitcgtgcatgtctggittattgaagacitcc.cat cac

aggggatgctic gtttctggcaac acttctggtoatt.cgg.cgctcqgg cat

ggtgttaccgctg.cgaaggcc.gc.ccatatgttttgtataggtttgcgtoa
titccagotcatttcago aggatctgag cqctgct gatctgatcgc.calata

atgaaaat atcc.ggctocacatcgcc to cacacacttcaac gaattcc.gc

45

tacgc.gtocatccago agcggctocaaaggcaagg caccggtacgggacga
ttacagdaacggaccgcaaac acgc.cittaacaac acaccitctgaaacgag

atcattatgacatcaa.gcaatggtttgcagaaaaatag

cactgg ccc.gaga.gcttgatcgctttggctacggttcatcggc gacc gag

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 46 as
follows:

tottttgaccgct cattgcagogtaaggataaaaatccagagcttgggaa
50 ggtotga

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 50 as

MEQEKSSCLRYGWTLNEKDLSRFLGTTQHYMWSTIKNEYALTESIDHLMA
QHQQQLMRSISFELFQSMPGWEALLNLLEHTGVPCAVASSSPRNLVELIL

55

follows:

KKTKLRRFFKEWICGTDWKESKPNPEIFLTAAKGILGWSPRACLWIEDSHH

MKISGSTSPAHTSTNSAQKSSSKGLLSGLAKHIFKGMLWSGNTSGHSALGH
GWTAAKAAHMFCIGLRHSSSFOODLSAADLIANNHYDIKQWFAEK
YASSSSGSKGKAPWRDDYSNGPOTRLNNTPLKRAL.ARELDRFGYGSSATE

This protein has significant homology, as detected by 60
BLAST analysis (5e-32), to a putative phosphatase from
Clostridium (Genbank Accession No. NP 347269, which is The protein of SEQ ID NO: 50 has been shown to be
hereby incorporated by reference in its entirety).
translocated by DC3000 in planta.
A twenty-fourth nucleic acid molecule encodes ORF25 65 A twenty-sixth nucleic acid molecule encodes ORF27 and
and has a nucleotide sequence according to SEQID NO: 47 has a nucleotide sequence according to SEQ ID NO: 51 as
as follows:

follows:
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A twenty-ninth nucleic acid molecule encodes HopPtoS2
(ORF30) and has a nucleotide sequence according to SEQ

44

ID NO: 57 as follows:
atgaatataaatcgacaactgcctgitatcaggctcqgagc gattgttgacitcc.cgacgtggg.cgitatct
cgcc aggcttgttc.cgaaagg cattattotactggacaggatcgg catgatttittaccgttittgct gcc.
aggctacatgtggatgcgcagtgttittggtctgtcaatagacgatttgatggataagttittctgacaag
cactitcagggct gag catcctgaatacagg gatgtctato cqgaggaatgttctgc catttatatgcat
accgctcaag actattotagt caccitcgta aggggggaaataggaacgcc.gct gtaccga gaggtoaat
aattatctitcgacittcaa.cat gaga attctgggc gaga agctdaaattgataatcacgacgaaaagcta
togcct cacataaaaatgctttcatctg.cgcttaatcgtttaatggatgtc.gc.cgcttittagaggaacg.
gtttatagaggcattc.gcggtgatttagataccattgctoggctotaccatctattogatacgagcggc
cggtacgtagagcc.cgctttcatgagtaca acto gaataaaggacagtgcc caggtgtttgagc.caggc
acgc.caaacaa.catagotttccagataagcctaaaaag aggc.gc.cgacatttcgggat.ct tcc.caag.cg
cc citcagaggaagaaatcatgct acco atgatgagtgagttcgtoattgaacatgcatcc.gctotttcc
gaaggaaag catttatttgtattaagttcagatttga

The HopPtoS2 protein encoded by this nucleic acid mol- 25
ecule has an amino acid sequence according to SEQID NO:
58 as follows:
MNINRQLPWSGSERLLTPDWGVSRQACSERHYSTGODRHDFYRFAARLHVDAQCFGLSIDDLMDKFSDK
HFRAEHPEYRDWYPEECSAIYMHTAODYSSHLVRGEIGTPLYREWNNYLRLQHENSGREAEIDNHDEKL
SPHIKMLSSALNRLMDWAAFRGTWYRGIRGDLDTIARLYHLFDTGGRYWEPAFMSTTRIKDSAOVFEPG
TPNNIAFQISLKRGADISGSSQAPSEEEIMLPMMSEFWIEHASALSEGKHLFWLSQI

HopPtoS2 has been shown to be a protein that is secreted by ADP-ribosyltransferases, it was determined to possess an
DC3000. HopPtoS2 has significant homology, as detected ART domain (pfam1129). In addition, HopPtoS2 has 20.5%
by BLAST search (1e-5), to Clostridium exoenzyme C3 identity to the HopPtoS1 as determined using EMBOSS
ADP-ribosyltransferase, (Nolling et al., J. Bacteriol. 183: 40 software.
4823–4838 (2001); GenBank Accession No. NP 346979,
A thirtieth nucleic acid molecule encodes HopPtoS3
each of which is hereby incorporated by reference in its (ORF31) and has a nucleotide sequence according to SEQ
entirety). Further confirming that HopPtoS2 has similarity to

ID NO: 59 as follows:

atgaatatoagtcc totatogggtgcc.cacggtag cago tacccittcagotcaatccacago atcgacg
gcatcgaaaggtoccitctggatcc tittct caaacagotcggcggctgtttitt caccctgcctgggtagc
agctotactggggccatactittct cocqctcat gag cagg tattgagccacaccitatto.ca.gcaatatt
aaaggaaagttgcgcacgacgc.ccc.caaaag gaccg.tc.gc.ccaggttgtctgacacaccitatgaagcag
gcqctttcttcaatgatcgtacaggagcgaaaacggcttaaaagttcaa.cccaagt cattggcc toggat
atagaacgtccagacagtatgatcaaaaaag.cgcttgatgaaaaagacggccaccc.gtttggc gag.cgc
ttittcagacgacgaatttcttgcg attcatctotatacgagctgtctittatagg.ccg atcaatcatcat
ctg.cgg tatgcc.ccgaacaatgatgttgcaccggttgtc gaggcactgaaaagtggtttggcaaagctt
gctcaag accotgattatcaagtgtctagocagottcatagagg catcaa.gcaaaagatgagtgatggc
gaggtoatgagtcgtttcaaac cqggtaag accitatcgtgatgaag.cgttcatgagcacatcaactoat
atgcaggtttcagaag agtttaccto cqacgttacgttgcacct gcigg to citcatcagotgtcaatata
ggc.ccctttitcgaaaaatccatac gaggacgaag.cgcttatctogc.ccctgacgc.ctittcaaagtaacc
ggtotg.cgcaa.gcaggacgataagtggcacgtogatttgaac gagatagoagata attcagacgagtga
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HopPtoS3 has an amino acid sequence according to SEQID

46

NO: 60 as follows:

MNISPWSGAHGSSYRSAQSTASTASKGPSGSFLKQLGGCFSPCLGSSSTGAILSPAHEQWLSHTYSSNI
KGKLRTTPPKGPSPRLSDTPMKQALSSMIVQERKRLKSQPKSLASDIERPDSMIKKALDEKDGHPFGER
FSDDEFLAIHLYTSCLYRPINHHLRYAPNNDWAPVVEALKSGLAKLAQDPDYQVSSQLHRGIKQKMSDG
EVMSRFKPGKTYRDEAFMSTSTHMQVSEEFTSDWTLHLRSSSAVNIGPFSKNPYEDEALISPLTPFKVT
GLRKQDDKWHVDLNEIADNSDE

HopPtoS3 has significant homology, as detected by BLAST
analysis (5e-3), to chicken ADP-ribosyltransferase
(Tsuchiya et al., J. Biol. Chem. 269:27451–27457 (1994):
Genbank Accession No. P55807, each of which is hereby
incorporated by reference in its entirety). Further confirming
that HopPtoS3 is an ADP-ribosyltransferase, it was deter

15

mined to possess an ART domain (pfam1129). In addition,
HopPtoS3 has 71.7% identity to HopPtoS1 as determined
using EMBOSS software.
A thirty-first nucleic acid molecule encodes ORF32 and
has a nucleotide sequence according to SEQ ID NO: 61 as
follows:

atgaatattaa.ccct tcc ctggg.cgctdatggcagogcc tactcgtc.gc.citcaaagtgatactitcgaag
gcc actdgaaaag cacct go go cittcttttittcaaac agttggg.cggctgtttitt.cgc.cgtgccttggit
toccatgcgtoaa.gcago caacaactgtcc.gc.cagtcatgcgcagacgcticagtcagaattactic cago
aac attcaggggacgagcc.gcacacgc.ca.gcc.gagag cacccitc.gc.cacgc.ctgtcagatacgcc catg
aag caggcgctitt cottcaatgatcgaacg.cgagcgtttgcggcttcaaggtotttcgg gaggaatgttc
toggg cattgacitcc.gc.cgatgcc atgattgg to gag cqcto acgaagaaggattcaaaccolaaaggct
gcqcgttittagtgatgatgagtttctic.gc.cgttcaccitctacacaacttgccitctacagaccitat caat
catcatctitcggitatcaacactag
35

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 62 as
follows:
40

MNINPSLGAHGSAYSSPQSDTSKATGKAPAPSFFKQLGGCFSPCLGSHAS
SSQQLSASHAQTLSQNYSSNIQGTSRTRQPRAPSPRLSDTPMKQALSSMI
45

ERERLRLQGLSGGMFSGIDSADAMIGRALTKKDSNPKAARFSDDEFLAVH
LYTTCLYRPINHHLRYOH

50

55

This protein has significant homology, as detected by
BLAST analysis (5e-3), to chicken ADP-ribosyltransferase
(Tsuchiya et al., J. Biol. Chem. 269:27451–27457 (1994):
Genbank Accession No. P55807, each of which is hereby
incorporated by reference in its entirety). Further confirming
that protein of SEQID NO: 62 is an ADP-ribosyltransferase,
it was determined to possess an ART domain (pfam1129). In
addition, this protein has 51.3% identity to HopPtoS1 as
determined using EMBOSS software.
A thirty-second nucleic acid molecule encodes ORF33
and has a nucleotide sequence according to SEQID NO: 63
as follows:

atgagctic gatcacgcacacca acacgcc.gcaattgg.cggtoag.cgatto acggggtotgc.cggtacgc
agtgtgcagttctato gtgg.cgct gatgg to agcctgttgacgc gagggtgacgcago act attitcgac

US 7,220, 583 B2
49
The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 64 as

50
The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 66 as

follows:

follows:

MSSITHTNTPOLAVSDSRGLPWRSWQFYRGADGQPWDARVTOHYFDKAGRLIASR DPRFSSRLKYGWCA
PWNLMQIWSLSGALLLSKSWDSGWRVSLNGEAGQLVDSCDGRDNPRQIEYDGLLR PLAINESGRMTERF
TYGGPATEAHNOCNOLIRHDDTAGSRLLRDYGLSGRALSEKRYFLOSPDSPDWPLAEPDRDALLEPWGL
QTRWAFNAQGEDLAOTDANGNVQRFSHGVAGQLHAVELTLANTAORQTLWSAIHY DAFNQAEQETAGNG
WWSRYWYDQQDGRLTELSALSADGSVLQKLNYSYDPAGNWLLINDASQPDRYCGNORIEPINRYCYDTL
YQLIEATGREWRNGASHGPALPGLQPLPTLDPCOWSNYTORYSYDAAGNLLQMRH EGAHNFTRNMHWDP
DSNRSLPDNDRYWDFATSFDANGNLLQLVRGQTMSWDWRNOLRQITTVQREDAPN
RKISTAQASGRTLTNEWRYLPGLEWRTTADGETLHWWTAQAGRNSWRVLHWEAGK PGAIANDQWRYSLG
DHLGSSTLELDQQGGLISQESYYPFGGTAWWAARSAWEAKYKTVRYSGKERDASG
RWINPDPAGDVDGLNLYRMVRNNPLWYWDAKGQQPEPWPKTIHQIWIGENKNALRAQVSNINRTVEMAW
GYKWKLHLETRTPEAYSEIEKDLRSEWWLLPDSOVFQNFKEKPLYAAYEDFRRNNONYAFAWDVLRMHT
WHELGGIYSDVDDWYAGAETGGMTQLGDNPLFAEPDEWLTLDPWHVPWEPQNSWESFMVNNSSFAAHSG
AGWLLDMMGEGAKRYDEAWEGGSYPDPTGMNGIGLSLLWNPNPAWRWRTLSNWWGPGLFTDTLHASDTA

YGELFSNLKGWWFOKQPFTFADQMARKMPLHRHIKSGAAQTWR

This protein has significant homology, as detected by

BLAST analysis (1e-128), to SepC insecticidal toxin (Hurst

MPITAQQLLQILPSAGQKAGVFAPWLNTAMSKHQILTPLRIAAFIAQVGH

et al., J. Bacteriol. 182:5127–5138 (2000); Genbank Acces
sion No. NP 065279, each of which is hereby incorporated
by reference in its entirety). This protein also has significant

ESGQLRYVREIWGPTPQQLGYEGRKDLGNTWAGDGSKYRGRGLIQITGRA

homology (2e-128), as detected by BLAST search, to puta- a

NYAECGEALGLDLIHHPELLEQPEHATMSAAWYWSSRGLNSLADKGDFLQ

tive insecticidal toxin from Yersinia pestis (Parkhill et al.,
Nature 413:523-527 (2001); GenBank Accession
NC 003143.1, each of which is hereby incorporated by
reference in its entirety).

ITRRINGGTNGLADRQALYDRALKVLA

A thirty-third nucleic acid molecule encodes ORF34 and
has a nucleotide sequence according to SEQ ID NO: 65 as

This protein has significant homology, as detected by
BLAST analysis (3e-36), to a lytic enzyme (Nakayama et
al., Mol. Microbiol. 38:213–231 (2000); Genbank Accession
No. BAA83137, each of which is hereby incorporated by
reference in its entirety).
A thirty-fourth nucleic acid molecule encodes ORF35 and
has a nucleotide sequence according to SEQ ID NO: 67 as

follows:

follows:

45

atgc.cgatcaccgc.gcagoagttgctgcagatacticco gag.cgctggcc agaaag.ccggc gtttittgca
cc.cgtoctogalacacago gatgagcaag caccagatcttgacgcc.gctg.cgcatc.gcggctitt catcgcc
caggtogg to atgagtc.cggccaactg.cgctacgtocgc.gagatttggggg.ccgacitcc.gcago agctg
ggittatgaaggcc.gcaaggacct cqgcaat accgtggcgggtgatggttcgaagtaccgcggg.cgcggC
citgatccagatcaccggcc.gggccaactatocc gaatgcggc gaggcgctggg cctag acct gatc cat
caccc.ggaactgctic gag cago.cggag cacgc.cacaatgtcgg cagogtgg tactggagcago.cgtggc
citgaactc.gctggc.cgacaaagggg actttcttcaaattacco gaagaatcaacggaggcaccalatgga
Ctgg.cggatcgg Caggcgctgtacga.ccggg.cgctgaaggtgctggcgtga
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-continued

TTFTRIPWDQRTPDMKALADEWTMTVQINLAIGIARRGQRQEALALLDRLQPWASGSPERQLTLASAYI
DAGEPARGREMARAAIAQAPLPSADLMLQYAGLLLAAGDDWOWNAILRNVQGQPMSWQTRKRFDDLLYR
YRIRQADLLREGGDLAGAYDTLAPALAQRPDDIQAVSAFARMYTANGDSARAFELYKPLLQRQPNDPOW
LLGAADAAVKAHDYGFAEKALSQFRKLERNDPQTLTEAARIYQSMGQTGAATELLRKAVAIEQSEKQRA
MAWQAVSTSTTSSNPFATGGSRSLAAASAIPAPAQVSLSGGRALETNSAPEISAPRDTAYPGQIAAPQP
LSAARTQSWRGNPFMAATDRDOASSAQQALNRILEQRSGFWSQGLAVRSNNSESGLSKLTWWETPLEVN
LPAGDNRWAVRVTPWSLNAGSLKSDAGARFGGGTSGAAGSQSDKGWGLAWAFERPEEGLKADIGTTPMG
FKYTTWAGGASWDRPLGNNPDLRYGLNWSRRPVTDSWTSFAGSTDERSGLSWGGVTANGGRGQLSYDDQ
TIGGYGYGSWHKLVGNNVKSNTRGEWGGGVYWYLRNAEDSKLTAGLSLMGMSYDNDQSYFTYGHGGYFS

AGEYKLDSSLFMGASLGLDNARDYROFSGALYLRYMFEDITGPLALPWSPYRSPYSN

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted. This
protein also has significant homology (e=0), as detected by
BLAST search, to cellulose synthase from Pseudomonas

25

fluorescens (Spiers et al., Genetics 161:33–46 (2002); Gen
Bank Accession P58937, each of which is hereby incorpo
rated by reference in its entirety).
A thirty-seventh nucleic acid molecule encodes ORF38
and has a nucleotide sequence according to SEQID NO: 73
as follows:

atgaaactgatacgacagat.ccgctogcagggtogtoagtc.gcc cittgttcgagg accittgcc cagotc
gagggg.cgcaa.gcgtcaatggctggc.cgagcgc.gc.cgtgcagttcgcactgggcttgcacggcc.gc.cgg
ccagaggtogata accocittcaaaggcaaactg.cgtgaagacct gtgctgcatcatgttcgatgacctg
togctgcacaccctdgtogagc gttacgcggcc agtgaag.ccct gcigacgacacgacago gagtacttic
agcaaactgatc.gc.cacgacac gaaataccgtggaacgg.cgcatcgtotttcacgggctgctggalacac
titcgacaggctgttgccitatcgaaaagag catctaccaactcaact accgcagogttcaatacgc.gcac
citggagcaggaagaa.gc.cct gtacggcaaactgataatggaacaa.cccattagtgcactgctggaagtg
cacacgc.ctgagtggcttcttgagaatctgtc.ttcgtttgagttitt.cgattgattga

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 74 as
45 follows:
MKLIRQIRSQGRQSPLFEDLAQLEGRKRQWLAERAWQFALGLHGRRPEVD
NPFKGKLREDLCCIMFDDLSLHTLVERYAASEALRRHDSEYFSKLIATTR

50 NTVERRIVFHGLLEHFDRLLPIEKSIYQLNYRSWQYAHLEQEEALYGKLI

MEQPISALLEVHTPEWLLENLSSFEFSID

This protein possesses N-terminal Hop features (see U.S.
55 patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted.
A thirty-eighth nucleic acid molecule encodes ORF39 and
has a nucleotide sequence according to SEQ ID NO: 75 as
follows:

atgcg actoactactaaaggcc gatacgctgttgacago catgcttgacct gg.cgitta catgcgcagaac
gggcc agtgtc.tctggcc.gacatctocq agcgg cagggcatttc.cctgtc.ttatcto galacagttgttc
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-continued

ALLFPEACVOLAYAEAAQAPSAAGEWSWLQQHARHHQISLNTWFQQAQGYAAENNLPSLRVPERTIHAW
RNSSTPQLVSTILFDPTPPKPAQYIAAASNVFOSEFFLALKRMIREHGTGPSYWOQIMDWSLSDASALY
GELAR

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed 10
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted.
A forty-third nucleic acid molecule encodes ORF44 and
has a nucleotide sequence according to SEQ ID NO: 85 as
follows:

atgaag cagotcgcggcaggcagdaatgtgcatottcttgaaaatgagt ctitt coagatagataaggtg
cgctttittgggggccacagottggacagattitc.gcaac aggtogaaag.cgtgtaccaag.cgtoccaggag
gcaaggcgaggcatcaatgacttitcgcttgatcc.gtgcaggc gagggittaccgc.gcattgag catcagt
gatgttgat cagtcgaaatcatcgaacttacgagtggctcaaggaagagctogc catggagttcgatggit
cagaccattgtcatcactcatcattgc.ccgttggtoaattact.gtggcc.ca.gagcagggcto accgcta
atgcct gottattoaaatgattggccagaactic gttcg to aggct gatgtgtgggtotttgggcacacg
cacagt catgtc gatgtcatggtggaaggatgcc.gact cattagtaaccotagaggittatcCaggtgag
agttgcggctittgccaatgacitttgttggtogatattalactag
30

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 86 as

-Continued

CPLWNYCGPEQGSPLMPAYSNDWPELVROADWWWFGHTHSHVDWMVEGCR

follows:

35 LISNPRGYPGESCGFANDFV VDIN.

MKQLAAGSNVHVLENESFQIDKWRFLGATAWTDFATGESWYOASQEARRG
MINDFRLIRAGEGYRALSISDWISRNHRTYEQLKEELAMEFDGQTIVITHH

40

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted.
A forty-fourth nucleic acid molecule encodes ORF45 and
has a nucleotide sequence according to SEQ ID NO: 87 as
follows:

atgacgctgacgcagogt Cagg catggcatcgc gagg cacagcggtttgg.cgagCaggtggtgaacatg
cgcaaag.ccagdaaggcgcactitcggc.caggcggaaaatgacago.cgcaccitatc.cggc.gc.gctittatc
gaccagdaactggctoaactgctgaaccq gottatc catcgctgcaacggcgcaa.ca.gatcaat atttca
citgacctacaggacgggcaccgaagtgctic gaaattic coggcgc.gc.ct gtattgc.ca.gaalacc.gagacc
gagaacgtttcactcaggcaactggtgcatacccaggcc ctd.cgcaccaaggccaaggatgcc.gtgctt
citacgc.gctgtcgacgcc galagg.cgt.ccc ccttgcgc acttggacaag caggcc.gta accq agctgatt
gcc acgctggaagatcaccgatacct cagtgattaccttgacct gcacctgaaaaccitcgg.cgitatgca
cagoagctoaa.gcggtoagaaaaag.ccatgttgcaa.gcticagatgaagatgg.cgctgctggagat.cgag
caa.caggcttittgcaccago.cggtogcgagtggat.ca aggctgtgctggattic.gc.ca.gc.ccc.ccaagga
cgtcgalaccatgg caggggaaag cattgaagtc.cgttttittcagogtcaiaccalattcaagatgaccaat
gtoatgctgattgcto cago.cggtaaattic gagaagggg.ccgctggtgctittgcacgctggatgctitcc
gacggtgtggtttitcc.gctggtttaa.cagoatgitatcacct gaccaccagotttctggaag aggcaccc
titc.ca.gcagtatctgatticagoaaataccggtttcCagg cqtcttgagacgctgcatgc catgcagtac
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-continued

SDIPWEEPKLDIEQVNQQSLRLIRLALLAGFWGALYLVWAELITVFAYLDNIILYEYTSGTGANMSMVP
ISLSDFLGAGVIIWITFWLAGNLPGLLEWLVLSRMNLAQGSAYATTTLLSYTIAGIGFWTTLSTLGWSW
DKLQWLVAALSWGLGFGMQEIFANFISGIMILFFRPVRIGDTITIGALSGTVSKIRIRATTITDFDRKD
IIVPNKTFITGOLINWSLTDTWTRVTLKLGVDYGSDLDLVRSLLLQAARENPRVLKEPEPIWYFLNFGE
STLDHELRMHVRDLGDRNPVLDEINRFINREFKKQHINISFROMEIYLKNTOGLEYKLVPAEPGEKHGA
PAGQTTLQPWNTKVAPATKDAPRPPERLRD

15

The protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in

Yersinia pestis (Parkhill et al., Nature 413:523-527 (2001);
GenBank Accession No. NP 406604, each of which is
hereby incorporated by reference in its entirety).

its entirety), Suggesting that it is likely to be secreted. This

A fiftieth nucleic acid molecule encodes ORF51 and has

protein also has significant homology (e=0), as detected by 20 a nucleotide sequence according to SEQ ID NO: 99 as
BLAST search, to putative potassium efflux system from follows:
atgtcaacgttgaatcatacgtctgctgtaaattgcc.gc.gtoagttittgatggtgaccgttgctatota

gacaccc.cc ditccagatcat gcc.gggtgagc gatgggct gtaaatato gtacctaac gatttagt caca
atcCactacgaggcc.gc.cagdaatcacgact accotttgctgctggccagoataaaaaatctgtttacc
gatgagc gttgttgtc.gtgctaaag.ccc.ggccttacacagoaa.gctttgaacatgitatttitt cagaggitt
aacagocittaa acctaacgc.gact catgttcgcttgttgcatcgag cqcagogtatttittctagaaaac
atgatcc.gtag cqtacagata accitc.gcaaggitat cagogtcacttitcgcaa.ccgcc gaattcaaaaat
tatalactaccagotaaaggtggataaatatacttittgcaaggcttgacaagggg.taccctcitctattog
gagctggttgaaaacaccitggataac gaaattatc.cgtagcc cataatattotgitatto catctotgtg
agcctggaccacticaag cacaccittatacacttittitt caggaac cotcgcggaag acaatatagt coag
cc.gatacggg.cgcttittcaccgacaacac catgacitcaactcaccitcottggcc.gatcagaaaac cqtg
gatgccttgtatacgacggtoaatggcaa.ccc.ggittatcagoatcaaaaaacgc.gcagattatcggtot
tatctgaac atc.gcacagaagttact gct tccaagaacctacaccaaagtag tacggacagtgag cago
citgtctgtgcattttacgggggaggc gtacaaacaattcaactacaagatgcttgttcaacaatgctitat
gcatcc.gagat cacco gagggaaggottatt acto cagogtgag caatggggtgtggaccact tcc.ggit
acgcatgacagogacgacaactgcaaagt cacttgttgattacaagggcgcaaccitacgtcc totacgag
agtaatgcggcagatagacgcactgaaac citgggcacaagaccc.gtacgttacitcattgcg acco gaga
gacct gtaa

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 100 as
55 follows:
MSTLNHTSAVNCRVSFDGDRCYWDTPIQIMPGERWAVNIVPNDLVTIHYE
60

AASNHDYPLLLASIKNLFTDERCWVLKPGLTQQALNMYFSEWNSLKPNAT
HVRLLHRAQRIFLENMIRSVQITSQGISWTFATAEFKNYNYQLKVDKYTF
ARLDKGYPLYSELWENTWITKLSWAHNILYSISWSLDHSSTPYTLFSGTL

AEDNIVQPIRALFTDNTMTQLTSLADQKTVDALYTTVNGNPVISIKKRAD
65

YRSYLNIAQKLLLPRTYTKVWRTVSSLSWHFTGEAYKQFNYKMLVNNAYA
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This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in

-continued
SEITRGKAYYSSWSNGWWTTSGTHDSDDNCKWTCDYKGATYWLYESNAAD

its entirety), Suggesting that it is likely to be secreted.
A fifty-first nucleic acid molecule encodes ORF52 and has
a nucleotide sequence according to SEQ ID NO: 101 as

RRTETWAQDPYWTHCDPRDL

follows:

atgc.gc.ctgatc.gc.gcagattctg.ccc.ggcc toccggaaaacaccacttacagogcc.gcc.gctg.cgtoc
aac accotggcgcgggcc at gcc.caacgc.cattcgcaatgcgctgggcaccotggggctggtggctd.cg
cgcacccagocaa.gcatcttitc.cgttgcc.gtc.gc.gcaacgtoag.cggtgg.cgaaaaagaggac gacctg
gag attctgctcaaactc.gc.ggcc.gc.cgctgtttc.gc.gc.ctgcaaag.ccaccagttggg.cggcctggag
cagaccc.gtaccalatgcc gatggcactcaggtgactacatggcaactggaagtgc.cgatgcgcaacgc.c
catgacatcgtgcc.gttgcaggtoaaggtgcagogcgaagacaa.gc.ct gatcaggacgccacc galagac
cgc gacgatat cq agatcaaggaaac cogtgaaaaactctggaaagttc gatctggctitt.cg acctggag
cc.gcttggc.cc catgcaggtgcatgcgcaactgctg.cgcggcacgctgtc.ca.gc.cagttatggg.ccgag
cgc.ccggatago.gcaa.cact gatc galacatgaactgggg catttgcgc gag.cgc.gagcgc.cgattgcc.g

citggcc.gtoggggaactggdgtgcago catggc gttcc.gcc.gcaagggcc.gc.gcaccgc.ccitcgaacaa
cgctggatcgacgagaacgc.ctga

30

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 102 as
follows:

MRLIAQILPGLPENTTYSAAAASNTLARAMPNAIRNALGTLGLWAARTQPSIFPLPSRNWSGGEKEDDL
EILLKLAAAAVSRLQSHQLGGLEQTRTNADGTOWTTWQLEWPMRNAHDIVPLQWKVOREDKPDQDATED
RDDIETKETREKLWKVDLAFDLEPLGPMOWHAQLLRGTLSSQLWAERPDSATLIEHELGHLRERLIACG
LAVGEIACSHGVPPQGPRTALEQRWIDENA

45

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted.
50 A fifty-second nucleic acid molecule encodes ORF53 and
has a nucleotide sequence according to SEQID NO: 103 as
follows:

atgagtagcgtc.gcago act gatcaccatat cqactggacagacgcagttcgittaaagtc.gc.gcggacg
to attittctgtgctacgaatcc cc citc.gc.cggcagatgtcgtgttgtcgtgtc.cgg gatcagttgaccac
aagacagag cagaaac coataaaaatagggggaagagacgtgagcc-taaatgatcacttgaaaaaag.ca
ttgattctgatccagogacgagcttgatgaaatcacc gacctittatgtgacgttgcc to cagaggtoga
ttcagttgcttgaccatttcactc galagg gaattggaaggaaattgatagogtotggtotgctcggitta
gacgcagoagattcaaagaataatacaaaatgtcacg to catat cqccaaaaaccalagcatcatc gatc
aaaag caaacaggtttcttggaac agtgatggtagcc.gg catgataaaaaaacattc gatgtgaacgct
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-continued

cittgtcag accottttctgaatcagot atc gagg tagt catgtc.catcgaaccocaacgtcagaaagaa
cagocaccc.ggc.ca.gcacacgc.cagoggat cagg gcc.cggatcgcaatgatcc.ggc catcgagcc.gcag
gtttcggacgtagagcc.ggag actdaaaaaggtogacggccagacgcaaggcca gaccoct gcc.cccago
caaag.ccagt cacaaagtcagaatcagagc.ca.gcagtccaacggcagogcttacgtgcctgacitat gag
cc.gcaggaaaaaaaggaag accagogcaatcatcagcc cactcaagg cact gatgctdatat cq acacc
aatgcgggctga

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ-ID NO: 108 as 15
follows:

MRCVRRSRRFFKLQAASCKKKQDRFSLADAPLSTFHRTIRKTLPRKLVRPFSESAIEVVMSIEPQRQKE
QPPGQHTPADQGPDRNDPAIEPOVSDWEPETEKGDGOTOGOTPAPSQSQSQSQNQSQQSNGSAYWPDYE
PQEKKEDORNHOPTOGTDADIDTNAG

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted.
A fifty-fifth nucleic acid molecule encodes ORF56 and
has a nucleotide sequence according to SEQID NO: 109 as 30
follows:

atgc.ccgt.cactggtgcaggotttatcaag.cgtttgacgcaattgtc.ccitctg.cgc.cggcatgg.cgctg
gtoccggtggcc.gtacagg cago.cgaaag.cgatccttgggaaggcatcaa.ccgttc catttitcagottc
aacgatacccttgacgcttatacgctoaa.gcc.gctggcaaagggittatcagtacatc.gcticcgcagttt
gtogalagacgg tattoata acttcttcago: aatato gg.cgatgtcggcaatctggc gaacaacgtottg
caggccaaacctgaag.cggcc.ggtgtagataccgcacgc.cittatcgtcaac actacgttcggtotgctg
ggcttcattgacgt.cgg caccc.gcatgggcctgcaacgcagtgatgaag actt.cggccagacactgggc
tactggggtgtgccaag.cggc.ccgttcgtggtgatticcgctgctgggcc caag cacggtgcgtgacgcc
attgccaagtaccc.ggacaccitacaccitcc.ccgtaccgctatattgatcacgtacccaccc.gcaa.cacg
gc gttggg.cgtoaatctggtogacacgc.gtgc.ca.gc.ctgctgtcc.gc.cgagcgc.ctggtoagtggtgat
cgctacaccittcatcc.gcaacgcttacittgcaga accgc.gaattcaaggtoaaggacggg caggtogaa
gacgatttittaa

The protein encoded by this nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 110 as
follows:

MPWTGAGFIKRLTQLSLCAGMALWPVAVOAAESDPWEGINRSIFSFNDTLDAYTLKPLAKGYOYIAPQF
VEDGIHNFFSNIGDWGNLANNWLOAKPEAAGWDTARLIVNTTFGLLGFIDWGTRMGLQRSDEDFGQTLG
YWGWPSGPFWWIPLLGPSTWRDAIAKYPDTYTSPYRYIDHWPTRNTALGWNLWDTRASILLSAERLWSGD

RYTFIRNAYLQNRFFKWKDGOVEDDF
65

This protein possesses N-terminal Hop features (see U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed

Jan. 13, 2003, which is hereby incorporated by reference in
its entirety), Suggesting that it is likely to be secreted.
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ttgcacaggcaaaaagaga cagotcaacgc gttgctgaaagcatcaa.cago atgc.gagag cago: aaaat
ggaatgcaacgc.gc.cga-agggcttctoragagccaaagaag.cgttgcaa.gctcgggaagcc.gc.gc.gcaag
cagottctggacgtgctic gaggc catcCaggctdgcc.gtgaagacitccaccgacaagaagat cagogcc
actgaaaagaacgc.cacgggcatcaactaccagtga

The Hrp-A related protein has an amino acid sequence 10
according to SEQ ID NO: 122 as follows:
MNITPLTSAAGKGSSAQGTDKISIPNSTRMINAASIKWLNKVRSAISDHIRTSIEKGKLFELASLGSNM
FGWPALSARPSTLQPWLAFEADPNHDLNLVRVYMODSAGKLTPWDPTPNAVTTTSNPSEPDAQSDTASS
SLPRRPPAGSWLSLLGIALDHAQRHSPRADRSAKGRPGREERNGARFNAKQTKPTEAEAYGDHQTPNPD
LHRQKETAQRVAESINSMREQQNGMQRAEGLLRAKEALQAREAARKQLLDWLEAIQAGREDSTDKKISA
TEKNATGINYQ

The HrpA-related protein, has significant homology, as

13, 2003, which is hereby incorporated by reference in its

detected by BLAST analysis (5e-07), to the C-terminal 43

entirety), Suggesting that it is likely to be secreted. HrpA is

Alfano et al., Proc. Natl. Acad. Sci. USA 97.4856. 4861

Sci. USA 94:3459 3464 (1997), which is hereby incorpo

amino acids of HrpA (GenBank Accession AF232004;

the Hrp pilus subunit protein (Roine et al., Proc. Natl. Acad.

(2000), each of which is hereby incorporated by reference in
its entirety). Expression of the hrp-A-related gene is activated
by HrpL, as indicated by miniTn5gus mutagenesis. This

rated by reference in its entirety)
A sixty-second nucleic acid encodes ORFO1152 and has

protein possesses N-terminal Hop features (see U.S. patent 30 a nucleotide Sequence according to SEQ ID NO: 123 as
application Ser. No. 10/341,180 to Collmer et al., filed Jan.

follows:

atgaccittaagaatcaatacitc gttctgctaccc.cggttgtacctotggaalacaggotctacatcgcag
cc.gacaccaccgc.cgg to acggcaa.gagcigacitgagcc tocc ccc.gtogccaatcct gcigg.cgcc-taaa
totagogc.caggtgttcagdaag cacacgggctdaagacgc.gcatc.gctggcaa.gcttitc.cgaacgtcag
accaattitcagtc.tc.gggattcc.cgg cactggtogtact citcaa.ccggcc cittgcgcagogggatto.cg
gagga aggtgagcaggitatcgaac gaggaga.gtcatgatcc.gttgctdaaggaag.cgcatcaactgcag
cgitatggtggagtcgg.cgct gacccatctgaaggcgg caccgacgtct citctgggagcgtoccgc.ccct
toaacggta aggcgtattaccaccalagatttitt.ccgtggctaaag.cct gcc.ccgctg.cgcgaagtc.gca
agcaatggcagdaacgc.caagaccalagatcaagatcaactcacago: aaag.ccctdaaac catcgcagog
gcqgtgaaagagctgagcaccc.ggctic gatcaccagagcaaggtgctogccacagocac coacgcactg
gtogctg.cgc.gtgagcatcttgaatcgctic galacaggccacccc.gc.ccitcgtcgacc galaccactggac
catgc.cagggctc.gc.gttcaacaa.gc.cgacticcaccaccc.gc.ctggccagtcago aactitcgtgagctg
attcagg gtacagacgtgttgcaactggg.cgc.gctgagtgaagggcaggatcaggttgaacagaaag.cc
gagittittct
55

The protein encoded by the nucleic acid molecule has an
amino acid sequence according to SEQ ID NO: 124 as
follows:

MTLRINTRSATPWVPLETGSTSQPTPPPVTARATEPPPVANPAAPKSAPGVQQAHGLKTRIAGKLSERQ
TNFSLGIPGTGRTLNRPLRSGIPEEGEQVSNEESHDPLLKEAHELORMVESALTHLKAAPTSLWERPAP
STVRRITTKIFPWLKPAPLREWASNGSNAKTKIKINSQQSPETIAAAVKELSTRLDHQSKVLATATHAL
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WAAREHLESLEQATPPSSTEPLDHARARVQQADSTTRLASQQLRELIQGTDVLQLGALSEGQDQWEQKA
EFS

Expression of ORFO1152 is activated by HrpL, as indicated
by miniTn5gus mutagenesis (Fouts et al., Proc. Natl. Acad.
Sci. USA 99(4):2275–2280 (2001), which is hereby incor
porated by reference in its entirety). This protein possesses 10
N-terminal Hop features (see U.S. patent application Ser.
No. 10/341,180 to Collmer et al., filed Jan. 13, 2003, which

is hereby incorporated by reference in its entirety), Suggest
ing that it is likely to be secreted.
A sixty-third nucleic acid molecule encodes HopPtoF 15
(formerly AVrPphF ORF2) and has a nucleotide sequence
according to SEQ ID NO: 125 as follows:
ataggtaatatttgcgg caccitcgggctoacgtoatgtgtatagoccatcc catacacaacgaataact
totagotcc citctacatccact catgttggtggagatacactgacatc cattcatcagotttc.gcatagt
cagaga gag cagtttctgaacatgcatgatccaatgagagtaatggg acttgaccatoataccgagctt
ttcagaacgacggatagtc.gctatataaaaaacgataaactc.gcgggcaatccacaatccatgg.cgagt
atccittatgcatgaagaactg.cgc.cccaatcgttittgc.ca.gc.catacaggtgcc.calaccacacgaagca
aggg.cgtacgttcc gaaaagaataaaag.ccaccgatctaggagttcCatcactgaacgtaatgactggc
togctagogc gagacggaattagagct tatgatcacatgagtgataatcaggtotctgtcaaaatgcga
citgg gagattittcticgaaaggggtggcaaggtotatgcc.gacgctitcgtctgtagctdac gatggggaa
acat cacaag citctgattgtcacattgcc.caaaggacagaaagtgcc.ggtogaaagggtotga

HopPtoF has an amino acid sequence according to SEQ ID

35

NO: 126 as follows:
MGNICGTSGSRHWYSPSHTQRITSAPSTSTHWGGDTLTSIHQLSHSQREQ

40

FLNMHDPMRVMGLDHDTELFRTTDSRYIKNDKLAGNPQSMASILMHEELR
PNRFASHTCAQPHEARAYWPKRIKATDLGVPSLNWMTGSLARDGIRAYDH
MSDNQVSVKMRLGDFLERGGKWYADASSVADDGETSOALIVTLPKGOKWP
45
WERW

Contrary to the previously identified sequence of hopPtoF
(see U.S. patent application Ser. No. 10/114.828 to Collmer
et al., filed Apr. 2, 2002, which is hereby incorporated by
reference in its entirety), hopPtoF possesses a rare ATA start
codon, which is believed to be involved in regulating protein
synthesis in DC3000. HopPtoF has been shown to be

50

expressed by DC3000 and it has been shown to be translo
cated in planta, where it is localized to the plant plasma
membrane and has a role in virulence. HopPtoF has also
been shown to cause a hypersensitive response in Arabi
dopsis Col-0. The homologous Pseudomonas Syringae pv.
phaseolicola AVrPpbF effector protein has been shown to
play a role in both development of the hypersensitive
response and virulence in several plants (Tsiamis et al.,
“Cultivar-specific avirulence and virulence functions
assigned to avrPphF in Pseudomonas syringae pv. phaseoli
cola, the cause of bean halo-blight disease.” EMBO J.
19(13):3204-3214 (2000), which is hereby incorporated by
reference in its entirety). Finally, HopPtoF has since been
shown to be cytotoxic to eukaryotic cells, specifically cul
tured mammalian CHO and HEK293 cell lines.

A sixty-fourth nucleic acid molecule encodes IaaLe, and
has a nucleic acid sequence according to SEQ ID NO. 208
as follows:

atgactgccitacgatgtagaaaaggaatggagcagaattitccaatact gcc.gctaaaacto accagaac
aac gattittgaaggtttcaccitaccaggactitcagaaccoacgtaccgatcatggacaaggaaggottc
gcqgcacaaac cqaacgctgccttgagc.gcaac gag.cgcaactgcctgatcggctttaccagtgg cacc
agcggcaac citcaaacgctgtt attactactacgactgttgaagttcgatgaag acagttc.ccgctocaac
gtott.ccgcagdaatggttt cattcaa.ccc.ggtgatcgctg.cgc.ca acct gttcaccatca acctgttt
totg.ccctdaacaa.catcaccaccatgatggcc.ggta actoc ggtgcgcatgtggtgtc.cgtagg.cgat
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atcaccct gctgaccalagagt cactitc gaggcgctdaactic gatcaagctdaacgtactgctic gg.cgta
cc citcgac catcct gcagttcatcgatgccatgcagcago acggtgtgcacatcgatatogaaaaggto
gtottcaatggc gaggg cctogaaaacctttcagaagaaaatcatcagggaa.gc.ctttggc gaac aggto
to catcgtcggcgtatatggcagttcc gaggg.cggcattctgg gttt caccaa.cagoc cittgcc acacc
gaatacgagtttctittc.cgacaaatactitcatc.gagaaagaaggc gacago atcct catcaccitcgttg
acco go gaga actt cacaccgctgcto cqgitatcgc.ctgg gag acaccgcaacgctitt.cgctgaaaggc
gacaagctictatttgactgacatccagogg gaggacatgagcttcaactitcatgggcaacct cattggit
citgggcatcattcaacaag.cgatcaaacagacactgggcc.gcacgctggaaatcCaggttcaccitgtca
gtgact gatgcgc.gcaaagaactggtgaccgtttitc gttcaggcc toggaagttcaacgaagatgaacgc
gccagaatcgaalacago catcgc.cgatatto.cggacatcaac gaggccitat cagaaag accagggcago
gtgctggttgttgc.gcaaggatgc.ca.gagacitacgc.cgtc.tc.ggagcgaggcaaaatgctotacatcatt
gaccgcaggaat

IaaLe, has an amino acid sequence according to SEQ ID
NO: 209 as follows:

MTAYDWEKEWSRISNTAAKTHQNNDFEGFTYQDFRTHWPIMDKEGFAAQTERCLERNERNCLIGFTSGT
SGNLKRCYYYYDCEVDEDSSRSNVFRSNGFIQPGDRCANLFTINLFSALNNITTMMAGNCGAHVVSVGD
ITLLTKSHFEALNSIKLNVLLGVPSTILQFIDAMQOHGVHIDIEKVWFNGEGLKTFQKKIIREAFGEQV
SIWGWYGSSEGGILGFTNSPCHTEYEFLSDKYFIEKEGDSILITSLTRENFTPLLRYRLGDTATLSLKG

DKLYLTDIQREDMSFNFMGNLIGLGIIQQAIKQTLGRTLEIQVHLSVTDARKELWTVFWQASEWNEDER
ARIETAIADIPDINEAYQKDQGSWLVWRKDARDYAVSERGKMLYIIDRRN

expression of a truncated protein or polypeptide from bac

IaaL has significant homology, as detected by BLAST
analysis (O), to IAA-lysine synthetase (GenBank accession
M35373; Roberto et al., Proc. Natl. Acad. Sci. USA 87:

5797–5801 (1990), each of which is hereby incorporated by
reference in its entirety).
Fragments of the above-identified proteins or polypep
tides as well as fragments of full length proteins can also be
used according to the present invention.
Suitable fragments can be produced by several means.
Subclones of the gene encoding a known protein can be
produced using conventional molecular genetic manipula
tion for Subcloning gene fragments, such as described by
Sambrook et al., Molecular Cloning. A Laboratory Manual.
Cold Springs Laboratory, Cold Springs Harbor, N.Y. (1989),
and Ausubel et al. (ed.), Current Protocols in Molecular
Biology, John Wiley & Sons (New York, N.Y.) (1999 and
preceding editions), each of which is hereby incorporated by
reference in its entirety. The subclones then are expressed in
vitro or in vivo in bacterial cells to yield a smaller protein or
polypeptide that can be tested for activity, e.g., as a product
required for pathogen virulence.
In another approach, based on knowledge of the primary
structure of the protein, fragments of the protein-coding
gene may be synthesized using the PCR technique together
with specific sets of primers chosen to represent particular
portions of the protein. Erlich, H. A., et al., “Recent
Advances in the Polymerase Chain Reaction.” Science 252:
1643–51 (1991), which is hereby incorporated by reference.
These can then be cloned into an appropriate vector for

terial cells as described above.
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As an alternative, fragments of a protein can be produced
by digestion of a full-length protein with proteolytic
enzymes like chymotrypsin or Staphylococcus proteinase A,
or trypsin. Different proteolytic enzymes are likely to cleave
different proteins at different sites based on the amino acid
sequence of the particular protein. Some of the fragments
that result from proteolysis may be active virulence proteins
or polypeptides.
Chemical synthesis can also be used to make Suitable
fragments. Such a synthesis is carried out using known
amino acid sequences for the polyppetide being produced.
Alternatively, Subjecting a full length protein to high tem
peratures and pressures will produce fragments. These frag
ments can then be separated by conventional procedures
(e.g., chromatography, SDS-PAGE).
Variants may also (or alternatively) be modified by, for
example, the deletion or addition of amino acids that have
minimal influence on the properties, secondary structure and
hydropathic nature of the polypeptide. For example, a
polypeptide may be conjugated to a signal (or leader)
sequence at the N-terminal end of the protein which co
translationally or post-translationally directs transfer of the
protein. The polypeptide may also be conjugated to a linker
or other sequence for ease of synthesis, purification, or
identification of the polypeptide.
The proteins or polypeptides used in accordance with the
present invention are preferably produced in purified form
(preferably at least about 80%, more preferably 90%, pure)
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by conventional techniques. Typically, the protein or
polypeptide of the present invention is secreted into the
growth medium of recombinant host cells (discussed infra).
Alternatively, the protein or polypeptide of the present
invention is produced but not secreted into growth medium.
In Such cases, to isolate the protein, the host cell (e.g., E.
coli) carrying a recombinant plasmid is propagated, lysed by
Sonication, heat, or chemical treatment, and the homogenate
is centrifuged to remove bacterial debris. The supernatant is
then Subjected to sequential ammonium Sulfate precipita
tion. The fraction containing the protein or polypeptide of
interest is subjected to gel filtration in an appropriately sized
dextran or polyacrylamide column to separate the proteins.
If necessary, the protein fraction may be further purified by
HPLC.

5

10

Suitable vectors include, but are not limited to, the
15

Other DNA molecules encoding other effector proteins or
polypeptides can also be identified by determining whether
such DNA molecules hybridize under stringent conditions to
a nucleic acid molecule as identified above. An example of
Suitable stringency conditions is when hybridization is car
ried out for about 8 to about 20 hours at a temperature of
about 37° C. using a hybridization medium that includes
0.9x sodium citrate (“SSC) buffer, followed by washing for
about 5 minutes to about 1 hour with 0.2XSSC buffer at 37°

C. Higher stringency can readily be attained by increasing
the temperature for either hybridization or washing condi
tions or increasing the sodium concentration of the hybrid
ization or wash medium. Nonspecific binding may also be
controlled using any one of a number of known techniques
Such as, for example, blocking the membrane with protein
containing solutions, addition of heterologous RNA, DNA,
and SDS to the hybridization buffer, and treatment with
RNase. Wash conditions are typically performed at or below
stringency. Exemplary high Stringency conditions include
carrying out hybridization at a temperature of about 42°C.
up to and including about 65° C. (inclusive of all tempera
ture in such range) for about 8 up to about 20 hours in a
hybridization medium containing 1M NaCl, 50 mM Tris
HCl, pH 7.4, 10 mM EDTA, 0.1% sodium dodecyl sulfate
(SDS), 0.2% ficoll, 0.2% polyvinylpyrrolidone, 0.2% bovine
serum albumin, and 50 lug/ml E. coli DNA, followed by
washing for about 5 minutes to about 1 hour, at about 42°C.
up to and including about 65° C. (inclusive of all tempera
tures in such range) in a 0.2xSSC buffer. Such hybridizing
nucleic acid molecules preferably hybridize over substan
tially over their entire length. Moreover, such hybridizing
nucleic acid molecules does not include previously reported
nucleic acid molecules that encode effector proteins.
The delivery of effector proteins or polypeptides can be
achieved in several ways: (1) as a stable transgene; (2)
transiently expressed via Agrobacterium or viral vectors; (3)
delivered by the type III secretion systems of disarmed
pathogens or recombinant nonpathogenic bacteria which
express a functional, heterologous type III Secretion system;
or (4) delivered via topical application followed by TAT
protein transduction domain-mediated spontaneous uptake

following viral vectors such as lambda vector system gt11,
gt WES...thB, Charon 4, and plasmid vectors such as pBR322,
pBR325, p.ACYC177, p.ACYC1084, puC8, puC9, puC18,
pUC19, pI G339, pR290, pKC37, pKC101, SV 40, pBlue
script II SK +/- or KS +/- (see "Stratagene Cloning Sys
tems’ Catalog (1993) from Stratagene, La Jolla, Calif.,
which is hereby incorporated by reference), pOE, pIH821,
pGEX, pET series (see F. W. Studier et. al., “Use of T7 RNA
Polymerase to Direct Expression of Cloned Genes. Gene
Expression Technology Vol. 185 (1990), which is hereby
incorporated by reference in its entirety), and any derivatives
thereof. Recombinant molecules can be introduced into cells
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into cells. Each of these is discussed infra.

The DNA molecule encoding the protein or polypeptide
can be incorporated in cells using conventional recombinant
DNA technology. Generally, this involves inserting the DNA
molecule into an expression system to which the DNA
molecule is heterologous (i.e. not normally present). The
heterologous DNA molecule is inserted into the expression
system or vector in proper sense orientation and correct
reading frame. The vector contains the necessary elements
for the transcription and translation of the inserted protein
coding sequences.

112
U.S. Pat. No. 4,237,224 to Cohen and Boyer, which is
hereby incorporated by reference in its entirety, describes the
production of expression systems in the form of recombinant
plasmids using restriction enzyme cleavage and ligation
with DNA ligase. These recombinant plasmids are then
introduced by means of transformation and replicated in
unicellular cultures including prokaryotic organisms and
eukaryotic cells grown in tissue culture.
Recombinant genes may also be introduced into viruses,
Such as vaccina virus. Recombinant viruses can be generated
by transfection of plasmids into cells infected with virus.

60

65

via transformation, particularly transduction, conjugation,
mobilization, or electroporation. The DNA sequences are
cloned into the vector using standard cloning procedures in
the art, as described by Sambrook et al., Molecular Cloning:
A Laboratory Manual, Cold Springs Laboratory, Cold
Springs Harbor, N.Y. (1989), which is hereby incorporated
by reference in its entirety.
A variety of host-vector systems may be utilized to
express the protein-encoding sequence(s). Primarily, the
vector system must be compatible with the host cell used.
Host-vector systems include but are not limited to the
following: bacteria transformed with bacteriophage DNA,
plasmid DNA, or cosmid DNA; microorganisms such as
yeast containing yeast vectors; mammalian cell systems
infected with virus (e.g., vaccinia virus, adenovirus, etc.);
insect cell systems infected with virus (e.g., baculovirus);
and plant cells infected by bacteria. The expression elements
of these vectors vary in their strength and specificities.
Depending upon the host-vector System utilized, any one of
a number of Suitable transcription and translation elements
can be used.

Different genetic signals and processing events control
many levels of gene expression (e.g., DNA transcription and
messenger RNA (mRNA) translation).
Transcription of DNA is dependent upon the presence of
a promoter which is a DNA sequence that directs the binding
of RNA polymerase and thereby promotes mRNA synthesis.
The DNA sequences of eukaryotic promoters differ from
those of prokaryotic promoters. Furthermore, eukaryotic
promoters and accompanying genetic signals may not be
recognized in or may not function in a prokaryotic system,
and, further, prokaryotic promoters are not recognized and
do not function in eukaryotic cells.
Similarly, translation of mRNA in prokaryotes depends
upon the presence of the proper prokaryotic signals which
differ from those of eukaryotes. Efficient translation of
mRNA in prokaryotes requires a ribosome binding site
called the Shine-Dalgarno (“SD) sequence on the mRNA.
This sequence is a short nucleotide sequence of mRNA that
is located before the start codon, usually AUG, which
encodes the amino-terminal methionine of the protein. The
SD sequences are complementary to the 3'-end of the 16S
rRNA (ribosomal RNA) and probably promote binding of
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contain a type III secretion system include many pathogenic
Gram-negative bacterium, Such as numerous Erwinia spe
cies, Pseudomonas species, Xanthomonas species, etc.
Other type III secretion systems are known and still others
by reference in its entirety.
5 are continually being identified. Pathogenic bacteria that can
Promoters vary in their “strength” (i.e. their ability to be utilized to deliver effector proteins or polypeptides are
promote transcription). For the purposes of expressing a preferably disarmed according to known techniques, i.e., as
cloned gene, it is desirable to use strong promoters in order described above. Alternatively, isolation of the effector
to obtain a high level of transcription and, hence, expression protein or polypeptide from the host cell or growth medium
of the gene. Depending upon the host cell system utilized, 10 can be carried out as described above.
any one of a number of suitable promoters may be used. For
Another aspect of the present invention relates to a
instance, when cloning in E. coli, its bacteriophages, or transgenic plant which express a protein or polypeptide of
plasmids, promoters such as the T7 phage promoter, lac the present invention and methods of making the same.
promoter, trp promoter, recA promoter, ribosomal RNA
In order to express the DNA molecule in isolated plant
promoter, the P and P. promoters of coliphage lambda and 15 cells or tissue or whole plants, a plant expressible promoter
others, including but not limited, to lacUV5, ompl, bla, lpp, is needed. Any plant-expressible promoter can be utilized
and the like, may be used to direct high levels of transcrip regardless of its origin, i.e., viral, bacterial, plant, etc.
tion of adjacent DNA segments. Additionally, a hybrid Without limitation, two suitable promoters include the nopa
trp-lacUV5 (tac) promoter or other E. coli promoters pro line synthase promoter (Fraley et al., Proc. Natl. Acad. Sci.
duced by recombinant DNA or other synthetic DNA tech- 20 USA 80:4803–4807 (1983), which is hereby incorporated by
niques may be used to provide for transcription of the reference in its entirety) and the cauliflower mosaic virus
inserted gene.
35S promoter (O'Dell et al., “Identification of DNA
Bacterial host cell strains and expression vectors may be Sequences Required for Activity of the Cauliflower Mosaic
chosen which inhibit the action of the promoter unless Virus 35S Promoter,” Nature, 313(6005):810-812 (1985),
specifically induced. In certain operations, the addition of 25 which is hereby incorporated by reference in its entirety).
specific inducers is necessary for efficient transcription of Both of these promoters yield constitutive expression of
the inserted DNA. For example, the lac operon is induced by coding sequences under their regulatory control.
the addition of lactose or IPTG (isopropylthio-beta-D-ga
While constitutive expression is generally suitable for
lactoside). A variety of other operons, such as trp, pro, etc., expression of the DNA molecule, it should be apparent to
are under different controls.
30 those of skill in the art that temporally or tissue regulated
Specific initiation signals are also required for efficient expression may also be desirable, in which case any regu
gene transcription and translation in prokaryotic cells. These lated promoter can be selected to achieve the desired expres
transcription and translation initiation signals may vary in Sion. Typically, the temporally or tissue regulated promoters
'strength' as measured by the quantity of gene specific will be used in connection with the DNA molecule that are
messenger RNA and protein synthesized, respectively. The 35 expressed at only certain stages of development or only in
DNA expression vector, which contains a promoter, may certain tissues.
In some plants, it may also be desirable to use promoters
also contain any combination of various "strong transcrip
tion and/or translation initiation signals. For instance, effi which are responsive to pathogen infiltration or stress. For
cient translation in E. coli requires an SD sequence about example, it may be desirable to limit expression of the
7–9 bases 5' to the initiation codon (ATG') to provide a 40 protein or polypeptide in response to infection by a particu
ribosome binding site. Thus, any SD-ATG combination that lar pathogen of the plant. One example of a pathogen
can be utilized by host cell ribosomes may be employed. inducible promoter is the gstl promoter from potato, which
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mRNA to ribosomes by duplexing with the rRNA to allow
correct positioning of the ribosome. For a review on maxi
mizing gene expression, see Roberts and Lauer, Methods in
Enzymology, 68:473 (1979), which is hereby incorporated

Such combinations include but are not limited to the SD

ATG combination from the cro gene or the N gene of
coliphage lambda, or from the E. coli tryptophan E, D, C, B
or A genes. Additionally, any SD-ATG combination pro
duced by recombinant DNA or other techniques involving
incorporation of synthetic nucleotides may be used.
Once the isolated DNA molecule encoding the polypep
tide or protein has been cloned into an expression system, it
is ready to be incorporated into a host cell. Such incorpo
ration can be carried out by the various forms of transfor
mation noted above, depending upon the vector/host cell
system. Suitable host cells include, but are not limited to,
bacteria, virus, yeast, mammalian cells, insect, plant, and the

is described in U.S. Pat. Nos. 5,750,874 and 5,723,760 to
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like.
Because it is desirable for recombinant host cells to

secrete the encoded protein or polypeptide, it is preferable
that the host cell also possess a functional type III secretion
system. The type III Secretion system can be heterologous to
host cell (Ham et al., “A Cloned Erwinia chrysanthemi Hrp
(Type III Protein Secretion) System Functions in Escheri
chia coli to Deliver Pseudomonas syringae AVr Signals to

60

Plant Cells and Secrete Avr Proteins in Culture, Microbiol.

95:10206-10211 (1998), which is hereby incorporated by
reference in its entirety) or the host cell can naturally possess
a type III secretion system. Host cells which naturally

65

Strittmayer et al., each of which is hereby incorporated by
reference in its entirety.
Expression of the DNA molecule in isolated plant cells or
tissue or whole plants also requires appropriate transcription
termination and polyadenylation of mRNA. Any 3' regula
tory region Suitable for use in plant cells or tissue can be
operably linked to the first and second DNA molecules. A
number of 3' regulatory regions are known to be operable in
plants. Exemplary 3' regulatory regions include, without
limitation, the nopaline synthase 3' regulatory region (Fraley
et al., Proc. Natl. Acad. Sci. USA, 80:4803–4807 (1983),
which is hereby incorporated by reference in its entirety) and
the cauliflower mosaic virus 3' regulatory region (Odell, et
al., Nature, 313(6005):810–812 (1985), which is hereby
incorporated by reference in its entirety).
The promoter and a 3' regulatory region can readily be
ligated to the DNA molecule using well known molecular
cloning techniques described in Sambrook et al., Molecular
Cloning: A Laboratory Manual, Second Edition, Cold
Spring Harbor Press, NY (1989), which is hereby incorpo
rated by reference in its entirety.
One approach to transforming plant cells with a DNA
molecule of the present invention is particle bombardment
(also known as biolistic transformation) of the host cell. This
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can be accomplished in one of several ways. The first
involves propelling inert or biologically active particles at
cells. This technique is disclosed in U.S. Pat. Nos. 4,945,

116
Preferably, transformed cells are first identified using,
e.g., a selection marker simultaneously introduced into the
host cells along with the DNA molecule of the present

050, 5,036,006, and 5,100,792, all to Sanford, et al., each of

which is hereby incorporated by reference in its entirety.
Generally, this procedure involves propelling inert or bio
logically active particles at the cells under conditions effec
tive to penetrate the outer surface of the cell and to be
incorporated within the interior thereof. When inert particles
are utilized, the vector can be introduced into the cell by
coating the particles with the vector containing the heter
ologous DNA. Alternatively, the target cell can be sur
rounded by the vector so that the vector is carried into the
cell by the wake of the particle. Biologically active particles
(e.g., dried bacterial cells containing the vector and heter
ologous DNA) can also be propelled into plant cells. Other
variations of particle bombardment, now known or hereafter
developed, can also be used.
Another method of introducing the DNA molecule into
plant cells is fusion of protoplasts with other entities, either
minicells, cells, lysosomes, or other fusible lipid-surfaced
bodies that contain the DNA molecule. Fraley et al., Proc.
Natl. Acad. Sci. USA, 79:1859–63 (1982), which is hereby
incorporated by reference in its entirety.
The DNA molecule may also be introduced into the plant
cells by electroporation. Fromm, et al., Proc. Natl. Acad. Sci.
USA, 82:5824 (1985), which is hereby incorporated by
reference in its entirety. In this technique, plant protoplasts
are electroporated in the presence of plasmids containing the
DNA molecule. Electrical impulses of high field strength
reversibly permeabilize biomembranes allowing the intro
duction of the plasmids. Electroporated plant protoplasts
reform the cell wall, divide, and regenerate.
Another method of introducing the DNA molecule into
plant cells is to infect a plant cell with Agrobacterium
tumefaciens or Agrobacterium rhizogenes previously trans
formed with the DNA molecule. Under appropriate condi
tions known in the art, the transformed plant cells are grown
to form shoots or roots, and develop further into plants.
Generally, this procedure involves inoculating the plant
tissue with a Suspension of bacteria and incubating the tissue
for 48 to 72 hours on regeneration medium without antibi

invention. Suitable selection markers include, without limi
5
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can be used to transform and select transformed host cells in
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Plant tissue suitable for transformation include leaf tissue,

root tissue, meristems, Zygotic and somatic embryos, and
anthers.

After transformation, the transformed plant cells can be
selected and regenerated.

accordance with the present invention. Cells or tissues are
grown on a selection media containing an antibiotic,
whereby generally only those transformants expressing the
antibiotic resistance marker continue to grow.
Once a recombinant plant cell or tissue has been obtained,
it is possible to regenerate a full-grown plant therefrom.
Thus, another aspect of the present invention relates to a
transgenic plant that includes a DNA molecule of the present
invention, wherein the promoter induces transcription of the
first DNA molecule in response to infection of the plant by
an oomycete. Preferably, the DNA molecule is stably
inserted into the genome of the transgenic plant of the
present invention.
Plant regeneration from cultured protoplasts is described
in Evans, et al., Handbook of Plant Cell Cultures, Vol. 1:
(MacMillan Publishing Co., New York, 1983); and Vasil I.
R. (ed.), Cell Culture and Somatic Cell Genetics of Plants,
Acad.

30

otics at 25–28° C.

Agrobacterium is a representative genus of the Gram
negative family Rhizobiaceae. Its species are responsible for
crown gall (A. tumefaciens) and hairy root disease (A.
rhizogenes). The plant cells in crown gall tumors and hairy
roots are induced to produce amino acid derivatives known
as opines, which are catabolized only by the bacteria. The
bacterial genes responsible for expression of opines are a
convenient source of control elements for chimeric expres
sion cassettes. In addition, assaying for the presence of
opines can be used to identify transformed tissue.
Heterologous genetic sequences such as a DNA molecule
of the present invention can be introduced into appropriate
plant cells by means of the Tiplasmid of A. tumefaciens or
the Ri plasmid of A. rhizogenes. The Ti or Ri plasmid is
transmitted to plant cells on infection by Agrobacterium and
is stably integrated into the plant genome. Schell, Science,
237:1176–83 (1987), which is hereby incorporated by ref
erence in its entirety.

tation, markers coding for antibiotic resistance, such as
kanamycin resistance (Fraley et al., Proc. Natl. Acad. Sci.
USA, 80:4803–4807 (1983), which is hereby incorporated
by reference in its entirety). A number of antibiotic-resis
tance markers are known in the art and other are continually
being identified. Any known antibiotic-resistance marker
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Press, Orlando, Vol. I, 1984, and Vol. III (1986), each of
which is hereby incorporated by reference in their entirety.
It is known that practically all plants can be regenerated
from cultured cells or tissues, including but not limited to, all
major species of rice, wheat, barley, rye, cotton, Sunflower,
peanut, corn, potato, Sweet potato, bean, pea, chicory, let
tuce, endive, cabbage, cauliflower, broccoli, turnip, radish,
spinach, onion, garlic, eggplant, pepper, celery, carrot,
Squash, pumpkin, Zucchini, cucumber, apple, pear, melon,
Strawberry, grape, raspberry, pineapple, soybean, tobacco,
tomato, Sorghum, and Sugarcane.
Means for regeneration vary from species to species of
plants, but generally a suspension of transformed protoplasts
or a petri plate containing transformed explants is first
provided. Callus tissue is formed and shoots may be induced
from callus and Subsequently rooted. Alternatively, embryo
formation can be induced in the callus tissue. These embryos
germinate as natural embryos to form plants. The culture
media will generally contain various amino acids and hor
mones, such as auxin and cytokinins. It is also advantageous
to add glutamic acid and proline to the medium, especially
for Such species as corn and alfalfa. Efficient regeneration
will depend on the medium, on the genotype, and on the
history of the culture. If these three variables are controlled,
then regeneration is usually reproducible and repeatable.
After the DNA molecule is stably incorporated in trans
genic plants, it can be transferred to other plants by sexual
crossing or by preparing cultivars. With respect to sexual
crossing, any of a number of standard breeding techniques
can be used depending upon the species to be crossed.
Cultivars can be propagated in accord with common agri
cultural procedures known to those in the field.
Diseases caused by the vast majority of bacterial patho
gens result in limited lesions. That is, even when everything
is working in the pathogen's favor (e.g., no triggering of the
hypersensitive response because of R-gene detection of one
of the effectors), the parasitic process still triggers defenses
after a couple of days, which then stops the infection from
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spreading. Thus, the very same effectors that enable para
sitism to proceed must also eventually trigger defenses.
Therefore, premature expression of these effectors is
believed to “turn on plant defenses earlier (i.e., prior to
infection) and make the plant resistant to either the specific
bacteria from which the effector protein was obtained or
many pathogens. An advantage of this approach is that it
involves natural products and plants seem highly sensitive to
pathogen effector proteins.
According to one embodiment, a transgenic plant is
provided that contains a heterologous DNA molecule of the
present invention. When the heterologous DNA molecule is
expressed in the transgenic plant, plant defenses are acti
vated, imparting disease resistance to the transgenic plant.
The transgenic plant can also contain an R-gene whose
product is activated by the protein or polypeptide product of
the heterologous DNA molecule. The R gene can be natu
rally occurring in the plant or heterologously inserted
therein. By disease resistance, it is believed that the effector
proteins of the present invention can impart to plants resis
tance against bacterial, viral, and/or fungal diseases.
In addition to imparting disease resistance, it is believed
that stimulation of plant defenses in transgenic plants of the
present invention will also result in a simultaneous enhance
ment in growth and resistance to insects.
Alternative to transgenic expression is topical application
of the effector proteins to plants. The embodiments of the
present invention where the effector polypeptide or protein
is applied to the plant can be carried out in a number of ways,
including: 1) application of an isolated protein (or compo
sition containing the same) or 2) application of bacteria
which do not cause disease and are transformed with a gene
encoding the effector protein of the present invention. In the
latter embodiment, the effector protein can be applied to
plants by applying bacteria containing the DNA molecule
encoding the effector protein. Such bacteria are preferably
capable of secreting or exporting the protein so that the
protein can contact plant cells. In these embodiments, the
protein is produced by the bacteria in planta.
Such topical application can be carried out using an
effector-TAT protein, which will afford transduction
domain-mediated spontaneous uptake of the effector protein
into cells. Basically, this is carried out by fusing an 11-amino
acid peptide (YGRKKRRQRRR, SEQ ID No. 127) by
standard rDNA techniques to the N-terminus of the effector
protein, and the resulting tagged protein is taken up into
animal cells by a poorly understood process. This peptide is
the protein transduction domain (PTD) of the human immu
nodeficiency virus (HIV) TAT protein (Schwarze et al.,
“Protein transduction: unrestricted delivery into all cells?
Trends Cell Biol. 10:290–295 (2000), which is hereby incor
porated by reference in its entirety). Other PTDs are known
and can be used for this purpose (Prochiantz, "Messenger
proteins: homeoproteins, TAT and others. Curr. Opin. Cell
Biol. 12:400–406 (2000), which is hereby incorporated by
reference in its entirety). See PCT Application Publication
No. WO 01/19393 to Collmer et al., which is hereby
incorporated by reference in its entirety.
When the effector protein is topically applied to plants, it
can be applied as a composition, which includes a carrier in
the form, e.g., of water, aqueous solutions, slurries, or dry
powders. In this embodiment, the composition contains
greater than about 5 nM of the protein of the present
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cide, nematicide, and mixtures thereof. Suitable fertilizers

Thus, a further aspect of the present invention relates
more generally to a method of modifying a metabolic
pathway in a cell by introducing into the cell an effector
protein or polypeptide of the present invention which inter
acts with a native cellular protein involved in a metabolic
pathway of the cell. As a result of introducing the protein or
polypeptide into the cell, the protein or polypeptide modifies
the metabolic pathway through its interaction with the native
cellular protein. By way of example, it is believed that
HopPtol 2 is a tyrosine phosphatase that interacts with
MAPK
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Yet another aspect of the present invention relates to a
method of causing eukaryotic cell death which is carried out
by introducing into a eukaryotic cell a protein which is
cytotoxic and causes cell death. The eukaryotic cell which is
treated can be either in vitro or in vivo. When treating
eukaryotic cells in vivo, a number of different protein- or
DNA-delivery systems can be employed to introduce the
effector protein into the target eukaryotic cell.
Another aspect of the present invention relates to a
method of inhibiting programmed cell death which is carried
out by introducing into a eukaryotic cell Susceptible to
programmed cell death, a protein that is a hypersensitive
response Suppressor, where the introduction thereof is per
formed under conditions effective to inhibit programmed
cell death of the eukaryotic cell. By inhibiting programmed
cell death, it is intended that such inhibition includes both

delaying the occurrence of programmed cell death as well as
preventing programmed cell death. The eukaryotic cell
which is treated can be either in vitro or in vivo. When

invention.

Although not required, this composition may contain
additional additives including fertilizer, insecticide, fungi
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include (NH)NO. An example of a suitable insecticide is
Malathion. Useful fungicides include Captan.
Other suitable additives include buffering agents, wetting
agents, coating agents, and, in Some instances, abrading
agents. These materials can be used to facilitate the process
of the present invention.
According to one embodiment, a transgenic plant includ
ing a heterologous DNA molecule of the present invention
expresses one or more effector proteins, wherein the trans
genic plant is capable of Supporting growth of compatible
nonpathogenic bacteria. The compatible nonpathogenic bac
teria can be naturally occurring or it can be recombinant.
Preferably, the nonpathogenic bacteria is recombinant and
expresses one or more useful products. Thus, the transgenic
plant becomes a green factory for producing desirable
products. Desirable products include, without limitation,
products that can enhance the nutritional quality of the plant
or products that are desirable in isolated form. If desired in
isolated form, the product can be isolated from plant tissues.
To prevent competition between the non-pathogenic bacteria
which express the desired product and those that do not, it
is possible to tailor the needs of recombinant, non-patho
genic bacteria so that only they are capable if living in plant
tissues expressing a particular effector protein or polypep
tide of the present invention.
The effector proteins or polypeptides of the present inven
tion are believed to alter the plant physiology by shifting
metabolic pathways to benefit the parasite and by activating
or Suppressing cell death pathways. Thus, they may also
provide useful tools for efficiently altering the nutrient
content of plants and delaying or triggering Senescence.
There are agricultural applications for all of these possible
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treating eukaryotic cells in vivo, a number of different
protein- or DNA-delivery systems can be employed to
introduce the effector protein into the target eukaryotic cell.
By way of example, hypersensitive response Suppressor
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proteins include, without limitation, AVrPphE,
AvrPpiB1, AvrPtoB, HopPtold 1, HopPtoE, HopPtoF (pre
viously designated AvrPphF ORF2), and HopPtoK.
Because programmed cell death (including apoptosis) is
involved in the pathogenesis of a variety of diseases, the HR
Suppressor proteins of the present invention can be used in
the regulation thereof and, thus, as therapeutic agents in the
intervention of a wide array of disease processes or maladies
(see Rudin & Thompson, Ann. Rev. Med. 48:267-81 (1997),
which is hereby incorporated by reference in its entirety).
The protein- or DNA-delivery systems can be provided in
the form of pharmaceutical compositions which include the
delivery system in a pharmaceutically acceptable carrier,
which may include suitable excipients or stabilizers. The
dosage can be in Solid or liquid form, Such as powders,
Solutions, Suspensions, or emulsions. Typically, the compo
sition will contain from about 0.01 to 99 percent, preferably
from about 20 to 75 percent of active compound(s), together
with the carrier, excipient, stabilizer, etc.
The compositions of the present invention are preferably
administered in injectable or topically-applied dosages by
Solution or Suspension of these materials in a physiologically
acceptable diluent with a pharmaceutical carrier. Such car
riers include sterile liquids, such as water and oils, with or
without the addition of a surfactant and other pharmaceuti
cally and physiologically acceptable carrier, including adju
vants, excipients or stabilizers. Illustrative oils are those of
petroleum, animal, vegetable, or synthetic origin, for
example, peanut oil, soybean oil, or mineral oil. In general,
water, Saline, aqueous dextrose and related Sugar Solution,
and glycols, such as propylene glycol or polyethylene gly
col, are preferred liquid carriers, particularly for injectable

120
the liposome carrier ultimately become permeable and
release the encapsulated drug at the target site. This can be
accomplished, for example, in a passive manner wherein the
liposome bilayer degrades over time through the action of
various agents in the body. Every liposome composition will
have a characteristic half-life in the circulation or at other
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Solutions.

Alternatively, the effector proteins can also be delivered
via Solution or Suspension packaged in a pressurized aerosol
container together with Suitable propellants, for example,
hydrocarbon propellants like propane, butane, or isobutane
with conventional adjuvants. The materials of the present
invention also may be administered in a non-pressurized
form such as in a nebulizer or atomizer.

Depending upon the treatment being effected, the com
pounds of the present invention can be administered orally,
topically, transdermally, parenterally, Subcutaneously, intra
venously, intramuscularly, intraperitoneally, by intranasal
instillation, by intracavitary or intravesical instillation,
intraocularly, intraarterially, intralesionally, or by applica
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tion to mucous membranes, such as, that of the nose, throat,
and bronchial tubes.

Compositions within the scope of this invention include
all compositions wherein the compound of the present

50

invention is contained in an amount effective to achieve its

intended purpose. While individual needs vary, determina
tion of optimal ranges of effective amounts of each compo
nent is within the skill of the art.

One approach for delivering an effector protein into cells
involves the use of liposomes. Basically, this involves
providing a liposome which includes that effector protein to
be delivered, and then contacting the target cell with the
liposome under conditions effective for delivery of the
effector protein into the cell.
Liposomes are vesicles comprised of one or more con
centrically ordered lipid bilayers which encapsulate an aque
ous phase. They are normally not leaky, but can become
leaky if a hole or pore occurs in the membrane, if the
membrane is dissolved or degrades, or if the membrane
temperature is increased to the phase transition temperature.
Current methods of drug delivery via liposomes require that
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sites in the body and, thus, by controlling the half-life of the
liposome composition, the rate at which the bilayer degrades
can be somewhat regulated.
In contrast to passive drug release, active drug release
involves using an agent to induce a permeability change in
the liposome vesicle. Liposome membranes can be con
structed so that they become destabilized when the environ
ment becomes acidic near the liposome membrane (see, e.g.,
Proc. Natl. Acad. Sci. USA 84:7851 (1987); Biochemistry
28:908 (1989), each of which is hereby incorporated by
reference in their entirety). When liposomes are endocy
tosed by a target cell, for example, they can be routed to
acidic endosomes which will destabilize the liposome and
result in drug release.
Alternatively, the liposome membrane can be chemically
modified such that an enzyme is placed as a coating on the
membrane which slowly destabilizes the liposome. Since
control of drug release depends on the concentration of
enzyme initially placed in the membrane, there is no real
effective way to modulate or alter drug release to achieve
“on demand drug delivery. The same problem exists for
pH-sensitive liposomes in that as soon as the liposome
vesicle comes into contact with a target cell, it will be
engulfed and a drop in pH will lead to drug release.
This liposome delivery system can also be made to
accumulate at a target organ, tissue, or cell via active
targeting (e.g., by incorporating an antibody or hormone on
the surface of the liposomal vehicle). This can be achieved
according to known methods.
Different types of liposomes can be prepared according to
Bangham et al., J. Mol. Biol. 13:238–252 (1965); U.S. Pat.
No. 5,653,996 to Hsu et al.; U.S. Pat. No. 5,643,599 to Lee
et al.; U.S. Pat. No. 5,885,613 to Holland et al.; U.S. Pat. No.
5,631,237 to Dzau et al.; and U.S. Pat. No. 5,059,421 to

Loughrey et al., each of which is hereby incorporated by
reference in their entirety.
An alternative approach for delivery of effector proteins
involves the conjugation of the desired effector protein to a
polymer that is stabilized to avoid enzymatic degradation of
the conjugated effector protein. Conjugated proteins or
polypeptides of this type are described in U.S. Pat. No.
5,681,811 to Ekwuribe, which is hereby incorporated by
reference in its entirety.
Yet another approach for delivery of proteins or polypep
tides involves preparation of chimeric proteins according to
U.S. Pat. No. 5,817,789 to Heartlein et al., which is hereby
incorporated by reference in its entirety. The chimeric pro
tein can include a ligand domain and, e.g., an effector protein
of the present invention. The ligand domain is specific for
receptors located on a target cell. Thus, when the chimeric
protein is delivered intravenously or otherwise introduced
into blood or lymph, the chimeric protein will adsorb to the
targeted cell, and the targeted cell will internalize the chi
meric protein, which allows the effector protein to de
stabilize the cell checkpoint control mechanism, affording
its cytotoxic effects.
When it is desirable to achieve heterologous expression of
an effector protein of the present invention in a target cell,
DNA molecules encoding the desired effector protein can be
delivered into the cell. Basically, this includes providing a
nucleic acid molecule encoding the effector protein and then

US 7,220,583 B2
121
introducing the nucleic acid molecule into the cell under
conditions effective to express the effector protein in the cell.
Preferably, this is achieved by inserting the nucleic acid
molecule into an expression vector before it is introduced

122
EXAMPLES

The following Examples are intended to be illustrative
and in no way are intended to limit the scope of the present

into the cell.

When transforming mammalian cells for heterologous
expression of an effector protein, an adenovirus vector can
be employed. Adenovirus gene delivery vehicles can be
readily prepared and utilized given the disclosure provided
in Berkner, Biotechniques 6:616–627 (1988) and Rosenfeld
et al., Science 252:431–434 (1991), WO 93/07283, WO
93/06223, and WO 93/07282, each of which is hereby
incorporated by reference in their entirety. Adeno-associated
viral gene delivery vehicles can be constructed and used to
deliver a gene to cells. The use of adeno-associated viral
gene delivery vehicles in vitro is described in Chatterjee et
al., Science 258:1485–1488 (1992); Walsh et al., Proc. Natl.
Acad. Sci. 89:7257 7261 (1992); Walsh et al., J. Clin Invest.
94: 1440–1448 (1994); Flotte et al., J. Biol. Chem. 268:
3781–3790 (1993); Ponnazhagan et al., J. Exp. Med 179:
733–738 (1994); Miller et al., Proc. Nat'l Acad. Sci.
91:10183–10187 (1994); Einerhand et al., Gene Ther.
2:336–343 (1995); Luo et al., Exp. Hematol. 23:1261–1267
(1995); and Zhou et al., Gene Ther. 3:223–229 (1996), each
of which is hereby incorporated by reference in their
entirety. In vivo use of these vehicles is described in Flotte
et al., Proc. Nat'l Acad. Sci. 90:10613-10617 (1993); and
Kaplitt et al., Nature Genet. 8:148-153 (1994), each of
which is hereby incorporated by reference in their entirety.
Additional types of adenovirus vectors are described in U.S.

invention.

Materials & Methods for Example 1–2
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Pat. No. 6,057,155 to Wickham et al.; U.S. Pat. No. 6,033,
908 to Bout et al.; U.S. Pat. No. 6,001,557 to Wilson et al.:
U.S. Pat. No. 5,994,132 to Chamberlain et al.; U.S. Pat. No.
5,981,225 to Kochanek et al.; and U.S. Pat. No. 5,885,808

to Spooner et al.; and U.S. Pat. No. 5,871,727 to Curiel, each
of which is hereby incorporated by reference in their
entirety).
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Retroviral vectors which have been modified to form

infective transformation systems can also be used to deliver
nucleic acid encoding a desired effector protein into a target
cell. One such type of retroviral vector is disclosed in U.S.
Pat. No. 5,849,586 to Kriegler et al., which is hereby
incorporated by reference in its entirety.
Regardless of the type of infective transformation system
employed, it should be targeted for delivery of the nucleic
acid to a specific cell type. For example, for delivery of the
nucleic acid into tumor cells, a high titer of the infective
transformation system can be injected directly within the
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tumor site so as to enhance the likelihood of tumor cell

infection. The infected cells will then express the desired
effector protein, thereby causing cytotoxic effects.
Particularly preferred is use of the effector proteins of the
present invention to treat a cancerous condition (i.e., the
eukaryotic cell which is affected is a cancer cell). This can
be carried out by introducing or administering to a patient,
a cytotoxic Pseudomonas protein under conditions effective
to inhibit cancer cell division, thereby treating the cancer
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condition.

By introducing, it is intended that the effector protein is
administered to the patient, preferably in the form of a
composition which will target delivery to the cancer cells.
Alternatively, when using DNA-based therapies, it is
intended that the introducing be carried out by administering
a targeted DNA delivery system to the patient such that the
cancer cells are targeted and the effector protein is expressed
therein. A number of targeted delivery systems are known in
the art and can be employed herewith.
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Strains and Media: Escherichia coli strain DH5O. was used

for cloning experiments, and P. S. tomato DC3000 or deriva
tives and P. S. phaseolicola 3121 were used for secretion or
translocation assays, respectively. Routine culture condi
tions for bacteria are similar to those described (van Dijk et
al., J. Bacteriol. 181:4790 4797 (1999), which is hereby
incorporated by reference in its entirety). Antibiotics were
used at the following concentrations: 100 g/ml ampicillin,
20 ug/ml chloramphenicol, 10 ug/ml gentamicin, 100 ug/ml
rifampicin, 10 g/ml kanamycin, and 20 g/ml tetracycline.
Secretion Assays: All of the secretion assays used P. S.
tomato DC3000 strains carrying a pML 123 derivative con
taining a PCR-cloned ORF (encoding a candidate Hrp
secreted protein) fused to nucleotide sequences that encoded
either the hemagglutinin or FLAG epitopes along with their
native ribosome binding sites (Labes et al., Gene 89:37-46
(1990), which is hereby incorporated by reference in its
entirety). Details about the primers and the constructs are
provided below.
HopPtoE: The hopPtoE gene was cloned using forward
primer
(agtaggatccatagaaaaataccataggggtgca, SEQ ID No. 128)
containing a BamHI site and reverse primer
(agtatictagatcacttgtcatcgtegtCcttgtagtegtcaatcacatgcgcttg.
SEQ ID No: 129) containing an Xbal site and FLAG
epitope codons. The hopPtoC gene was cloned into
plasmid vector plN162.
HopPtoG: The hopPtoG gene was cloned using forward
primer
(atgcggatcccgtatgaccttgtaaaat, SEQID No: 130) contain
ing a BamHI site and reverse primer
(atgctictagatcaag.cgtaatctggaa
catcgtatgggtagccgttgtaaaactgctt, SEQID No. 131) con
taining an Xbal site and HA epitope codons. The
hopPtoG gene was cloned into plasmid vector plN131.
HopPtoH: The hopPtoH gene was cloned using forward
primer
(agtcggatccgataatcctggatgatccattg, SEQID No: 132) con
taining a BamHI site and reverse primer
(agtcctcgagtcacttgtcatcgtcgtccttgtagtettgatgtgccctgtactt,
SEQ ID No: 133) containing an XhoI site and FLAG
epitope codons. The hopPtoH gene was cloned into
plasmid vector plN150.
HopPtol: The hopPtol gene was cloned using forward
primer
(agtaaagcttacgggcagg tattgcaag, SEQ ID No. 134) con
taining a BamHI site and reverse primer
(agtatictagatcacttgtcatcgtegtCcttgtagtettttittgggcagccagcg,
SEQ ID No: 135) containing an Xbal site and FLAG
epitope codons. The hopPtoC gene was cloned into
plasmid vector plN165.
HopPtol: The hopPtoll gene was cloned using forward
primer
(agtaggatcctgcctccaactattggct, SEQID No: 136) contain
ing a BamHI site and reverse primer
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(agtatictagatcacttgtcatcgtcgtccttgtagtictetcgctttgaacgcctg.
SEQ ID No: 137) containing an Xbal site and FLAG
epitope codons. The hopPtoL gene was cloned into
plasmid vector plN224.
HopPtoS1: The hopPtoS1 gene was cloned using forward
primer
(ataggat.ccc.gagaacggcgcggacgtg, SEQ ID No: 138) con
taining a BamHI site and reverse primer
(atatotagatcatttatcatcatcatctittataatcctcgtcagagctictetgc.
SEQ ID No: 139) containing an Xbal site and FLAG
epitope codons. The hopPtoC gene was cloned into
plasmid vector plN142.
HopPtoS2: The hopPtoS2 gene was cloned using forward
primer
(gatggatccacgcacataacaacggtg, SEQID No. 140) contain
ing a BamHI site and reverse primer
(atatctagatcatttatcatcatcatctittataatcaatctgacttaatac, SEQ
ID No: 141) containing an Xbal site and FLAG epitope
codons. The hopPtoC gene was cloned into plasmid
vector plN223.
Constructs carrying different epitope-tagged ORFs were
electroporated into DC3000 and a DC3000 hrcC mutant and
grown in Hrp-inducing conditions (Yuan & He, J. Bacteriol.
178:6399–6402 (1996), which is hereby incorporated by
reference in its entirety). Additionally, all of the DC3000
strains also carried pCPP2318, a construct that contains
blaM lacking signal peptide sequences (Charkowski et al., J.
Bacteriol. 179:3866–3874 (1997), which is hereby incorpo
rated by reference in its entirety). DC3000 cultures were
separated into cell-bound and Supernatant fractions as
described (van Dijk et al., J. Bacteriol. 181:4790 4797

(1999), which is hereby incorporated by reference in its
entirety). Proteins were separated with SDS/PAGE by stan
dard procedures (Sambrook et al., Molecular Cloning. A
Laboratory Manual, Cold Spring Harbor Lab Press, Plain
view, N.Y. (1989), which is hereby incorporated by refer
ence in its entirety), transferred to polyvinylidene difluoride
membranes, and immunoblotted by using anti-FLAG
(Sigma), anti-hemagglutinin (Roche Molecular Biochemi
cals), or anti-B-lactamase (5 Prime->3 Prime) as primary
antibodies. Primary antibodies were recognized by goat
anti-rabbit IgG-alkaline phosphatase conjugate (Sigma),
which were visualized by chemiluminescence by using a
Western-Light chemiluminescence detection system
(Tropix. Bedford, Mass.) and X-Omat X-ray film.
Plant Materials and Translocation Assays: Arabidopsis
thaliana accession Columbia (Col-0) and rps2-201 (Kunkel
et al., Plant Cell 5:865-875 (1993), which is hereby incor
porated by reference in its entirety) mutant plants were
grown in a growth chamber with 12 h of light at 24°C. (22
C. at night) and 70% relative humidity. Details about the
primers and constructs described below.
AvrRpt2: The avrRpt2 gene was cloned using forward
primer
(attggtacctictagaggatccaaccttcaatctgaa, SEQ ID No: 142)
containing KpnI, Xbal, and BamHI sites and reverse
primer
(atgtcgacttagcggtagagcattgcg, SEQID No. 143) contain
ing an Sal site. The avrRpt2 gene was cloned into

plasmid vector pNavrRpt2.

HopPtoG-AVrRpt2: The chimeric gene was cloned using
forward primer
(gcgaatticgttagttgattttgtctagcg, SEQID NO: 144) contain
ing an EcoRI site, and reverse primer (gaggatccg.ccgt
tgtaaaactgcttaga, SEQ ID NO: 145) containing a
BamHI site. The chimeric gene was cloned into plas

mid vector phopPtoGNavrRpt2.
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The partial avrRpt2 gene with the N-terminal 40 codons
deleted was amplified by using standard PCR procedures
and cloned into pMOD (Epicentre Technologies, Madi
son, Wis.). After confirmation by sequence analysis, it
was cloned into the KpnI and SalI sites of the broad-host
plasmid pLK, resulting in paavrRpt2. DNA fragments
spanning 200 bp upstream of the Hrp boxes and the
complete ORF for hopPtoG was cloned into paavrRpt2 to
produce phopPtoG-AavrRpt2. The construct was intro
duced in P. S. phaseolicola 3121 by electroporation.

Bacterial strains in 10 mM MgCl, at a cell density of 10
15

colony-forming units/ml were infiltrated into A. thaliana
Col-0 and Col-0 rps2-201 plants with a needleless
Syringe.
Identification of Putative Effector Protein ORFs: Several
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approaches were employed for the identification of putative
effector proteins, including the use of a Hidden Markov
Model to analyze regions upstream of ORFs for hrp-related
promoters (Fouts et al., Proc. Natl. Acad. Sci. USA 99(4):
2275–2280 (2001), which is hereby incorporated by refer
ence in its entirety), a miniTn5gus transposon-based assay
which identifies HrpL-activated insertions, via insertions
downstream of Hrp boxes (Fouts et al., Proc. Natl. Acad. Sci.
USA99(4):2275–2280 (2001), which is hereby incorporated
by reference in its entirety), and computer search for can
didate Hrp-secreted proteins based on an algorithm that
identifies compliance or non-compliance with export signal
rules of known effector proteins (N-terminal 50 amino acids)
(Petnicki-Ocwieja et al., Proc. Natl. Acad. Sci. USA
99:7652–7657 (2002); U.S. patent application Ser. No.
10/341,180 to Collmer et al., filed Jan. 13, 2003, each of

which is hereby incorporated by reference in its entirety).
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Materials & Methods for Example 3–8
Bacterial Strains, plasmids, and media: Escherichia coli
strains DH5C. and DB3.1. (Invitrogen) were used for general
cloning and Gateway technology manipulations, respec
tively. P. S. pv. tomato DC3000 and P. fluorescens strains
were grown in King's B (KB) broth at 30° C. (King et al.,
J. Lab. Med. 22:301–307 (1954), which is hereby incorpo
rated by reference in its entirety). E. coli and Agrobacterium
tumefaciens C58C1 were grown in LB broth at 37° C. or 30°
C., respectively. Unless otherwise noted, constructs used
were made by PCR and Table 1 below includes a list of
nucleotide primer sequences that were used. The pHIR11
derivative, pIN 18, which lacks she A and hopPsyA was
generated as described previously (van Dijk et al., Mol.
Microbiol. 44:1469–1481 (2002), which is hereby incorpo
rated by reference in its entirety). Briefly, 2 kb regions
upstream and downstream of she A and hopPsyA were PCR
cloned into pEBluescript-II KS on either side of an inptII
antibiotic marker. When transformed into the E. coli strain

C2110 (Kahn and Hanawalt, J. Mol. Biol. 128:501-525
(1979), which is hereby incorporated by reference in its
entirety) containing pHIR11, this construct recombined into
pHIR11 because ColE1 plasmids, such as pBluescript-II KS,
cannot replicate in this polA mutant at 42° C. When this
strain was grown at 30° C., the ColE1 replicon replicated,
forcing it to recombine out of pHIR11. pHIR11 derivatives
that lacked she A and hopPsy A were identified with PCR.
Antibiotics were used at the following concentrations (ug/
ml): rifampicin, 100; ampicillin, 100; gentamicin, 10; kana
mycin, 50; tetracycline. 20; nalidixic acid, 20; and specti
nomycin 50.
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TABLE 1-continued

Additional information on plasmid constructions
Gene

Primer Nucleotide Sequences (5'-->3') and Other

Name

Relevant Features

NO:

avrPpiB1P

P860: ttggatccgtatgcacgcaaatcctittaagctic
(Bam HI)

200 pCilda

P861: ttctegagtcagtcgcctaggaaattatttagttcc

2O1

hopPtoE

(Xho I)
P858: ttgaatticatgaatagagttccggtagctic (Eco RI)

hopPtoF
hopPtoG

P859: ttctegagtcagtcaatcacatgcgcttgg (Xho I)
P856: ttgaatticatgggtaatatttgcggcacctic (Eco RI)
P857: ttctegagtcagacccttitcga.ccgg (Xho I)
P862: ttgaatticatgcaaataaagaacagtcatcto (Eco RI)
P863: ttctegagtcagccgttgtaaaactgcttagag (Xho I)

SEQ ID Parent
Plasmid

202 pCilda
2O3
204 pGilda
205
206 pCilda
2O7

Hypersensitive Response Assays: The broad-host-range vec
tor pML 123 was used to express effector genes in
Pseudomonas strains (Labes et al., Gene 89:37-46 (1990),
which is hereby incorporated by reference in its entirety).
The pML 123 constructs containing hopPtoC, hopPtold1,
hopPtol)2, and hopPtol are described in U.S. patent appli
cation Ser. No. 10/114.828 to Collmer et al., filed Apr. 2,
2002, which is hereby incorporated by reference in its
entirety; and pML 123 constructs containing hopPtoE, hopP
toG, hopPtoh, hopPtol, hopPtoL, hopPtoS1, and hopPtoS2
are described above. A pML 123 construct containing hopP
toB was similarly prepared. pML123 constructs containing
hopPtoF, hopPtoK, hopPtoT, avrPtoB, avrPphEPto,
avrPpiB1Pto, and avrPto are detailed in Table 1. Pfluore
scens(pHIR11) carrying pML 123 constructs with effector

bodies. Generation of anti-AVrPto antibodies has been

described (van Dijk et al., J. Bacteriol. 181:4790 4797
(1999), which is hereby incorporated by reference in its

pLN504
pLN505
pLN506

from Chemicon International and the anti-FLAG antibodies

25

30

genes or vector controls with an OD600 of 0.2 (ca. 10
Otiana tabacum cv. Xanthi, N. benthamiana, or A. thaliana

pLN507

entirety). The anti-B-lactamase antibodies were purchased

cells/ml) in 5 mM MES (pH 5.6) and infiltrated into Nic
WS-0 leaves. For bacterial mixing experiments involving
two different P. fluorescens strains, Pfluorescens(pLN 18)
and a pML 123 effector construct were infiltrated 2 h before
P. fluorescens(pHIR11). The plants were scored for the
production of an HR after 24 h. DC3000 strains were tested
for their ability to elicit an HR on Nicotiana tabacum cv.
xanthi by infiltrating strains with an OD600 of 0.2 along
with 10-fold serially diluted samples with a needleless
Syringe.
Type III secretion assays, SDS-PAGE, and immunoblot
analysis: DC3000 and DC3000 hrcC mutant (Yuan and He,
J. Bacteriol. 178:6399–6402 (1996), which is hereby incor
porated by reference in its entirety) carrying the plasmids
pLN162, pIN526, pCPP2318, which encode for HopPtoE
FLAG, AVrPto, and B-lactamase, respectively, were grown
in type III-inducing minimal medium (Huynh et al., Science
245:1374–1377 (1989), which is hereby incorporated by
reference in its entirety). Cells were adjusted to an initial
OD600 of 0.3 and grown for 6 h and separated into cell
bound and Supernatant fractions by centrifugation at 4° C.
Protein samples from bacterial cultures were prepared simi
larly as described (van Dijk et al., J. Bacteriol.
181:4790 4797 (1999), which is hereby incorporated by
reference in its entirety). Cell and supernatant fractions were
analyzed by SDS-PAGE (Sambrook and Russell, Molecular
Cloning: A Laboratory Manual, Cold Spring Harbor Labo
ratory Press, Cold Spring Harbor, N.Y. (2001), which is
hereby incorporated by reference in its entirety), transferred
to polyvinylidene difluoride membranes, and immunobloted
using anti-AVrPto, -8-lactamase, or -FLAG as primary anti

Plasmid
Construct
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were purchased from Sigma Chemical Co. Primary antibod
ies were recognized by goat anti-immunoglobulin G-alka
line phosphatase conjugate (Sigma Chemical Co.), and
visualized by chemiluminescence using a chemiluminces
cence detection system and X-Omat X-ray film.
Agrobacterium-mediated transient assays: The avr gene
hopPsyA was recombined into a derivative of pPZP212
(Hajdukiewicz et al., Plant Mol. Biol. 25:989–994 (1994),
which is hereby incorporated by reference in its entirety),
pIN462, which was modified to be a Gateway Destination
vector, resulting in plN474. The bax gene was PCR-cloned
into pTA7002, creating plN531, and expression of bax was
induced with dexamethasome as previously described
(Aoyama and Chua, Plant Journal 11:605–612 (1997),
which is hereby incorporated by reference in its entirety).
The effector genes carried on Gateway entry vectors avrP
phEPto, avrPpiB1Pto, avrPtoB, hopPtoE, hopPtoF, and
hopPtoG were recombined into pIN462 (which fused each
gene to a hemagglutinin epitope) creating constructs
pLN535, pI N503, pI N502, pI N524, pI N525, and
pIN530, respectively. Agrobacterium-mediated transient
expression experiments were done by infiltrating A. tume
faciens C58C1 (van Larebeke et al., Nature 252: 169-170
(1974), which is hereby incorporated by reference in its
entirety) harboring the disabled Tiplasmid pMP90 (Koncz
and Schell, Mol. Gen. Genet. 204:383–396 (1986), which is
hereby incorporated by reference in its entirety) at an
OD600 of 0.4 into N. benthamiana and N. tabacum cv.
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xanthi plants using a needleless Syringe as described (van
den Ackerveken et al., Cell 87: 1307–1316 (1996), which is
hereby incorporated by reference in its entirety). For co
expression experiments, Agrobacterium strains carrying
pPZP212 binary plasmids with different effector genes were
infiltrated 4h prior to infiltration of strains expressing either
Bax or HopPsyA. Evidence of production of effectors from
transient assays was acquired by harvesting 1 cm diameter
leaf disks from infiltrated Zones, grinding leaf tissue with a
mortar and pestle in the presence of liquid nitrogen, and
resuspending plant material in 50 ul of 1x SDS-PAGE
tracking buffer. SDS-PAGE and immunoblot analysis were
performed as described above using high affinity anti
hemagglutinin antibodies (Roche).
Construction of DC3000 effector mutants: In-frame internal

65

fragments of the effector genes were PCR cloned into XcmI
digested pKnockout-. (Windgassen et al., FEMS Microbiol.
Lett. 193:201–205 (2000), which is hereby incorporated by
reference in its entirety) using the primer sets listed in Table
1 above. The resulting constructs were conjugated sepa
rately into DC3000 by triparental mating using spectinomy
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cin as selection for the plasmid marker. The following
effector mutants were confirmed with primers that flanked
each coding region: hopPtol) 1, UNL104; hopPtoC,
UNL106; hopPtoE, UNL139; hopPtoK, UNL107; hopPtol,
UNL108; hopPtoF, UNL109; avrPhEPto, UNL113:
avrPpiB1Pto, UNL114; hopPtoH, UNL118; hopPtoT,
UNL122; hopPtoG, UNL124; hopPtoS1, UNL126; and
avrPtoB, UNL127.

Yeast viability assays: To determine whether type III effec
tor-encoding plasmids rescued yeast from Bax-induced
lethality, the effector genes avrPphEPto, avrPpiB1Pto, hopP
toG, hopPtoF, and hopPtoE were PCR-cloned into the yeast
expression vector pGilda (Clontech, Palo Alto, Calif.) result
ing in constructs plN508, pI N507, pILN506, pILN505, and
pIN504, respectively. Table 1 above contains information
for the nucleotide primers used to make these constructs. S.
cerevisiae EGY48 strain containing pG4-5-Bax (kindly
provided by J. C. Reed, Burnham Institute, La Jolla, Calif.)
and various pGilda plasmids containing effector genes were
grown in SC-U-L/glucose media overnight. The chicken
Bcl-XL cloned in pGilda was kindly provided by C. Thomp
son (University of Chicago, Chicago, Ill.), which acted as a
positive control for PCD suppression in these experiments.
The yeast cultures were then serial 10-fold diluted into SC
medium, and 5 ul of each dilution was dropped onto
SC-U-L/Galactose or SC-UL/Glucose plates. Cells were
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with mobile genetic elements suggested horizontal acquisi
tion. Several of the predicted proteins shared amino acid
identity with proteins likely to be effectors. For example,
HopPtoS1 (ORF5) yields several ADP-ribosyltransferases in
BLASTP searches (highest BLAST E value 1e-5), including
a type III-secreted ADP-ribosyltransferase from Pseudomo
nas aeruginosa (Yahr et al., Mol. Microbiol. 22:991–1003
(1996)), and HopPtoh (ORF2) is homologous to an ORF
adjacent to the avrPpiC2 avr gene of P. S. pisi (Arnold et al.,
Microbiology 147: 1171–1182 (2001), which is hereby incor
porated by reference in its entirety) (see Table 2 below).
To test whether these proteins travel the Hrp pathway, the
ORFs were cloned into a broad-host-range vector fused to
either the hemagglutinin or FLAG epitope. DC3000 wild
type and Hrp mutant cultures carrying these constructs were
separated into Supernatant and cell fractions and analyzed
with SDS/PAGE and immunoblots. Five of the eight pro
teins tested were secreted via the DC3000 Hrp system (FIG.
1A) and consequently were designated as HopPtoE, HopP
toG, HopPtoH, HopPtol, and HopPtoS1, respectively.
Although three ORFs (ORF6, ORF 7, and ORF8) were not
detectably secreted in culture, they may still be effectors
because AvrB similarly is not secreted in culture although
translocated in planta (van Dijk et al., J. Bacteriol. 181:
4790 4797 (1999); Gopalan et al., Plant Cell 8:1095-1105
(1996), each of which is hereby incorporated by reference in
its entirety).
TABLE 2

ORFs with 5' Hrp Promoter Sequences and Encoding Proteins
Demonstrated to be Secreted by the P. Syrigae Hrp System
Initial

New

Size

Homolog

GenBank

designation

designation

(bp)

G + C (BLASTP E value)

Accession

ORF1

HopPtol
HopPtoH

1,899

48.9 None

657

47.2 ORF3 from P. s. pisi

NA
CAC 16702

ORF3
ORF4

HopPtoE

636

50.7

HopPtoG

1,482

ORF5

HopPtoS1

852

ORF2f

%

avrPpiC2 locus (le-114)
None

NA

43.7 Hypothetical protein from
R. Solanacearum (le-137)

NP 521884

46.5

P55807

Chicken ADP-

ribosyltransferase (1e-5)

fEach of the listed Genbank Accessions is hereby incorporated by reference in its

entirety.

ORF2: homolog described in Arnold et al., Microbiology 147:1171-1182 (2001), which
*ORF5:homolog described in Tsuchiya et al., J.Biol.Chem. 269:27451-27457 (1994),

is hereby incorporated by reference in its entirety.

which is hereby incorporated by reference in its entirety. Determined to possess an ART
domain (pfam1129), further confirming its similarity to ADP-ribosyltransferases.
50

incubated at 30° C. for 5 days, and photographed. For
oxidative stress experiments, EGY48 strains containing
pGilda effector constructs were grown in SC-U media
overnight and treated as described in Abramovitch et al.
(Abramovitch et al., EMBO 22:60–69 (2003), which is
hereby incorporated by reference in its entirety).

To determine whether the export signal-based search had
identified any novel Hrp-secreted proteins, secretion assays
were also performed on ORF29 and ORF30, both of which
55 seemed to be particularly promising candidates. The prod
ucts encoded by ORF29 and ORF30 share similarity with a
putative type III effector from S. enterica, SrfC, and ADP
ribosyltransferases, respectively. Both ORFs were PCR
Example 1
cloned into a broad-host-range vector fused to the FLAG
60
epitope, and each construct was introduced into DC3000
wild-type
and Hrp mutant strains. The epitope-tagged
Demonstration of Pseudomonas syringae pv. tomato
ORF29
and
ORF30 proteins were secreted by DC3000 in a
DC3000 Protein Secretion
Hrp-dependent
manner without leakage of a cytoplasmic
From the hidden Markov model analysis, 28 candidate
effector ORFs were identified that were not homologs of 65 marker protein (FIG. 1B), and consequently they were
known Avr proteins/Hops or of any proteins unlikely to be designated as HopPtol, and HopPtoS2, respectively (see
secreted, and whose low G+C '% content and association
Table 3 below).
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TABLE 3

Selected ORFs Encoding Candidate Effector Proteins That Were
Identified by the Genomewide Search Based on Export-Signal Patterns
Homolog
New

Designation
ORF29.

ORF308.

Size

%

Designation (bp) G + C
HopPtoL

270

HopPtoS2

O
795

61.0

46.5

Hrp

promoterf
l

y

Mobile (BLASTP E

GenBank

DNA value)

Accession

l

SPI-2 regulated

AAF74575

in

SrfC (1e-21)
Clostridium

NP 346979

exoenzyme C3
ADP ribosyl
Tansferase (1e-5)
ORF312,

NA

897

49.8

y

y

Chicken ADP

P55807

ribosyl
transferase (5e-3)
ORF32.É.

NA

507

54.2

y

y

Chicken ADP

P55807

ribosyl
transferase (5e-3)
ORF33

NA

282

55.2

l

y

3
ORF34:

NA

534

SepC insecticidal NP O65279

toxin (1e-128)
63.5

y

in

Lytic enzyme

BAA83137

(3e-36)

findicates that the ORF is within 10 kb of a HrpL-responsive Hrp promoter identified in Fouts

Indicates that a transposon, plasmid, or a phage-related sequence is within 10 kb.
Each of the listed Genbank Accessions is hereby incorporated by reference in its entirety.
"ORF was determined to possess an ART domain (pfam1129), further confirming its similarity to ADP

ribosyltransferases.
Homolog identified in Worley et al., Mol. Microbiol. 36:749-761 (2000), which is hereby incorporated
by reference in its entirety.

Homolog identified in Nolling et al., J. Bacteriol. 183:4823-4838 (2001), which is hereby incorporated

by reference in its entirety.

Homolog identified in Tsuchiya et al., J. Biol. Chem. 269:27451-27457 (1994), which is hereby incor
Homolog identified in Hurst et al., J. Bacteriol. 182:51.27-5138 (2000), which is hereby incorporated

porated by reference in its entirety.

by reference in its entirety.
*Homolog identified in Nakayama et al., Mol. Microbiol. 38:213-231 (2000), which is hereby incorpo
rated by reference in its entirety.
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Interestingly, the export signal-based search found a puta
tive effector, SrfC, that is predicted to travel the type III
pathway encoded by SPI2 of S. enterica (Worley et al., Mol.
Microbiol. 36:749-761 (2000), which is hereby incorporated
by reference in its entirety). A further indicator of the
efficacy of the search was the finding of three additional
ADP-ribosyltransferases, ORF 30, 31, and 32, all with
significant amino acid sequence identity to HopPtoS 1
(Table 3).
Example 2
AvrRpt2 Translocation Assay Indicates that at Least One of
the Additional Hops Is Translocated into Plant Cells.
HopPtoG was selected to test for translocation into plant
cells because it shared no similarities with any sequences in
the databases and was shown to be secreted (FIG. 1B). P. s.
phaseolicola carrying a plasmid expressing hopPtoG-A avr
Rpt2 elicited an RPS2-dependent hypersensitive response in
A. thaliana Col-0 (FIG. 1C), indicating that targeting infor
mation in HopPtoG directed translocation of the AvrRpt2
fusion protein into plant cells. Thus, HopPtoG appears to be
a Hrp-injected effector protein.
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Discussion of Examples 1-2
One demonstration of the selectivity of the export signal
rules is that only the chicken ADP-ribosyltransferase

NRT2, shows major violations of the rules even though

this protein is more similar to HopPtoS1 and S2 than either
of the type III-secreted ADP-ribosyltransferases from P
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aeruginosa, ExoS and ExoT (see Petnicki-Ocwieja et al.,
Proc. Natl. Acad. Sci. USA 99:7652–7657 (2002); U.S.
patent application Ser. No. 10/341,180 to Collmer et al., filed
Jan. 13, 2003, each of which is hereby incorporated by
reference in its entirety).
HopPtoS1 and HopPtoS2 share sequence similarity with
ADP-ribosyltransferases, proteins that have long been impli
cated in bacterial pathogenesis in animals through the modi
fication of host signal transduction pathways (Finlay &
Falkow, Microbiol. Mol. Biol. Rev. 61:136–169 (1997),
which is hereby incorporated by reference in its entirety),
but until now have not been implicated in the bacterial
pathogenesis of plants. The DC3000 genomic studies
described in Fouts et al. (Proc. Natl. Acad. Sci. USA
99:2275–2280 (2002), which is hereby incorporated by
reference in its entirety) clearly show that several of the
effectors in DC3000 are redundant. By using the pattern
based export prediction, three ADP-ribosyltransferase genes
(in addition to hopPtoS1) that have N-termini putative
export signals were identified in the genome of DC3000.
One of these, ORF32, appears to be truncated. The other
two, HopPtoS2 and ORF31, are full-length genes based on
sequence alignments. HopPtoS2 is secreted by the Hrp
system (FIG. 1B) and ORF31 shares high amino acid
sequence identity with the Hrp-secreted HopPtoS1. Inter
estingly, HopPtoS1 contains putative myristoylation and
palmitoylation sites at its N terminus, whereas the other two
do not, indicating that HopPtoS1 may be localized to the
plasma membrane. Thus, there appear to be at least three
Hrp-secreted ADP-ribosyltransferases and these may local
ize to different regions of the plant cell. The existence of
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these proteins in Pseudomonas Syringae is particularly note
worthy given that ADP-ribosyltransferase genes have not
been identified in the bacterial plant pathogen genomes that
have been published thus far (Simpson et al., Nature 406:
151-159 (2000); Wood et al., Science 294:2317-2323
(2001); Goodner et al., Science 294:2323–2328 (2001):
Salanoubat et al., Nature 415:497–502 (2002), each of
which is hereby incorporated by reference in its entirety).
Significantly, the genomewide search for export signals
yielded a homolog of the S. enterica candidate effector SrfC,
further adding to the growing list of effectors shared between
plant and animal pathogens. It is also noteworthy that one of
the ORFs found by the genomewide search (ORF48) is a
homolog of a bacterial catalase (BLASTP 1e-126), and
another (ORF49) is a glucokinase homolog (BLASTP
3e-42). These putative effectors likely have a role in oxida
tive stress and regulation of Sugar metabolism, respectively.
Example 3
HopPtoE Suppresses the Hypersensitive Response in
Tobacco and a DC3000 hopPtoE Mutant Possesses an
Enhanced Hypersensitive Response Phenotype
In the course of experiments with confirmed DC3000 type
III effectors, the effector HopPtol 2 was observed capable of
suppressing the HR elicited by P. S. phaseolicola on Nic
Otiana benthamiana plants. These results prompted the
screening other effector proteins for HR suppressor activity
(Collmer et al., Trends Microbiol. 10:462-470 (2002)). To
do this, the pHIR11 system was used, allowing nonpatho
gens such as E. coli and Pfluorescens to elicit the HR and

5

and it was crucial to consider this alternative. To test this,
DC3000 and a DC3000 hrcC mutant defective in the TTSS,

10

15

vided in trans to UNL 139, the mutant strain was less

effective at HRelicitation than DC3000 (FIG. 2C). Thus, the
enhanced HR phenotype of the hopPtoE mutant was
complemented by hopPtoE. These observations are consis
tent with HopPtoE acting as an HR Suppressor and Suggest
that HopPtoE contributes incrementally to the ability of the
pathogen to Suppress the HR.
Example 4
HopPtoE. Does Not Block the DC3000 Type III Secretion
System
One possible explanation for the observed phenotypes
was that HopPtoE was blocking the type III secretion of

AvrPto and HopPtoE were secreted in culture via the TTSS
(FIG. 3B), indicating that, at least in culture, over-expres
sion of hopPtoE did not block type III secretion. It was next
determined whether expression of hopPtoE in DC3000
altered its HR-eliciting ability. Because DC3000 contains a
native copy of hopPtoE in its genome, these experiments
actually tested whether over-expression of HopPtoE altered
the HR phenotype. DC3000 strains, with and without plas
mid-encoded hopPtoE, were infiltrated into tobacco at high

inoculum levels (10 cells/ml). After 24 hours, DC3000
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UNL 139, elicited an HR in tobacco when infiltrated into leaf

panels at high inoculum (FIG. 2C).
Based on this result, it is likely that effectors have
functionally redundant roles, which may partially mask a
phenotype. Therefore, a more sensitive HR assay was per
formed, where 10-fold serially diluted bacterial strains were
infiltrated into tobacco leaf panels to detect any subtle
difference in the 5 ability of different strains of bacteria to
elicit an HR. When UNL 139 was tested in this assay, it was
more effective than DC3000 at HR elicitation at lower cell
density (FIG. 2C). Interestingly, when hopPtoE was pro

both carrying plasmids that contained avrPto and hopPtoE,
were grown in a medium that induced type III Secretion.
These cultures were separated into Supernatant and cell
fractions, and analyzed them by SDS-PAGE and immuno
blots with either anti-FLAG or -AVrPto antibodies. Both

secrete effectors in culture via the TTSS. This tool allowed

for testing whether individual effectors were capable of
suppressing the HopPsyA-dependent HR as depicted in FIG.
2A. P. fluorescens(pHIR11) strains carrying a number of
different effector constructs were infiltrated into tobacco (N.
tabacum cv. xanthi). Interestingly, HopPtol)2, the effector
that suppressed an HR elicited by P. phaseolicola, did not
suppress the HopPsyA-dependent HR (FIG. 4A). The first
identified effector to suppress or block the HR elicited by P
fluorescens(pHIR11) was HopPtoE (FIG. 2B). To detect a
potential phenotype consistent with HopPtoE acting as an
HR suppressor, a DC3000 mutant defective in HopPtoE was
constructed. Both DC3000 and the hopPtoE mutant,
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other type III substrates, including Avr proteins. There is
actually a precedent for type III substrates, such as HrpZ and
HrpW, to block the type III secretion of proteins from P
syringae (Alfano et al., Mol. Microbiol. 19:715–728 (1996):
Charkowski et al., J. Bacteriol. 180:5211–5217 (1998), each
of which is hereby incorporated by reference in its entirety)

45

elicited an HR on tobacco, whereas DC3000 with a plasmid
containing hopPtoE did not (FIG. 3B), indicating that over
expression of HopPtoE suppressed the HR. However, after
approximately 3 h, DC3000 with hopPtoE in trans also
elicited an HR. Thus, hopPtoE in trans in DC3000 only
delayed the ability of this pathogen to elicit an HR. When
these experiments were repeated in N. benthamiana, the HR
delay was greater than 24 h, indicating that the Suppression
ability of HopPtoE depended to a certain extent on the test
plant. To eliminate the possibility that HopPtoE affected the
ability of Pfluorescens(pHIR11) to deliver the Avr protein
HopPsyA into plant cells, a different bacterial strain was
used to deliver HopPsy A (as compared to the strain used to
deliver HopPtoE) into plant cells. To accomplish this, a
pHIR11 derivative, pIN 18, was constructed so as to lack
hopPsyA and ShcA, a gene that encodes a chaperone for
HopPsyA (van Dijk et al., Mol. Microbiol. 44:1469–148
(2002), which is hereby incorporated by reference in its
entirety). P. fluorescens(pLN 18) does not elicit an HR on
tobacco because it lacks HopPsy A (FIG. 3C), while main
taining the ability to secrete proteins via its functional TTSS.
In planta mixed-inoculum experiments were performed
by first infiltrating into tobacco Pfluorescens(pLN 18) with
hopPtoE contained in a broad-host-range plasmid and, after
2 h, P. fluorescens(pHIR11). P. fluorescens(pHIR11) was
infiltrated at an OD600 sufficient to cause HR elicitation.

50

FIG. 3C shows that P. fluorescens(pLN 18) retained the
ability to suppress the pHIR11-dependent HR. This indicates
that the HR suppression activity does not occur in the
bacterial cell.

Example 5
55

60
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pHIR11 Assays Identify Seven Effectors Capable of Sup
pressing the HopPsyA-Dependent Hypersensitive Response
Nineteen confirmed effector genes were cloned into a
broad-host-range plasmid and tested to determine whether
the encoded effectors were able to suppress the HR elicited
by P. fluorescens(pHIR11) (see FIG. 4A for a list of the
effectors tested). Each candidate Suppressor gene was
expressed in Pfluorescens(pHIR11) and these strains were
infiltrated into tobacco and Arabidopsis thaliana ecotype
Ws-0, two plants that produce an HR in response to pHIR11
containing bacteria.
Surprisingly, seven of the nineteen effectors tested were
able to suppress the pHIR11-dependent HR on both A.
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thaliana and tobacco (FIGS. 4B-C). In planta mixed-inocu
lum experiments similar to those describe in FIG. 3C
demonstrated that all of the identified suppressors were able
to inhibit the pHIR11-dependent HR. These results indicate
that the site of suppressor activity was outside of the
bacteria. Two of the identified suppressors, HopPtoF and
AvrPtoB, were homologs of AvrPphF and VirPphA, respec
tively, two AVr proteins able to “block” the HR produced by
P. S. phaseolicola (Jackson et al., Proc. Natl. Acad. Sci. USA
96:10875–10880 (1999); Tsiamis et al., EMBO J.
19:3204-3214 (2000), each of which is hereby incorporated
by reference in its entirety). The VirPphA homolog, AvrP
toB, was recently reported to suppress the HR elicited by
AvrPto (Abramovitch et al., EMBO J. 22:60–69 (2003),
which is hereby incorporated by reference in its entirety).
Thus, these findings demonstrate that AvrPtoB and HopPtoF
are HR suppressors. The other HR suppressors identified
were AvrPphE, AvrPpiB1, HopPtol)1, and HopPtoK.
The HR suppression observed for HopPtoD1 and HopPtoK
was not complete (i.e., the HR was present, although much
reduced).
Example 6
Agrobacterium Transient Assays that Co-Deliver HopPsyA
and Individual Hypersensitive Response Suppressors Con
firm that Each Effector Alone Suppresses the HopPsyA
Dependent Hypersensitive Response Inside Plant Cells
To determine if the HR suppression is due solely to the
suppressor proteins, both HopPsyA and individual HR Sup
pressor effectors were transiently co-delivered using Agro
bacterium-mediated transient assays (agroinfiltrations) (van
den Ackerveken et al., Cell 87: 1307–1316 (1996), which is
hereby incorporated by reference in its entirety). In each
case, the effector suppressed the HopPsyA-dependent HR
(FIG. 5A). Protein expression was confirmed with immu
noblots that showed the agroinfiltrations produced both
HopPsy A and the specific suppressor tested (FIG. 5B).
These data complement the bacteria-delivered suppressor
data shown above, because agroinfiltrations demonstrate
that the Suppressor activity is dependent only on the Sup
pressor and that the Suppressor acts within plant cells,
whereas the experiments where P. fluorescens(pHIR11)
deliver each Suppressor resemble what happens in nature
and protein levels are closer to the levels that the pathogen
"inject' into plant cells.
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at 10-fold higher dilution than wild type DC3000 (FIG. 6).
As an example, UNL105 caused a confluent HR at a titer of

10° cells/ml, whereas DC3000 only produced a spotty HR or
produced a typical HR at dilutions of 10° cells/ml or higher.
no HR at this titer. It is important to note that DC3000

This enhanced HR phenotype produced by each suppressor
mutant resulted from the absence of the effector, because
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Example 7
50

DC3000 Suppressor Mutants Display an Enhanced Ability
to Elicit a Hypersensitive Response on Nonhost Plants,
Consistent with Loss of Hypersensitive Response Suppres
sion Activity in the Pathogen
Based on the above findings, it was recognized that a
pathogen may encode multiple HR Suppressors, each con
tributing, perhaps incrementally, to the Suppression of the
HR and/or plant defenses. To analyze these proteins in more
detail, mutants defective in each gene corresponding to the
effectors listed in FIG. 4A were made. The ability of
DC3000 and the suppressor mutants to induce defense
responses on non-host plants were tested, similar to the
experiments described in FIG. 2C. Tobacco leaves were

55

Pseudomonas Syringae Hypersensitive Response Suppres
sors Inhibit Programmed Cell Death Induced by the Pro
apoptotic Protein Bax in both Plants and Yeast
The pro-apoptotic mouse protein Bax has been shown to
induce PCD in plants that resembles the HR (Kawai-Yamada
et al., Proc. Natl. Acad. Sci. USA 98: 12295–12300 (2001):
Lacomme and Santa Cruz, Proc. Natl. Acad. Sci. USA

96:7956–7961 (1999), each of which is hereby incorporated
by reference in its entirety). Bax is a member of the Bcl-2
family of pro-apoptotic proteins and is thought to initiate
programmed cell death (PCD) by localizing to the mito
chondria and causing the release of pro-apoptotic factors,
including cytochrome c (Jurgensmeier et al., Proc. Natl.
Acad. Sci. USA 95:4997-5002 (1998), which is hereby
incorporated by reference in its entirety). Recently, Abra
movitch et al. (EMBO J. 22:60–69 (2003), which is hereby
incorporated by reference in its entirety) reported that AvrP
toB suppresses Bax-induced PCD in plants. The suppressors
identified in Examples 3–7 were tested in their ability to
suppress Bax-induced PCD in plants. With the exception of
AVrPpiB1, all of them suppressed Bax-induced cell death
in plants (FIG. 7A). Interestingly, AvrPphE, HopPtoG,
HopPtoF, and HopPtoE also suppressed Bax-induced PCD
in yeast (FIG. 7B). The fact that AvrPtoB was unable to
suppress Bax-induced PCD in yeast highlights a difference
between the activity of these suppressors. Moreover, AvrP
phE, HopPtoG, HopPtoF, and HopPtoE were unable to
suppress the PCD initiated in yeast by H.O., while AvrPtoB
did suppress PCD in this assay (Abramovitch et al., EMBO
J. 22:60–69 (2003), which is hereby incorporated by refer
ence in its entirety). This further demonstrates that the PCD
Suppressors display different PCD Suppressing characteris
tics.

Discussion of Examples 3–8
60

infiltrated with different dilutions of DC3000 or each

mutant, and then their ability to elicit an HR was analyzed.
Interestingly, all the mutants were more effective at eliciting
an HR at lower concentrations, generally producing an HR

when each was supplied in trans the HR-eliciting ability
returned to a DC3000-like HR (FIG. 6).
Although HopPtoG was not identified as an HR suppres
sor in the assays with Pfluorescens(pHIR 11), the hopPtoG
mutant UNL 124 caused an enhanced HR phenotype. More
over, additional assays shown below Suggest that HopPtoG
does function as a Suppressor. Thus, these findings demon
strate that the phenotype of potential Suppressor mutants on
non-host plants is consistent with and complements HR
suppression data. Therefore, the HR titration assays should
be useful in the identification of other HR suppressors in
bacterial plant pathogens.

65

Effectors delivered by the Hrp TTSS appear central to P.
syringae pathogenesis, but the anti-host functions of these
proteins remain obscure. The above Examples identify a
founding inventory of Hrp effectors from P. S. tomato
DC3000 using several novel bioassays and provide evidence
that many of these proteins appear to suppress one or more
broadly conserved eukaryote PCD pathways. To understand
these results, it is useful to consider the collection of
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effectors that were assayed, the utility and limitations of the
bioassays, and the role of plant cell death in disease and
defense. The nineteen effectors considered here were

recently identified in DC3000 on the basis of their homology
with known effectors and/or their ability to be secreted
and/or translocated by the Hrp TTSS. In general, P. syringae
TTSS effectors identified on the basis of avirulence pheno
types are designated AVrs, whereas those identified through
secretion assays are designated Hops. However, the working
assumption is that all of the “AVrs' are injected into plant
cells by the Hrp system and many of the “Hops' will confer
avirulence phenotypes to bacteria if tested in hosts that
happen to carry a corresponding R gene; that is, effectors,
AVrs, and Hops are synonymous terms.
It must be noted that the effector described herein do not

represent the entire inventory of DC3000 effectors. Effectors
encoded within the Hrp pathogenicity island are described
els where (Alfano et al., Proc. Natl. Acad. Sci. USA
97:4856–4861 (2000), which is hereby incorporated by
reference in its entirety. Additional candidate effectors in
DC3000 have also been identified (Collmer et al., Trends
Microbiol. 10:462-470 (2002), which is hereby incorporated
by reference in its entirety).
However, the set of effectors analyzed here suggests that
many DC3000 effectors have HR suppression activity. The
bioassays used herein were designed to efficiently detect HR
Suppressor activity, determine whether Suppressor action
occurs in plant cells rather than in bacteria, and determine if
the test effectors could also suppress PCD in other plants and
the model eukaryote, yeast. The primary Screen, based on
suppression of the HR elicited by Pfluorescens(pHIR11) in
tobacco, proved to be simple and effective (FIG. 2).
Although there is the formal possibility that suppressors
identified with this bioassay could be merely interfering with
the delivery of HopPsyA, multiple lines of evidence indicate
that they act after delivery into plant cells. For example,
HopPtoE overexpression had no effect on the secretion of
AvrPto (FIG. 3A), a representative type III substrate, and
HopPtoE suppressed HopPsyA-dependent HR elicitation
when delivered by a functional TTSS in a different strain
(FIG. 3C) or when transiently expressed in plant cells
following inoculation with A. tumefaciens (FIG. 5A). It is
also noteworthy that the suppressors identified herein func
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tioned when delivered via the TTSS, a natural route that is

thought to yield relatively low levels of effectors within
plant cells. Agrobacterium-mediated transient expression, in
contrast, can produce far higher levels of effectors within
plant cells potentially leading to artifactual responses. It
should also be noted that HopPtold1 and HopPtoK appear to
exhibit limited suppressor activity.
In an attempt to identify plant targets or sites of action of
the Suppressors in plants, HopPtoE, AVrPphE,
AvrPiB1, AvrPtoB, HopPtoF, and HopPtoG were sub
jected to cursory bioinformatic analyses. BLASTP and PSI
BLAST searches (Altschul et al., Nucleic Acids Res. 25:
3389–3402 (1997), which is hereby incorporated by refer
ence in its entirety) did not identify any proteins (other than
clear AVr homologs) that shared significant similarity with
any of the suppressors. However, 3D-PSSM analyses, a
method that uses protein fold recognition to identify proteins
with similar folding patterns (Kelley et al., J. Mol. Biol.
299:499–520 (2000), which is hereby incorporated by ref
erence in its entirety), indicated that AVrPtoB had similarity
to heme-dependent peroxidases (above 90% certainty:
PSSM E value 0.0895). Moreover, when AvrPtoB was
aligned with a lignin peroxidase, a representative heme
dependent peroxidase (Welinder, Eur: J. Biochem. 151:
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497–504 (1985), which is hereby incorporated by reference
in its entirety), the amino acids within the peroxidase active
site were present similarly spaced in AvrPtoB. This result is
intriguing because of the clear involvement of reactive
oxygen species (ROS) in plant defense (Mittler, Trends
Plant Sci. 7:405–410 (2002), which is hereby incorporated
by reference in its entirety) and the potential of peroxidases
to modulate ROS. Moreover, there have been reports of
peroxidases rescuing Bax-induced cell death in yeasts (Ka
mpranis et al., J. Biol. Chem. 275:29207–29216 (2000);
Moon et al., Biochem. Biophys. Res. Commun. 290:457-462
(2002), each of which is hereby incorporated by reference in
its entirety) and transgenic antisense tobacco plants with
reduced amounts of ascorbate peroxidase were "hyperre
sponsive' to Psyringae (Mittler et al., Proc. Natl. Acad. Sci.
USA 96:14165-14170 (1999), which is hereby incorporated
by reference in its entirety), producing a phenotype remi
niscent of the enhanced HR phenotypes produced by the
suppressor mutants reported here. However, Abramovitch et
al. (EMBO J. 22:60–69 (2003), which is hereby incorporated
by reference in its entirety) reported that AvrPtoB possessed
predicted structural features similar to domains within Bcl-2
family members, an equally intriguing finding due to the
involvement of these proteins in PCD regulation. Yeast has
emerged as model for studying PCD and has proven par
ticularly useful for the analysis of cell death inducers and
suppressors obtained from multicellular eukaryotes with
more complex PCD pathways (Madeo et al., Curr. Genet.
41:208–216 (2002), which is hereby incorporated by refer
ence in its entirety). An example of the utility of the yeast
system to plant PCD research is found in the induction of
yeast PCD by the plant defense protein osmotin (Narasim
han et al., Mol. Cell 8:921-930 (2001), which is hereby
incorporated by reference in its entirety). A particularly
fruitful use of the yeast system involves heterologous
expression of the mammalian Bax protein, which induces
PCD in yeast. Yeast expressing Bax can be screened, as done
here, for heterologously expressed genes that block Bax
induced PCD. This system has been used to identify the
Arabidopsis ethylene-responsive element binding protein
(AtEBP) as a suppressor of PCD (Pan et al., FEBS Lett.
508:375-378 (2001), which is hereby incorporated by ref.
erence in its entirety) and its relevance to plant biology is
further indicated by observations that Bax expression in
tobacco can induce an apparent HR and that Bcl-2 (an
anti-aptototic gene of the Bax/Bcl-2 family) expression in
tobacco strongly alters plant-pathogen interactions (Dick
man et al., Proc. Natl. Acad. Sci. USA 98.6957–6962 (2001):
Lacomme and Santa Cruz, Proc. Natl. Acad. Sci. USA

96:7956–7961 (1999), each of which is hereby incorporated
by reference in its entirety).
Four of the five effectors tested (AVrPphE, HopPtoG,
HopPtoF, and HopPtoE) suppress Bax-induced yeast PCD,
indicating that the targets are likely to be broadly conserved
and not unique to plants. Interestingly, AvrPpiB1 and
AvrPtoB failed to do so, even though both suppressed the
HR elicited by Pfluorescens(pHIR11) in both tobacco and
Arabidopsis, and DC3000 avrPtoB and avrPpiB1Pto
mutants produced enhanced HRS. It is also puzzling that
HopPtoG failed to suppress the HR elicited by Pfluorescens
(pHIR11) although a DC3000 hopPtoG mutant had
enhanced HR activity and HopPtoG suppressed Bax-in
duced yeast PCD. Moreover, it is also noteworthy that
HopPtol)2, an effector that was recently identified to sup
presses an HR elicited by avirulent P. syrinage strains did
not suppress the HR elicited by P. fluorescens(pHIR11).
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These exceptions suggest that multiple bioassays will be
required to identify all of the DC3000 effectors with some
ability to suppress PCD.
While the suppressors described here were identified due
to their ability to suppress PCD, it is possible they suppress
other more general plant defenses as well. Indeed, HopP
toD2 has been found to be an active protein tyrosine
phosphatase that appears to modulate a mitogen-activated
protein kinase (MAPK) pathway in tobacco. An analogous
MAPK pathway in Arabidopsis is part of the plant innate
immune system activated in response to bacterial flagellin
(Asal et al., Nature 415:977–983 (2002); Felix et al., Plant
J. 18:265-276 (1999), each of which is hereby incorporated
by reference in its entirety). The innate immune systems of
mammals, insects, and plants have the capacity to recognize
common markings on microorganisms, such as flagellin or
LPS (Boller, Annu. Rev. Plant Physiol. Plant Mol. Biol.
46:189–214 (1995); Medzhitov and Janeway, Trends Micro
biol. 8:452–456 (2000), each of which is hereby incorpo
rated by reference in its entirety). These common compo
nents have been referred to as pathogen-associated
molecular patterns (PAMPs) and they are not known to elicit
the HR in plants. Thus, the assays used herein would not
detect the activity of Suppressors that specifically targeted
PAMP-induced defense pathways unless the target was at
convergence points of PCD pathways and PAMP-induced
innate immunity pathways. Future research will determine
whether these PCD suppressors specifically target AVr
induced PCD pathways or also suppress other plant defenses
generally grouped into a broad category of defenses typi
cally referred to as non-host resistance (Heath, Curr. Opin.
Plant Biol. 3:315–319 (2000), which is hereby incorporated
by reference in its entirety).
A general model of Suppressor function must also recon
cile several behaviors of bacterium-plant interactions that
involve multiple effectors. Expression in P. syringae of a
heterologous effector typically results in HR elicitation in
test plants that carry a corresponding R gene despite the
presence of resident Suppressor effectors. For example,
DC3000 heterologously expressing avrRpt2 or avrRps4 elic
its the HR in Arabidopsis plants carrying the corresponding
R genes (Hinsch and Staskawicz, Mol. Plant—Microbe
Interact. 9:55–61 (1996); Kunkel et al., Plant Cell
5:865-875 (1993), which is hereby incorporated by refer
ence in its entirety). On the other hand, Suppressors can
block HR elicitation by resident effectors, as revealed by the
original discovery of suppressors like VirPphA and effectors
with masked avirulence activity in P. S. phaseolicola (Jack
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(1999), which is hereby incorporated by reference in its
entirety) and by the observations presented here that several
effectors can block HR elicitation by HopPsyA in the
heterologous P. fluorescens(pHIR11) system. Perhaps the
simplest explanation is that there is a hierarchy in the
delivery of effectors by wild-type strains. Such a hierarchy
in delivery has been proposed to explain the deployment of
effectors with conflicting activities, such as the Salmonella
SopB and SptP proteins, in animal pathogens (Cornelis and
van Gujsegem, Annu. Rev. Microbiol. 54:734–774 (2000);
Galán and Zhou, Proc. Natl. Acad. Sci. USA 97:8754–8761
(2000), each of which is hereby incorporated by reference in
its entirety). The global identification of a set of suppressors
in P. S. tomato DC3000 should facilitate systematic inves
tigation of the underlying functions of TTSS effectors in P.
Syringae pathogenesis.
A final aspect of PCD and pathogenesis is that the ability
to elicit host cell death appears to be a general characteristic
of TTSS-dependent pathogens like P. syringae despite the
fact that these bacteria typically rely upon living host cells
as sites of multiplication (Alfano and Collmer, J. Bacteriol.
179:5655–5662 (1997); Knodler and Finlay, Microbes
Infect. 3:1321–1326 (2001), each of which is hereby incor
porated by reference in its entirety). This is particularly
puzzling with P. syringae because late-stage infections with
most strains produce necrotic lesions, but the symptomless
growth of P. S. syringaegacS mutants suggests that such cell
killing maybe gratuitous (Willis et al., Mol. Plant—Microbe
Interact. 3:149-156 (1990), which is hereby incorporated by
reference in its entirety). Similarly puzzling are recent
observations suggesting that plants compromised in PCD
pathways are unexpectedly more resistant to P syringae
(Lincoln et al., Proc. Natl. Acad. Sci. USA 99:15217–15221
(2002); Stone et al., Plant Cell 12:1811–1822 (2000);
Richael et al., Physiol. Mol. Plant Pathol. 59:213–221
(2001), each of which is hereby incorporated by reference in
its entirety). Thus, rapid and delayed host cell death are
associated with defense and disease, respectively, and patho
gen manipulation of cell death pathways may be a central
process in pathogenesis.
Although the invention has been described in detail for
the purposes of illustration, it is understood that such detail
is solely for that purpose, and variations can be made therein
by those skilled in the art without departing from the spirit
and scope of the invention which is defined by the following
claims.

SEQUENCE LISTING

<160> NUMBER OF SEQ ID NOS: 209
<21 Oc SEQ ID NO 1
<211 LENGTH 1899
<212> TYPE DNA

ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 1

atgcttatc g g g cacagctt goatcacatg cq acco act g citgtggattic tag cctacca

60

actitcc.gcaa citagc.ca.gac tatcagdaat accaaaagtc. g.gctggatcc goat cqtgtc

120

cgtgaactta cattcatcgg agtggg tagt agtgttgcct acct actoraa toagcttaat
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Asp

Ser

Gly

65

Asp Asp

Wall Thr Thr Pro Phe Telu
70
Ser

Trp Ala Glu

Asn Wall

85

Gly Lys

Wall Ser Ile Wall

75

Gly
8O

Arg Gly Lys Gly Tyr Ile
90

Asn

95

His Glin Thr Glu Ile Ile Ser Glin Trp Asp Glin Glin Wall Pro
100

Asp

Pro Asn

105

Tyr Ala Ala

Ala Glu Phe Ser Ala Ser Asn Arg Arg
120
125

115

Glin Telu Thr
130

110

Thr Wall Glu Telu
135

Wall Thr
145

Gly

Asp

Asn

Gly

Ala

Gly

Pro His Thr Ser Ile

Gly

Ala Glu His Teu
140

Ile Ser Arg Teu Asp Asp
15 O

Gly Cys

Glin Ile Teu Glin Ser
1.65

Glin Ile Wall Teu
170

Trp

18O

155

Ala Glin

Phe Arg Ile Asn Telu
160

Gly

185

Teu

Asp

210

19 O

Asp Glu Phe

Ser Pro Glin Thr Phe Ala

Arg Ala

Ala Telu

Ser

Asp Ala

Gly

Pro Asn

220

Gly Lys

230

Gly

Met

215

225

Ala

Teu

Gly

Asn Ser Wall Thr Ser His Thr Glin

Ala Glu Lys Arg Teu Asp Asn Ile Lys Telu His Glu Glin
195
200

Arg Gly Lys Wall

Thr
175

Ile Asp Ala Ala Glu
245

Thr Wall Wall Ile His
235
Ala

Gly

Glu Teu

Gly

250

240

Ala Asn Ala
255

Wall Trp Phe Thr Arg Ser Thr Asn Pro Wall Teu Teu Asp Gly Asn Glin
260
265
27 O
Phe Ala Pro Glu Teu Ala Lys Ser Ala Ile His
275
280
285

Lel

Telu

Asp Ile

Pro Thr

29 O
Lel

His

Ser Ser Teu

Gly

310

Asp Ala Asp Tyr

Gly

Phe

Lel

Glin Asp Ser Arg Glu Pro
315

Wall Tyr Ala Met
330

325

Gly

Telu Glu Asn

Ser Ala Ala Ala Ile Telu

340

Gly

Gly

Wall
320

Glin Asp Ile His
335

Ser Teu Teu

Asp His

345

Lel

Wall Ile
370

Gly

Ile Wall
385

Gly

Telu Glin Ser

Arg Gly

Ser Asn Ser

Asp

Asn

Gly

Thr

Lel

Ile

375

Ala Ala Wall Ala Glin Telu Ala Thr Asn Wall Glin His Ser
390
395
400

Asp His Ala

Teu

Asp

Ile Telu Glu Glu Met Thr Arg Telu
410
415

405

Glin Thr Glu Lys Telu Ser Glin Met Teu Teu Glu
420
425
43 O

Pro Glu

Pro Ser Wall Glin Ile Glin Thr

435

Tyr

Telu

Lys Thr Trp Glin

4 40

Glin Pro Pro Asp
450

Teu Ala Ala

465

Glu

35 O

Ile Tyr Asp Tyr Asp Glin Wall Tyr Ser Asp Glin Pro Phe
355
360
365

Gly

Arg

295

305
Lel

Lys

Wall Asp

Telu

Gly

Ala

Asp

Ser

4 45

Glin Wall Telu Glin Asn Glin Wall Glu Asn
455
460

Arg Asp Tyr Phe Glin Arg Glin Thr
470

475

Asn Glu Glin

Gly
480

US 7,220,583 B2
145

146
-continued

Asn Telu

Asp Gly Val Ala Ala Glu Wall Lys
485

Wall Ala Ser Wall Ile Wal Ser Pro Gln Leu
5 OO
505
Ala Ala

Asn Glin Thr Telu Thr Glu

490

Ala Leu Ser Gly Lieu Met

495

Gly

Pro Ala

Phe Thr Thr Asp Asn Arg

530

535

Ala Arg
545

Tyr Pro Asn. Ile Gly Asn

Glu Wall

Val Thr Leu Arg His Leu

550

Thr Met Teu Arg Ala
540

Asn. Ser Glin

Pro

Gly Glu Met Met Asp Lys Gly Ala
Pro Val Leu Gly Val Pro
595

600

Ala Tyr Lieu. His Ala Lieu. Asn. Ser
610
615
Ser Glin

Ile Ala

Arg Phe Ile Glu

570

585

Arg

Gly

Glu

Ala Glu Ala Ser Ala Phe Ile Asp
555
560

565

Wall Ala

Gly

Wall Ala Asn
525

515
Asn Asn

Thr Ile Lys Ala Ser

575

Glin Pro Teu Wall Ser Telu
59 O

Ala Ser Wall Arg Thr Ala
605

Gly Ala His Asp Gly

Glu

Thr Pro Telu

62O

Arg Trp Lieu Pro Lys Lys

625

630

SEQ ID NO 3
LENGTH
TYPE

657
DNA

ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400 SEQUENCE: 3

atgatcactc cqtctogata to caggcatc tatato.gc.cc cccitcagtaa c galacc.gaca

60

gcagotcaca catttaaaga acaag cagag gaag cacttg accatat cag cgcc.gcaccc

120

totggc gata agctattgcg

acticttgcca gtoaaaaaga tagaaaagtic

18O

acgctaaaag agattgaaat aaataaccag tgttataccg aagctgttct gag cagragg

240

aaaaatatoc

caactggaaa agtacgaacc agaaaactitt aac gaga acc ggcacattgc atcacagcta
to acgaaagg ggacctttac caaaggtgaa ggalagcaa.cg cgattattgg citggtoacca

360

gacaaagcaa goatacgctt aaatcagaat ggcto accqt tacaccittgg aatggataac

420

gacgacaaaa toacgaccct agctdatgag citcgttcatg citcgacatgt gttaggtggc

480

agct cottag cqgatggcgg agatcgctat aatccacgta Cgggatctgg Caaagaggaa

540

cittagg gcc.g. ttggattaga taagtaccgc

600

tattoactita

Caaaaaaac C.

gtoagagaac

to catc.cgag citgaac acgg cctg.cctotg cgcatcaagt a Cagg gCaca totaatag
SEQ ID NO 4
LENGTH
TYPE

218
PRT

ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400 SEQUENCE: 4
Met

Ile Thr Pro Ser Arg Tyr Pro Gly Ile Tyr

1

5

Asn Glu

10

Pro Thr Ala Ala His Thr Phe Lys Glu
25

Teu

Asp His Ile Ser Ala Ala Pro Ser Gly Asp
35

Ile Ser
5O

40

Thir Lieu Ala Ser Glin Lys Asp Arg Lys
55

Ile Ala Pro Telu Ser
15
Glin Ala Glu Glu Ala
3O
Teu Telu

Arg

45

Wall Thr Telu
60

Glu

657
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Ile Glu Ile Asn. Asn. G ln
65
70

Cys Tyr

Thr Glu Ala Wall Leu Ser Arg Arg
75
8O

Glin Leu Glu Lys Tyr G lu Pro Glu Asin Phe Asn
85
90

Glu Asn Arg His Ile

Ala Ser Glin Teu Ser A.
100

Lys Gly Glu Gly Ser

Thr Phe Thr
105

95

110

Asn Ala Ile
115

Ile Gly. T rp Ser Pro Asp Lys Ala Ser Ile Arg

Glin Asn Gly

Ser Pro L eu. His Lieu

120

130

Gly Met Asp Asn Asp Asp Lys Ile

135

140

Thir Thr Leu Ala His G lu Lieu Wall
145
1 50
Ser Ser Lieu

His Ala Arg

Gly Gly

His Wall Leu

155

160

Ala Asp G ly Gly Asp Arg Tyr Asn Pro Arg Thr Gly Ser
1.65

Gly Lys Glu

Lieu. Asn

125

170

Glu Lieu. Arg
18O

Lieu. Thir Lys Lys Pro S er
195

175

Ala Val Gly Lieu. Asp

Tyr Ser

185

Glu Asn
200

19 O

Ser Ile Arg Ala Glu His Gly Lieu
2O5

Pro Leu Arg Met Lys Tyr Arg Ala His Glin
210

<210

215

SEQ ID NO 5

&2 11s LENGTH 636
&212> TYPE DNA
<213> ORGANISM: Pseudomonas

<400

syringae pv. tomato DC3000

SEQUENCE: 5

atgaatagag titt.cogg tag citcgt.ca.gc.g actitggcagg cagtcaacga tottgttggag

60

caagtaag.cg agagaaccac gttgttctacg acaggittatc agacggcaat ggg.ccgcttg

120

aacaaaccgg aaaaatcaga tgcggatgcg citgatgacta tgaggagggc gcaa.cagtac

18O

acggatagcg C galagc gaac ttatatttcg gaaacgctda tgaatctggc agatttgcag

240

caaaggaaaa totatogcac Calacagoggg aacttgcgtg gc gcgattga gatgacgc.ct

acgcaactica cagattgcgt. acagaagtgc cgc galagagg ggttctocaa ttgttgacata

360

Caggcgctgg aaatcggctt gcaccittcga cataagttag gaatctoaga

titt caccatc.

420

gtggtocatcc acco cagcaa tgcatttcc.g

480

alaaggagcga. ttgtag acto ttggacggga Caggg.cgtgg tggagctgga cittcaag acc

540

cgattgaaat toaa.gcaccg ggalagagaac tacgcagtga acgc.caatat gCacgagtgg

600

atc.gagagat acggccaa.gc gcatgtgatt gactga

636

tacago aacc gtaagttaag

ccatalactat

<210> SEQ ID NO 6
<211& LENGTH 211
&212> TYPE PRT

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 6

Met Asn Arg Val Ser Gly Ser Ser Ser Ala Thr Trp Glin Ala
1

5

10

Asp Leu Val Glu Glin Val Ser Glu Arg Thr Thr
25

Leu Ser Thr
3O

Wall Asn
15

Thr Gly

Tyr Glin Thr Ala Met Gly Arg Lieu. Asn Lys Pro Glu Lys Ser Asp Ala
35

40

45

Asp Ala Lieu Met Thr Met Arg Arg Ala Glin Glin Tyr Thr Asp
5O

55

60

Ser Ala

US 7,220,583 B2
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150
-continued

Lys Arg Thr Tyr Ile S er

Leu Ala Asp

Leu Glin
8O

Glin Arg Lys Ile Tyr Arg Thr Asn Ser Gly Asn Leu Arg Gly

Ala Ile
95

65

70

Glu Thr Teu Met Asn
75

85

90

Glu Met Thr Pro Thr G ln Leu Thr Asp
100
105

Glu Gly Phe Ser Asn. Cys Asp Ile
115

Cys Wall Glin Lys Cys Arg Glu
110

Glin Ala Leu

Glu Ile Gly Lieu. His

120

125

Leu Arg His Lys Lieu G ly Ile Ser Asp Phe Thr Ile Tyr Ser Asn Arg
130

135

140

Lys Lieu Ser His Asn Tyr Val Val Ile His Pro Ser Asn Ala Phe Pro
145

1 50

155

160

Lys Gly Ala Ile Val Asp Ser Trp Thr Gly Glin Gly Val Val
1.65

Glu Lieu
175

170

Asp Phe Lys Thr Arg L. eu Lys Phe Lys His Arg

Glu Glu Asn
19 O

Tyr Ala

Glu Trip Ile Glu Arg Tyr Gly Glin

Ala His

18O

185

Wall Asn Ala Asn Met H is
195

200

2O5

Val Ile Asp
210

<210

SEQ ID NO 7

<211& LENGTH: 1482
&212> TYPE DNA

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 7

atgcaaataa agaacagtica

gottcaagaa tggtgcagaa

tacttittaat

60

gcct cqccita agatggaagt aactaatgca atagoaaaaa ataatgalacc tgctg.cgctg

120

agcgctacgc aaactgcaaa gacacacgaa ggc gattcaa aaggccaatc cagdaataac

18O

totaaattgc cctitcc.gc.gc catgaggtac gctgcatacc ttgcagg cag cgcctacctc

240

tacgataaaa citgccaataa

totctattoa

ttittitt tott totaccactt

citctgcatca tggcaaaggit

ggttttacca gCgatgc.ca.g gottaacgat gcacaagata aag.cgcgaala gc gctaccala

360

gcago actict tgaaaataaa aactc.gctitt taag.ccc.gct taggotttgc

420

aacaac cata

ggagagaatc agttcttaac gatgattgat tat cqtgcag caactaagat

ttacctcitcc.

480

gacctagttg acacggagca agcgcacaca tdaattctga agaat attat gtgcctgaaa

540

ggtgagctta ccaatgaaga ggcaataaaa

600

aaactica acc cggaaaaaac accaaaagac

tatgacctta caaatagoga agcctatata agcaagaa.ca

aatattoctitt

gaccggc gtt

660

aaaaatgagg agacgggatc tactggittat acatctogtt

citaticacaaa.

gcc atttgtg

720

gaaaaaggcC tgaaac actt tataaaag.cg act catggcg aaaaagctot cacgc.ccaag

cagtgitatgg aaactcittga

cgaaaaagta toacgctcaa cagtgattoc

840

caattic goag CaggcCaggC acttittggitt ttcagacagg totatgcggg tgaagacgct

9 OO

tggggggatg Cggaacgggt catattgaaa agc cattata atcgggg CaC tgtactccaa

96.O

gatgaagctg ataaaataga actaagtagg cc.gttctdag agcaagattit agcaaagaac

1020

atgtttalaga ggaataccag cattgcaggg ccagtgctdt accacgcata

tatttatata

1080

caagaaaaaa tottcaa.gct accoccc.gac aaaatagaag atttgaaa.ca taaatcaatg

1140

gcag acttga aaaacctgcc tittgacticat gttaa.gctta gcaattic.cgg tgtgggattit

1200

galagacgc.ct Cagggittagg agacitcgttt acagotcitca acgcgacgto citgttgttaat

1260

talactitactit

US 7,220,583 B2
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152
-continued

cacgcaagaa taatgagtgg tgagc citc.cc ttgtcaaaag atgatgttgt gattctgata

1320

ggttgcctica acgc.cgtata cgacaatticg agcggaataa ggcattctot cogcqaaatt

1380

gCac gagggit gctttgttggg tgctggittitt acggtoc agg acggtgacga cittctacaaa

1440

cagatctgca aaaacgc.citc taagcagttt tacaacggct

1482

a.a.

SEQ ID NO 8
LENGTH
TYPE

493
PRT

ORGANISM: Pseudomonas syringae pv. tomato

DC3 OOO

<400 SEQUENCE: 8
Met

Glin Ile Lys Asn. Ser His Lieu Tyr

1

5

Asn Thr Phe

Ser Ala Ser

Arg

Met Wall Glin

10

Asn Ala Ser Pro Lys

15

Met Glu Wall Thr Asn Ala Ile Ala

25

3O

Asn Asn Glu Pro Ala Ala Leu Ser Ala Thr Glin Thr Ala

35

His Glu

40

45

Gly Asp Ser Lys Gly Glin

Ser Ser Asn Asn Ser

5O

55

Phe Arg Ala
65

Asp

Met Arg Tyr Ala Ala

Telu Ala

70

Arg Lys Arg Tyr Glin

125

Arg

Asp

Asp Thr Glu Glin Ala His

15 O

Ala Ala Thr
155

1.65

Thr Ser Ile Teu
170

19 O

Asp

Telu

Teu Thr Asn Ser Glu Ala

2O5

Thr Gly Tyr Thr Ser Arg

Gly

Wall
220

Asn Glu Glu

Ser Ile Thr

Pro Phe Wall

230

235

Gly Lieu Lys His Phe Ile

Ala Thr His
250

245

Lys Glin Cys Met Glu
260

240

Gly

Glu Lys Ala
255

Thr Telu Asp Asn Teu Telu Arg
265
27 O

Lieu. Asn. Ser Asp Ser Glin Phe Ala Ala Gly Glin Ala

275

280

295

Ile Leu Lys Ser His Tyr

Glu Asp Ala Trp
3OO
Asn

310

Asp Glu Ala Asp Lys Ile Glu Lieu
325

Telu

285

Arg Glin Val Tyr Ala Gly

29 O

Glu Arg Wall
305

175

Lys

Ile Ser Lys Asn Lys Tyr Ser Telu Thr
210
215

Teu Wall Phe

Asn Ile

185

200

Ser Ile Thr

160

Asn Glu Glu Ala Ile

Lys Thr Pro Lys Asp

Teu Thr Pro

Asn Glin

Telu Ser

18O

195

Glu

Ile

Lys Gly Glu Lieu. Thr

Asn Pro Glu

Ser

Cys Gly Glu
140

Met Ile Asp Tyr Arg

Gly

Teu

135

Telu

Asp Ala Glin

Asn Asn His Ser Ser Thr Telu Glu

Phe Telu Thr
145

Thr
225

Telu

110

120

Asn Ser Leu Lleu Ser Pro Telu

Telu Wall

Teu Asn

105

130

Met

Ser Ala

Thr Ala Asn. Asn. Phe Phe Telu Ser Thr Thr Ser Telu His
85
90
95

Ala
115

Lys

Gly

75

100

Asn

Telu Pro

60

Asp Gly Lys Gly Gly Phe Thr Ser Asp Ala Arg
Asp

Thr

Gly Asp

Arg Gly Thr Wall

Telu Glin

315
Ser

Ala

320

Arg

Pro Phe Ser Glu Glin

330

335

Asp

US 7,220,583 B2
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154
-continued

Leu Ala Lys Asn Met Phe Lys Arg
340

Asn. Thir Ser
345

Ile Ala Gly

Leu Tyr His Ala Tyr Ile Tyr Ile Glin Glu Lys Ile Phe Lys
355

Pro Wall

35 O

360

Leu Pro

365

Pro Asp Lys Ile Glu Asp Leu Lys His Lys Ser Met Ala Asp Lieu Lys
370

375

Asn Lieu Pro

Leu Thir His Val Lys

385

38O
Teu Ser Asn

Ser Gly Val Gly Phe

395

400

390

Glu Asp Ala Ser Gly Lieu Gly Asp
405

Ser Phe Thr Ala Lieu. Asn Ala Thr
410
415

Ser Cys Val Asn His Ala Arg Ile Met Ser Gly

435
Asn. Ser Ser

420

425

Wal Wall Ile Leu. Ile
4 40

Gly Cys Lieu

Glu Pro Pro Teu Ser
43 O
Asn Ala Wall
4 45

Gly Ile Arg His Ser Leu Arg Glu Ile Ala Arg

450

455

460

Phe Val Gly Ala Gly Phe Thr Val Glin Asp Gly Asp Asp Phe
465

470

475

480

Glin Ile Cys Lys Asn Ala Ser Lys Glin Phe Tyr Asn Gly
485

<210

490

SEQ ID NO 9

&2 11s LENGTH 852
212. TYPE DNA

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 9

atgggtaata tttgtggtac ttctggctcc aatcatgttgt atagt cogcc tattagccct

60

caac atgcat citggttcgto cacaccagtg cccagtgctt citgggiac gat gctittctdtc

120

agtcatgaac aaatattaag ccagaactat gctagoaata taaaggggaa atato go acg

18O

aaccoccgaa aag gaccatc toctaggctt totgatacgc tgatgaagca ggcgctgtct

240

toagtgatca cacaag agaa aaag.cgacitt aaaagtcaac caaagtcaat agcc.caagat
attcagocto caaacago at gatcaaaaat gcacttgatg aaaaaga cag

ccaccottitt

360

ggtgattgct titt cagacga tgaatttctt gc gatccatc totatac gag ttgttctttac

420

agaccgatca

tgttgtc gag

480

gcaatgaata gCggtttggC caaacttgct caataccctg attatcaggt gtotggtoag

540

citgcatagag gcatcaagca aaagatggat gatggtgaag titatgagtcg cittcaagcc.g

600

ggtaatacitt atcgtgatga cgc gttcatg agcacatcga citagaatgga tgttacagaa

660

gaatttacitt cc gatgtcac gttacatctg cagtcctcat cago.cgtcaa tataggtocc

720

ttittcaaaaa.

accatcatct

gc gg tatgcc cc.gaaaaatg

accoatacga ggacgaag.cg citcatccc.gc ccctdacgc.c tittcaaagta

accggtotgc acalagcagga Cgataggtgg cacgtccact tgaac gagat cgcagaga.gc

840

totgacgagt ga

852

<210> SEQ ID NO 10
&2 11s LENGTH 2.83
&212> TYPE PRT

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000

US 7,220,583 B2
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156
-continued

<400
Met

SEQUENCE: 10

Gly Asn. Ile Cys G ly Thr Ser Gly Ser Asn His Val Tyr

1

5

10

Pro Ile Ser Pro Glin H is Ala Ser

2O

Ala Ser

Gly

Gly Ser Ser
25

Ser Asn. I le

Tyr Ala
5O

Gly

15

Thr Pro Wall Pro Ser
3O

Thr Met L eu Ser Lieu Ser His Glu Glin Ile Leu Ser Glin
40
45

35
Asn

Ser Pro

Lys Gly Lys Tyr Arg
55

Thir Asn Pro Arg Lys
60

Pro Arg L. eu Ser Asp Thir Leu Met Lys Glin Ala

Pro Ser

65

Teu Ser

70

75

8O

Ser Wall Ile Thr Glin G lu

Lys Lys Arg Lieu Lys

Ser Glin Pro Lys Ser
95

85

90

Asp Ile G lin

Ile Ala Glin

100

Pro Pro Asn. Ser Met
105

Ile Lys Asn

Ala Leu

110

Asp Glu Lys Asp Ser H is Pro Phe Gly Asp Cys Phe Ser Asp Asp Glu
115

120

Phe Telu Ala Ile His L. eu Tyr
130
135

125

Thr Ser Cys Lieu Tyr Arg Pro

Arg Tyr Ala Pro Lys Asn Asp Wall

His His Telu
145

1 50

155

Ser Gly L. eu Ala Lys

Ala Met Asn

1.65

Wall Ser

Gly

Glin Lieu. H is
18O

Ile Asn

140

Ala Pro Wall Wall Glu
160

Leu Ala Glin Tyr Pro Asp Tyr
170
175

Glin

Arg Gly Ile Lys Gln Lys Met Asp Asp Gly
185

19 O

Glu Wall Met
195

Ser Arg Phe Lys Pro Gly Asn Thr

Phe Met Ser
210

Thr Ser Thr Arg Met Asp Val Thr

200

Asp Ala
2O5

215

Glu Glu Phe Thir Ser
220

Asp Wall Thr Lieu. His L. eu Glin Ser Ser Ser Ala Wall Asn. Ile Gly Pro
225

2 30

235

Asn Pro Tyr Glu Asp

Phe Ser

245

Wall Thr G ly
260

Pro Phe

240

Glu Ala Leu Ile Pro Pro Leu. Thr
250
255

Lieu. His Lys Glin Asp Asp Arg Trp
265

His Telu Asn Glu Ile Ala Glu Ser
275

His Wall

27 O

Ser Asp Glu

280

SEQ ID NO 11
LENGTH
TYPE

393
DNA

ORGANISM: Pseudomonas

syringae pv. tomato DC3000

<400 SEQUENCE: 11

atgagctitat cqc.cgacgct gcaaaagcta

tgggCCC gaC aaaaaatgcc

60

aagcct gtca cagaggctat C CagtggCag galagg catgg atataacgct gcatgtcago

120

ggcgacagcC ttacct tact agctaaaatc atagaactoc gtacagaccc taaagacgac

18O

attittattgc

tacccatacg titt.cogggcc

CCgtggcgc.g

240

cittaccatca

accotgatga aagtgcc.ctg gttittctott atgaacacga

titt to accitt

actaatatat

citggacaaag ccc.gttittga gag cotgctg gccaactittg citgaaacggc gcaggagctt

360

C gagacacag cgacacattt togttittaac tga

393

US 7,220,583 B2
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-continued

SEQ ID NO 12
LENGTH

130

TYPE PRT
ORGANISM

Pseudomonas syringae pv. tomato DC3000

<400 SEQUENCE: 12
Met Ser Leu Ser Pro Thr Leu Glin

Lys Lieu Thr

1

Thr Lys Asn

Ala Lys P ro
2O

Met

Asp Ile Thir Lieu. H is Wal Ser Gly Asp

45

Thr Asp Pro Lys Asp Asp
55

Telu Telu Thr His Thr Phe Pro

Ile Telu Leu Arg

60

Gly Lieu Arg

65

Teu

Arg

Gly Ala

75

Teu Thr Ile Asn. Pro A. sp

Glu Ser

85
Teu Lleu. A sp

Asp Phe His

8O

Ala Leu Wall Phe Ser Tyr Glu. His
90
95

Lys Ala Arg Phe

100

Glu Gly

Ser Teu Thr Telu Leu Ala

40

Ile Ile Glu Lieu. Arg
5O

Gly Pro
15

Wall Thr Glu Ala Ile Glin Trp Glin
25
3O

35

Lys

Asn Ile Telu

10

105

Glu Ser Teu Telu Ala Asn
110

Phe Ala Glu Thr Ala G ln Glu Lieu Arg Asp Thr Ala Thr His
115
120
125

Phe Arg

Phe Asn
130

SEQ ID NO 13
LENGTH
TYPE

387
DNA

ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400 SEQUENCE: 13

atgaaacaac gag.cga-cagt catctgcaaa CgtgacggCC aggtgctitta cgitacgcaaa

60

gctgggctitt gcc aggtggC aagattgaag CCggggaaac gccttitccag

120

ccaaaatc.cc.

gc gagctttg cgaagaalacc ggtctggaaa atctogatct gttgtacctg

18O

gCggtgtacg agaaaggtga ggtoacgcac tacgtgttca ccacticaggt toct9.ccitac

240

agcgagccitt cgc.cccagaa cgagatttct gcc togcaaat ggcttgc gcc

caaaaatctt

ggcg accitta aggc.ca.gcag cgc gaccalag gctatogtoa agtcgitatgg cc.gc.caggct

360

galagacggitt tacticagogc taactag

387

SEQ ID NO 14
LENGTH
TYPE

128
PRT

ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400 SEQUENCE: 14

Met Lys Glin Arg Ala Thir
1

5

Wall Ile Cys Lys Arg Asp
10

Tyr Val Arg Llys Pro L.ys Ser Arg Trp Ala

Teu Pro

Gly

Glin Wall Leu
15

Gly Gly Lys Ile

25

Glu Ala Gly Glu Thr P ro
35

Phe Glin Ala Ala Wall Arg Glu Telu
40
45

Glu Thr Gly Lieu Glu Asn Lieu. Asp
5O

Telu Telu

Tyr

55

Teu Ala Wall

70

Tyr Glu

60

Lys Gly Glu Val Thr H is Tyr Val Phe Thr Thr Glin Wall
65

Cys Glu

75

Pro

Ala Tyr
8O

US 7,220,583 B2
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Val Ile Gly Asn Ala Glin Met Asn Asp Asp Lieu Asn. Ile Gly Ile Val
115

120

Asn Ala Cys

Asn Wall Ala Wal Wall
135

130

Ser Thr Pro
145

125

Ser Val Asp Tyr Arg Lieu

Ala Leu

140

Val Glu Gly Leu Met Asp Asp Cys
15 O

Phe Ser Ala

Ala Cys

155

160

Trp Lieu Lieu Gly Ser Asp Cys Lys Glu Phe Ala Gly Lieu Pro Wall Ile
1.65

170

175

Val Val Gly Glu Ser Ala Gly Gly His Leu Ala
18O

185

Ala Ala Thr Telu Telu
19 O

Lys Lieu Lys Ala Arg Pro Asp Lieu Lieu Lys Arg Val Val Gly Thr Wall
195

200

2O5

Leu Tyr Tyr Gly Val Tyr Asp Lieu Thr Gly Thr Lys Ser Val Arg Thr
210

Ala Gly Pro
225

215

220

Glu Thir Lieu Wall Leu
230

Asp Gly Pro Gly Met Val Gly Ala
235

240

Met Arg Lieu Leu Ala Pro Asp Arg Thr Asp Glu

Glu Pro
255

245
Pro Leu Ser

250

Pro Leu Tyr Gly Asp Lieu. Thir Asp
260

Met Phe Wall
275

Leu Pro Pro Ala Leu

265

27 O

Gly Glu Lieu. Asp Pro Lieu Lieu. Asp Asp Thr Lieu
280

Ala Glu Arg Trp Lys Asn Ser Ala Asp Val Glu Met His Leu
29 O

295

Glu Ser Pro
305

His Gly Phe Ile His

Wall Leu Ala

Arg Ser His Glu Trp

310

325

Glu Met

285
Lieu Pro

3OO

Phe Pro Thr Ala Leu Ala Arg Lys
315
320
Ile Asn Ala
330

Arg Met Glu Gly Arg
335

Pro

<210

SEQ ID NO 17

&2 11s LENGTH 483
&212> TYPE DNA

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 17

atgcaaac ct

attatacccita to caaaaaac

toctatggct cattc.gc.cca tgaaaacgag

cctcccaccg ttggtacagt totgctgact

60

cittgttgctoc cgacgctitta

120

attacctaaat

agagtaggca aagagctogc tgatggtttc gatgg.cgagg

titcatcatct

aggcgctctg

18O

atgctgatga tittcc.gacitt to cagoagag

aag catctgc tgctaagaaa

240

ggttctittgc taggaattac titcgcttggc

tacct attat

ccitatggatc tactggtgaa

aaag.cgaagc gaatcatcga agcaggttgt gg tatttittc togtoagagt gagtggtgat

360

attgaaaacc citaaag caaa aattgaagtt tatagotctt ggtotgaata ccagaagttc

420

cittgaaccoa ttittgaagac aggtgactitt tat coagtga aaacgtogto gtttitcc.gaa

480

taa

483

<210> SEQ ID NO 18
&2 11s LENGTH 160
&212> TYPE PRT

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000

US 7,220,583 B2
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-continued

gtggg.cgatt cc.gcacct gc caagcc.gc.cc gtcaag.ccgt. tgtacgagca cittgggcctic

1260

actgacatgt cggtag actt atcc.gc.cgtt aaaaaggctt acagagatgc cgc gatgaag

1320

alaccaccctg ataaaaac cq Cggcaa.cgag gcc gaggcgg cc.gagcqctt caaagtcatt

1380

toaaatgcgt. acaagattitt gtocg accog gagttgcgca aag catacga caacggcc.gt

1440

atcaatgagg citggtaatag ggCatga

1467

SEQ ID NO 20
LENGTH
TYPE

488
PRT

ORGANISM: Pseudomonas

syringae pv. tomato

DC3 OOO

<400 SEQUENCE: 20
Met Ile Asn Lieu. Thir H is Ile Ala Ser Ser Teu Ala

1
Ser

5

Asp

Ser

Thr Lys P ro Lys

Met Glu

2O

His Ile Ala

Gly Lys Vall

Glin Lys
5O

Gly

Teu

Ala Teu Ser G ly
70

Glu

Gly

Lys

Teu Ser Met Ile

60

Glu Pro Wall Asn Asn Wall Glu Thr His
75
Telu Ala

Arg Ala Ala Phe Asp Wall Ala
90

95

Trp Glu Arg Asp

Ser Met His Asn Wall Met Ser Phe

100

105

Asp Ala Met

130

110

Asn Ser

Ala Tyr Phe Ser Ser Asn Telu
155

Telu

Pro Glu Pro

140

Asn Ala Arg His

Asn

Met Asn Asp Leu Thr

Telu

1 50

Gly Asp Arg Val Arg Arg
18O

Pro Met Pro Glu Pro Phe

185

Pro Glin Thr Pro Pro

200

Pro

Arg

Pro Ala Ser G ly

Arg

Pro

235

Pro Pro Arg Thr Arg

250

Lys Ala G lu
260

Ala Glin Glin
275

305

Glin Ala Arg Pro

Gly Arg Pro Asp G ly Ala
3 10

255

Pro Arg Pro Ala Ser
265

Gly Arg

Pro

Asp Gly

27 O

Glu Thr Pro Pro Arg Thr Arg Pro Glin
280
285

Ala Asn Ser Thr Pro P rd Pro Pro Pro
29 O
295
Ser

240

Pro Glin Ala Asn Ser Thr Pro Pro

245
Pro Pro Pro

Ala Glu

Asp Gly Ala Glin Glin Glin Ala Arg

2 30

Pro Glu Thr

Gly

2O5

Thr Arg Pro Glin Ala Asn. Ser Ala Pro Pro Pro Pro Pro
210
215
220

225

Trp

19 O

Tyr Gly Ala G ln Glin Glin Ala Arg
195

160

Ile Arg
175

Glin Wall Phe Asn
170

1.65

Glin Ser Asn

Gly

Gly

Asp

Ala
135

Glu Ala Thr
145

Pro

Asn Wall Ala Ser

Wall Ser Asp S er Lys Gly Lys Met Teu Phe Ser Telu
115
120
125

Telu Ala

Arg

Gly

Leu Lleu. Asn. Glu Arg Glin Glin
55

85

Teu

Arg Ala Ile

Ala Telu Glin Wall Thr Ser Ser Telu Telu Glu
40
45

Gly Gly Gly Arg Phe Asn

Ser Wall Wall

Telu

15

25

35

65

Arg Ala Ala

10

Ala Glu Pro Arg Pro Ala

Glin Glin Glin Ala Arg Pro Glu Thr Pro
315
320
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-continued

Pro Arg Thr Arg Pro Glin Ala Asn
325

Ala Glu Pro

Ser Ala Pro Pro Pro Pro Pro Lys
330
335

Arg Pro Ala Ser Gly Arg Pro Asp Gly Thr Glin
340

345

Ala Arg Pro Glu Thr Pro Pro Arg Thr Arg Pro
355

360

Pro Pro Pro

Pro Pro Lys Ala Glu

370

Pro Ser Ala

375

Ser Thr Ala
385

Glin Glin

35 O

Glin Ala Asn Ser Ala
365

Gly Gly Glu Arg Pro
38O

Arg Pro Asn. Asn. Thr
390

Val Gly Asp Ser Ala Pro Ala Lys
405

Ser Ala Ala
395

400

Pro Pro Wall Lys Pro Leu Tyr
410
415

His Leu Gly Leu Thir Asp Met Ser Val Asp Lieu
420

Asp Ala Ser Ala Arg

425

Glu

Ser Ala Wall
43 O

Ala Tyr Arg Asp Ala Ala Met Lys Asn His Pro Asp Lys Asn Arg Gly
435

Asn Glu Ala
450

4 40

4 45

Glu Ala Ala Glu Arg Phe Lys Val
455

Ile Ser Asn
460

Ala Tyr

Lys Ile Lieu Ser Asp Pro Glu Lieu Arg Lys Ala Tyr Asp Asn Gly Arg
465

470

Ile Asn. Glu

475

480

Ala Gly Asn Arg Ala
485

<210> SEQ ID NO 21
&2 11s LENGTH 864
&212> TYPE DNA

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 21

atgaac atta cgcc.gctoac

ggcaagggct cgtcc.gcaca agg Cacagac
gtggttgaat

120

alaggtgcgta gc gccatcag tgaccacatc cgcaccagoa to gagaaagg gaaactgttc

18O

gagctogcct ccittgggcag caacatgttc ggtgtc.ccgg citctittcago gc gcc cctog

240

aaaattitc.ca titcc.ca actic

cacgc.gcatg atcaatgcc.g

60

cittcaatcaa.

acgcto caac citgtgttggc gtttgaggct gaccc caatc acg acctgaa ccittgtcagg
gtotatatgc aggacagogC cggcaa.gcto acticcictggg accogacgc.c caacg.cggto

360

acgacgacgt. cgaatccatc agagcctgat gcgcagagcg atacggcttic gtoatcatta

420

ccitcgg.cggc citc.ccgcagg citcggtgctg agtttgctogg gcattgcgct ggatcacgc.g

480

caacgc.caca gtoctogcgc ggacaggtot gccalagggiac gacCtggcc.g agaggagagg

540

aacggggcaa. ggttcaatgc caa.gcaaaca aa.gc.cga-cag aggctgaagic citacggtgat

600

catcagacac ccaatcctga tittgcacagg caaaaag aga cagotcaacg cgttgctgaa

660

agcatcaa.ca gCatgc gaga gcago: aaaat ggaatgcaac gcgc.cgalagg gottctoaga

720

gccaaagaag

togggaag CC

agcttctgga cgtgcto gag

gccatcCagg citggcc.gtga agacitccacc gacaagaaga tdagogccac tgaaaagaac

840

gccacgggca toalactacca gtga

864

<210> SEQ ID NO 22
&2 11s LENGTH 2.87
&212> TYPE PRT

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000

US 7,220,583 B2
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170
-continued

<400

SEQUENCE: 22

Met Asn. Ile Thr Pro Leu Thir Ser
1
5

Ala Ala Gly Lys Gly Ser

Gln Gly. Thr Asp Lys Ile Ser Ile

Pro Asn. Ser

10

Thr Arg Met

25

Ala Ala Ser
35

40

His Ile Arg Thr Ser Ile Glu Lys Gly Lys Lieu
55

Leu Gly Ser Asn Met Phe Gly Val
65

70

Thir Leu Glin Pro Wall Leu Ala Phe
85
Asn Lieu Wall

Pro Ala Leu
75

Ser Ala Arg

90

120

Pro Asp Ala Glin Ser Asp Thr Ala
130

Pro Ser

8O

95

105

115

Thr Pro

110

Thir Thr Ser Asn. Pro Ser Glu
125

Ser Ser Ser

135

145

Phe Glu. Leu Ala Ser
60

Glu Ala Asp Pro Asn His Asp Lieu

Trp Asp Pro Thr Pro Asn Ala Wall Th

Pro Ala Gly

Ser Ala Ile Ser Asp
45

Arg Val Tyr Met Glin Asp Ser Ala Gly Lys Lieu
100

Ile Asn

3O

Ile Lys Trp Lieu. Asn Lys Val Arg

5O

Ser Ala
15

Leu Pro Arg Arg Pro
140

Ser Wall Leu Ser Leu
15 O

Leu Gly Ile Ala Lieu. Asp His Ala
155

160

Glin Arg His Ser Pro Arg Ala Asp Arg Ser Ala

Pro Gly

1.65

170

Arg Glu Glu Arg Asn Gly Ala Arg
18O

Thr Glu Ala
195

175

Phe Asn Ala
185

Glu Ala Tyr Gly Asp His Glin Thr
200

His Arg Glin Lys Glu Thr
210

:

Glin

Lys Gln Thr Lys Pro
19 O
Pro Asn. Pro

Asp Lieu

2O5

Arg Val Ala

Glu Ser Ile Asn. Ser
220

Met Arg Glu Gln Gln Asn Gly Met Glin Arg Ala Glu Gly Lieu Leu Arg
225

230

235

Ala Lys Glu Ala Leu Glin Ala Arg
245

Asp Wall Leu

Glu Ala Ala
250

Glu Ala Ile Glin Ala Gly
260
265

240

Arg Lys Glin

255

Arg Glu Asp Ser Thr Asp Lys
27 O

Lys Ile Ser Ala Thr Glu Lys Asn Ala Thr Gly Ile Asn Tyr
275

280

Telu Telu

Glin

285

<210> SEQ ID NO 23
&2 11s LENGTH 429
&212> TYPE DNA

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 23

atgcgcacat cc.gittaatgg totgcttgag cacagoctoga agaCCCtggg citttgatact

60

togg cattgc aggccttgcg Cgacgacggit tatttactgt ggcaaggcaa. ggataag caa

120

gccagtctitc tggttcccitc tactgacggc gacgc.gctitt togctatotg taccttgagc

18O

cgtgtc gatc cc.gagcacga cggacgtotg citggcgcttg cattgcacct galacctgtct

240

cctgtccaca Cgatgagcgc atgtatagoa cittgatgtcg agcaaaacac gttgttgttctt
cgctacacco atgaccttgg Cgggaacggg gcagataccc tgttgcttgc gctcqaaaac

360

gcc.caag.cgc ttgctogaa.ca gatcaagcag gtaatcgaaa actittaggca Cgatc aggga

420

cgc.cgatag

429

US 7,220,583 B2
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172
-continued

<210> SEQ ID NO 24
<211& LENGTH: 142
&212> TYPE PRT

<213> ORGANISM: Pseudomonas syringae pv. tomato
<400

DC3 OOO

SEQUENCE: 24

Met Arg Thr Ser Val Asn Gly Leu Leu Glu His
1

5

Thr Telu
15

Ser Teu

10

Gly Phe Asp Thir Ser Ala Leu Glin Ala Lieu Arg Asp Asp Gly Tyr
2O

Telu

25

Leu Trp Glin Gly Lys Asp Lys Glin Ala Ser Lieu
35

Teu Wall Pro Ser Thr

40

45

Asp Gly Asp Ala Leu Phe Ala Ile Cys Thr Lieu
5O

55

Arg Wall Asp

Pro

60

Glu His Asp Gly Arg Lieu Lleu Ala Lieu Ala Lieu
65

Ser

70

His Teu Asn Telu Ser

75

Pro Val His Thr Met Ser Ala Cys Ile Ala Leu Asp
85

90

Thr Lieu. Cys Lieu Arg Tyr Thr His Asp Leu Gly Gly
100

Wall Glu Glin Asn
95
Asn

105

Gly

Ala Asp

110

Thr Lieu Lleu Lieu Ala Leu Glu Asn Ala Glin Ala Teu Ala Glu Glin Ile
115
120
125

Lys Glin Val Ile Glu Asn. Phe Arg His Asp Glin Gly Arg Arg
130

135

140

<210> SEQ ID NO 25
&2 11s LENGTH 474
&212> TYPE DNA

<213> ORGANISM: Pseudomonas syringae pv. tomato
<400

DC3 OOO

SEQUENCE: 25

atgatcgc.gt togcaa.ccgg actgctagaa cacagotctga aacggcttgg atacgacgc.c

60

gcagatttgc aatcc.citt.cg g gatgaaggg tatttgctgt ggCacgggaa aaacggtoac

120

accagoctot toggtgc.ccgc tigctggcggg gatgcgctitt ttgtcatcag caccctgagc

18O

tacatc gatc ctdaac agga cqggcggctg. citggcgcttg cgctgcattt gaacttgtc.g

240

ccagoccaca citctggg.cgc cagtatc.gcg citggatato.g agcaaaatac cittgttgcctg
gcttgaaag.c

360

actcaggcac ttgcc.gagca gatcaagcag gtcatcgaaa cct tcc.gcag tgaattcgga

420

cgttacacgc acg accitcac toggcacggc acagacaatt

ttag

cgc.ccgc.caa toccc.gc.cca cacago.ccga C ggccagatg

474

<210> SEQ ID NO 26
&2 11s LENGTH 157
&212> TYPE PRT

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 26

Met Ile Ala Phe Ala Thr Gly Leu Leu Glu His
1

5

2O

Glu

25

Leu Trp His Gly Lys Asn Gly His Thr Ser Lieu
35

55

Gly Tyr

Telu

3O
Teu Wall Pro Ala Ala

40

Gly Gly Asp Ala Leu Phe Val Ile Ser Thr Lieu

Telu

15

Gly Tyr Asp Ala Ala Asp Leu Glin Ser Lieu Arg Asp

5O

Arg

Ser Teu

10

45
Ser

60

Tyr Ile Asp

Pro

US 7,220,583 B2
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174
-continued

Glu Glin Asp
65

Gly Arg L. eu
70

Pro Ala His Thir Leu G ly

Thr Telu Cys

Lleu Ala Leu Ala Teu His Teu Asn Telu Ser
75

Ala Ser

Leu Arg Tyr Thr His Asp Lieu
100

Asn Telu Ser

Pro Ala His

Thr

Gly His Gly

105

Arg Ala L. eu

115

Glin Wall
130

Ile Ala Teu Asp Ile Glu Glin Asn
90
95

Glu Ser Thr Glin Ala Teu Ala Glu Glin Ile
120
125

Ile Glu Thr Phe Arg

Ser Glu Phe

Gly Arg

135

140

Thir Ala Arg Arg Pro Asp Ala

Wall Ala Teu
155

145

Thr Asp

110

1 50

Pro Pro Met

SEQ ID NO 27
LENGTH
TYPE

534
DNA

ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400 SEQUENCE: 27

gtgaaaaagt Ctggcgctgg aactcaagcc tatgc gttgt togccitctg.c gacgggaagic

60

togtogaagg gc gttctaag taccattgcc agg caccitga cgg gatgttt tgcacccaac

120

aag actg.cgc ttcattcago aac agcc.gtt togtatgagc tattgcc.ggg

caattattot

18O

gtogcc.gc.ca gtgtgcatgg cittgtcggitt gatcaccgcc agcc.ggcgct gacacgactg

240

agtaacgtgc tgttcaatca ggCactgg.cg citggacct gg agc gttittga C gaggg.cgc.g
ccago.cgacg aaatgttcag gccttcactg aaacg.cgaag gtgcc catcc cc.gattggcc

360

gact cactgg gtggcgagca actggctgtg caaac catgg aga agggcct taaacggctg

420

gCagaggatc citgcgcagtc citttgcgc.ga tgccattcat

480

gataccactt caccitcaa.gc

atcactitcait

titttittacco

gatcagtagt

totgtgg.cga gct catctgg citga

534

SEQ ID NO 28
LENGTH
TYPE

177
PRT

ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400 SEQUENCE: 28

Wall Lys Lys Ser
1
Ala Thr

Gly

Gly Ala Gly Thr
5

Ser Ser S er

Lys Gly

2O
Teu Thr

Wall Leu Ser Thr Ile Ala Arg His
25

Gly Cys Phe Ala Pro Asn Lys Thr
35

40

Ala Wall Ser
5O

Tyr Glu L eu

Gly

Leu Ser W al

Wall His
65

Glin Ala Tyr Ala Teu Phe Ala Ser
10
15

Lleu Pro

Ala Teu His Ser Ala Thr
45

Gly Asn Tyr

55

60

Asp His Arg Glin

70

Pro Ala Teu Thr

85

100

Ala
115

Teu Glu

Telu

Arg Phe
95

Arg

Pro Ser Telu

105

His Pro Arg Lieu Ala Asp Ser

Ala Wall Glin Thr Met G lu Lys
130
135

Asp

90

Asp Glu Gly Ala Pro Ala Asp Glu Met Phe Arg

Gly

Arg

75

Ser Asn Wall Leu Phe Asn Glin Ala Leu Ala Teu

Glu

Ser Wall Ala Ala Ser

110
Teu

Gly Gly

120

Gly Lieu Lys Arg

Glu Glin Telu

125
Teu Ala Glu

140

Asp

Pro

US 7,220,583 B2
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178
-continued

Ser Gly Val Leu Ser Pro Arg Phe Asp Val Met Gly Ser Val Gly Trp
100

105

110

Asn Ala Ala
115

Ala Ile Arg Ala Thr Ser Arg Val Gly Thr Leu Arg Glu

Lys Gly Thr

Leu Phe Thr Asn Lieu Met Leu Ser Asn Asn. Phe
135
140

130

120

125

Lys His

Leu Lleu Lys Arg Val Val Asn Asp Pro Ala Leu Glin Gln Lys Lieu. Asp
145

15 O

155

160

Gly Gly Lieu Asp Lieu. Asn Tyr Lieu Lys Ala Cys Glu Gly Asp Leu Tyr
1.65

Wal Met Ser

170

Gly Trp Ala Ala Arg
18O

Gly Lys Ala Arg Tyr Glu Thr Ala
195

175

Ala Ser Glu
185

2O5

Ser Ala Arg Glu Lieu Ala Phe His Arg His Asn
215

Ser Ala Glin
225

Glin Ile

19 O

Ser Asn Lieu Ser Glin Thr Lieu. Ile

200

210

Ser Arg Glu

Thr Lys Val Gly Phe Asp Lys Gly
230

235

Pro Wall Asn His Pro
220
Leu Pro Glu Glu Ser
240

Asp Leu Glin Wall Leu Arg Gly His Gly Ser Ser Val Trp Ser Wall Lys
245

250

255

Ala Glu Wall
265

Ser Gly Lys

Ile Ala Gly Pro Ser Gly Thr Ala Ser Arg Met

Wall Ala Wall
285

Pro Gly Ser Asp Phe Ala Lys Arg
260

275

280

Phe Leu Ala
29 O

Pro Ala Cys Lieu Lys Ser Lieu Gly
295

Pro Ile

27 O

Ala Arg

Ile Glu Ser Glu Glin
3OO

Asn Lieu Lys Glu Lieu Val Arg Tyr Ala Cys Tyr Ala Tyr Phe Gly Glin
305

310

Asp Ser His

315

320

His Ser Met Leu Glu Wall Asn Lieu

Gly Val Ala Ser His

325

330

Gly Met Pro Glu Gln Trp Asp Asp Thr Leu Tyr
340

345

Asn Ser Ile
355

Lys Gly Arg Gly Phe Gly Ile Asp

Glin Wal Wall
370

Arg Glin Ala Ala Glin Lys Ser

360

335

Asn Glu Pro Phe Ser
35 O
Asn Lieu Ala
365

His Arg

375

<210> SEQ ID NO 31
&2 11s LENGTH 1173
&212> TYPE DNA
<213> ORGANISM: Pseudomonas

<400

syringae pv. tomato DC3000

SEQUENCE: 31

atgcggtttg atgctg.ccc.g aggCC agaag cc caaag.ccc citatggatgc accgtcatca

60

ttacgtttgc gag.cgatago aggtgcatg cc.cagtgaag aag Caggaac gactgcacct

120

gctgacgtga atcagoctoc acctgctgat gttcgtocag aaatgggtot aggtoctdtg

18O

agacitctt.cg ttaaactgat ggtaggaact citggcgctdt C gaCaggagt cc.gttittgca

240

agatacccag gtgattitcgc gaaggatc.cg ggagg cagtg tatgggcago aatcaatctg
cago atc.gct cgagcgtolac acatcttgaa caaggcaata agacggttct tgagc gtttc

360

ggtgcacata titccaaaaga cagtgcgtgt ttcaaagcto gc gctgacgt. cacacac gat

420

gttcccitcag gCgtgg Cagg gCagtggaac

aacgggtaaa actgaaccot

480

to gaga.gc.ca to C gg cacag gtogc.cggac atgagttcat acactgttac

540

aa.cattcatt

CaCaaaa.. CCC

US 7,220, 583 B2
179

180
-continued

acgcatcc to agtttgtcga acgc.catata aaa.catcc.gc actggaaag.c cctgaac gala

600

gggttgacga. citcgtttgac agagaaactg cca gacccta ag.cgtctott gcc cattccc

660

ttggcaaagg

720

atc.ccitat.ca

tggtttcaag citgtccaccg ggg acto citg gcc.ggatgcg

gcCagg cqaa togaagacga agttggcgaa gatgttgttgt tgaaag.cgtt citttggcggc

gatgacCagg citattagtga agtagctaaa gcc.gctgcto agatctaccc caagattgcc

840

toacgtatta CC gagaggga gttgttatcaa gCggg cagoa tgcgtggagg acaac agctg

9 OO

gcc.gagtgtt acgtaggtgc tittgctcaaa aacggtoaga aactgcctda cagttttacg

96.O

aattatctg.c tacctgitatt tagctattoa gatataagcc citggtoacgc gaaaaaaata

1020

Caggcgcaag Cggaaaaaag totaaaag.cgg atgggaattg tgttctgatac ag.cgttttitt

1080

to acct gacc tgaag accoa gag actggca cittgg catgc tacgggagga cctgctgatg

1140

cactggaaaa aagttattoc ggatagaaag

1173

taa

<210> SEQ ID NO 32
&2 11s LENGTH 390
&212> TYPE PRT
<213> ORGANISM: Pseudomonas

<400

syringae pv. tomato DC3000

SEQUENCE: 32

Met Arg Phe Asp Ala Ala Arg Gly Gln Lys Pro Lys Ala Pro Met Asp
1

5

10

15

Ala Pro Ser Ser Leu Arg Lieu Arg Ala Ile Ala
25
Glu Glu Ala
35

Gly. Thir Thr Ala Pro Ala Asp Wall
40

Gly Gly Met
3O

Asn Glin Pro Pro Pro
45

Ala Asp Wal Arg Pro Glu Met Gly Val Gly Pro Val Arg Lieu
5O

55

Pro Ser

Phe Wall

60

Lys Lieu Met Val Gly. Thir Leu Ala Leu Ser Thr Gly Val Arg Phe Ala
65

70

75

8O

Arg Tyr Pro Gly Asp Phe Ala Lys Asp Pro Gly Gly Ser Val Trp Ala
85

Ala Ile Asn

90

Leu Gln His Arg Ser
100

95

Ser Wall Thr His Leu Glu
105
110

Glin Gly

Asn Lys Thr Val Leu Glu Arg Phe Gly Ala His Ile Pro Lys Asp Ser
115

120

125

Ala Cys Phe Lys Ala Arg Ala Asp Wall Thr His Asp Val Pro Ser Gly
130

135

140

Val Ala Gly Gln Trp Asn His Lys Thr Glin Arg Wall Lys Lieu
145

15 O

Asn. Pro

155

Asn. Ile His Phe Glu Ser His Pro Ala Glin Wall
1.65

160

Ala Gly His

170

Ile His Cys Tyr Thr His Pro Glu
18O

Phe Wall Glu
185

Arg His Ile Lys His
19 O

Pro His Trp Lys Ala Lieu. Asn. Glu Gly Leu Thr Thr Arg Lieu
195

Glu Phe
175

200

Thr Glu

2O5

Lys Lieu Pro Asp Pro Lys Arg Lieu Leu Pro Ile Pro Leu Ala
210

215

220

Pro Tyr His Gly Phe Lys Lieu Ser Thr Gly Asp Ser Trp Pro Asp Ala
225

230

235

Ala Arg Arg Ile Glu Asp Glu Val Gly Glu Asp
245

250

240

Wall Leu Lieu

Lys Ala
255

US 7,220,583 B2
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Phe Phe Gly Gly Asp Asp Glin Ala

Ile Ser Glu
265

260

Ala Glin Ile
275

Val Ala Lys

Ala Ala

27 O

Tyr Pro Lys Ile Ala Ser Arg Ile Thr Glu Arg
280

Tyr Glin Ala Gly Ser Met Arg Gly Gly Glin Glin
29 O

295

Leu Ala Glu
3OO

Val Gly Ala Lieu Lleu Lys Asn Gly Gln Lys Lieu Pro Asp Ser
305

3 10

Asn Tyr Lieu

315

Phe Thr
320

Tyr Ser Asp Ile Ser Pro Gly His

Leu Pro W al Phe Ser

325

Ala Lys Lys

Glu Lieu

285

330

Ile Glin Ala Glin Ala Glu
340
345

335

Lys Ser Glin Lys Arg Met Gly
35 O

Ile Wall Phe
355

Asp Thr Ala Phe Phe Ser Pro Asp Leu Lys Thr Glin Arg

Leu Ala Leu
370

Gly Met L eu Arg Glu Asp Leu Lieu Met His Trp

360

365

375

38O

Wall Ile Pro Asp Arg Lys
385
3 90

<210

SEQ ID NO 33

&2 11s LENGTH 474
&212> TYPE DNA

<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000
<400

SEQUENCE: 33

atgaac aggc ttcacaagac Cagtctgctg gcq gotatat tgaccgcatc ccc.ctgcatt

60

atgg cagota acgcto atgc tatgagttgt cctgtc.ccgc aaag.cgtgaa gtacgittaat

120

ggitatctata togcgc.cgga aacgtttgct ggttgggagg ggalactgggit

ttcticalacca

18O

cacaagaaac actic cattaa. agagtttitcc actgcttitat atctittcagt ggataaaagt

240

Cagaagggag galacattgac taact gtagt tattoactaa gCggagataa tgg.cgtaata

gatcttgagt atcgaaaatc aggaaatgag aatagacitaa agacactitat cgttitccatt

360

galaggtoagc acaattggat taaagagcigt ggcgcggttg gaattcaagg atatgaatgt

420

acaaagttcag catctgagtg tdagttctgtt

474

taaacgagga citga

<210> SEQ ID NO 34
&2 11s LENGTH 157
&212> TYPE PRT
<213> ORGANISM: Pseudomonas

<400

syringae pv. tomato DC3000

SEQUENCE: 34

Met Asn Arg Leu. His Lys Thr Ser Leu Lleu Ala Ala Ile Leu Thr Ala
1

5

10

15

Ser Pro Cys Ile Met Ala Ala Asn Ala His Ala Met Ser Cys Pro Wall
25

Pro Glin Ser
35

Val Lys Tyr Val Asn Gly Ile Tyr
40

Phe Ala Gly Trp Glu G ly Asn Trp
5O

Ser Ile Lys
65

Wal Ser Glin

55

Ile Ala Pro Glu Thr
45

Pro His Lys Lys His
60

Glu Phe S er Thr Ala Leu Tyr Lieu
70
75

Glin Lys Gly Gly. Thir L eu.

3O

Thir Asn

Ser Val Asp Lys Ser
8O
Ser Leu Ser

85

Gly Asp
95

Asn Gly Val Ile Asp L. eu Glu Tyr Arg Lys Ser Gly Asn. Glu Asn Arg
100

105

110

